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Abstract 
The intestinal hormone Fibroblast Growth Factor 19 (FGF19, rodent homologue FGF15) 
has recently been linked to both positive and negative health outcomes. The expression of 
FGF15/19 is regulated by the bile acid-sensing transcription factor farnesoid X receptor 
in the ileum. After its production, this enterokine travels to the liver where it blocks de 
novo bile acid production via CYP7A1. Circulating FGF15/19 levels are known to rise 
postprandially which can influence both blood cholesterol and glucose levels. However, 
the influence of dietary patterns on the regulation of FGF15/19 expression is largely 
unknown.  
 
In this thesis, dietary regulation of FGF15 is explored in rodent studies. Mice fed a high 
starch (HS) diet showed increased expression of FGF15 compared to mice fed a chow 
control diet.  The importance of starch digestion was confirmed by acarbose treatment, 
which inhibited both starch digestion and FGF15 expression. Further, increased glucose 
in the ileum was shown to induce the expression of FGF15. Importantly, this regulation 
was found to be independent of the microbiota. In addition, in mice fed HS diets 
supplemented with soluble fibres, FGF15 expression was suppressed. This latter effect 
may also contribute to the known cholesterol-lowering effects of soluble fibres.   
While the HS diet induced the expression of FGF15, this work highlights the long-term 
negative health effects of such a diet, showing dysregulation of the gut-liver axis in our 
mouse model that eventually led to increases in cell proliferation, and, in some mice, the 
development of hepatic carcinoma. Reducing HS diets in a caloric restriction (CR) model 
counteracted these negative health effects and in the long term downregulated the 
expression of FGF15. Decreased FGF15 expression correlated with a reduction in ileal 
bile acids in the CR model.  
 
In conclusion, we showed that increased luminal glucose reaching the ileum, consumption 
of soluble fibre, and long-term CR influenced the expression of the important gut-hormone 
FGF15. This influence on its regulation may influence gut-liver health with a profound 
impact on systemic bile acids and cholesterol levels.  
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1.1 The small intestine 
The small intestine is the longest part of the gastrointestinal (GI) tract and can roughly be 
divided in three parts; duodenum, jejunum and ileum. Enterocytes along the length of the 
small intestine have specialized functions dictated by their position (Welcome 2018). 
Enterocytes in the duodenum are specialized towards digestive processes, which is 
supported by digestive enzymes secreted from the pancreas and bile acids from the 
gallbladder and liver (Stuart 2011). Additionally, initial absorption of glucose starts via 
the action of enterocytes in the duodenum (Rolston 1999). In the jejunum, enterocytes are 
specialized in the uptake of nutrients, with the bulk of the absorption of dietary fat, 
carbohydrates and amino acids also taking place in this anatomical region. More towards 
the latter part of the small intestine, in the ileum, vitamin B12 and bile acids are absorbed 
via the enterocytes (Stuart 2011; Davis and Attie 2008). Importantly, food digestion 
mostly takes place in the duodenum and upper jejunum, exposing the intestine to a high 
concentration of monomeric nutrients, like mono-saccharides, fatty acid and amino acids 
(Stuart 2011). The different specializations of the enterocytes along the tract of the small 
intestine reveals its complexity and highly regulatory nature. Relevantly, the regulation of 
differentiation between jejunal and ileal enterocytes has been linked to the expression of 
the transcription factor GATA4. When GATA4 was expressed in ileal enterocytes they 
lost their the expression of genes involved in bile acid metabolism, which are an important 
identifier of ileal enterocytes (Thompson et al. 2017).   
 
1.1.1 Intestinal epithelial cells 
Intestinal epithelial cells are ordered into crypts (crypts of Lieberkühn) and villi. The 
complete intestinal epithelium is replaced every few days and this process is driven by the 
functions of multipotent intestinal stem cells that arise from the intestinal crypts. (Li and 
Clevers 2010). Active stem cells in the lower part of small intestinal crypts can be 
identified by the expression of LGR5 (Barker et al. 2007) and produce two mature cell 
lineages: absorptive cells (enterocytes) and secretory cells (Paneth, goblet, 
enteroendocrine and tuft cells). The most abundant cell type in the small intestine villi are 
the enterocytes which are responsible for nutrient and bile acid absorption and metabolism 
and hormone production (Bowcutt et al. 2014; Hou et al. 2017). The secretory cell types 
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are located throughout the crypt villus’ structure. At the base of the crypts, Paneth cells 
secrete antimicrobial peptides and proteins that are essential for host-microbe interactions. 
Paneth cell markers include lysozyme LYZ1 and LYZ2 (Clevers and Bevins 2013). Goblet 
cells produce mucus and thereby are responsible for the single layer of mucus that lines 
the small intestine. The dominant gene responsible for mucus production in goblet cells in 
the small intestine is MUC2 (Birchenough et al. 2015). Enteroendocrine cells comprise 
over 10 different cell types that produce distinct hormones, such as glucagon like peptide 
1 (GLP-1), serotonin and secretin. Enteroendocrine cells can be identified by the 
expression of the tight junction protein claudin-4 (CLDN4) (Nagatake et al. 2014). Tuft 
cells have a chemosensory function and are the sole producers of the cytokine IL-25 in 
small intestinal cells. In healthy conditions tufts cells account for <1% of all cells in the 
small intestine, however, this can increase to 15% during infection (von Moltke et al. 
2015). Taken together, all these specialized small intestinal cells form a monolayer of 
epithelium that cover the entire small intestine providing physiological support and 
protection for the host. In addition to this monolayer the small intestine host a large amount 
of immune cells, mostly present in the lamina propria located below the IEC monolayer, 
including macrophages, dendritic cells and T-cells (Mowat and Agace 2014).    
 
1.1.2 Intestinal barrier function 
The small intestine is essential for the absorption of nutrients, but also acts as a barrier 
between the food consumed and the internal organs. The intestine is among the first organs 
to be exposed to external components we consume. Further, the intestinal barrier function 
is crucial in the symbiotic relationship with the gut microbiota. Loss of intestinal barrier 
function has been linked to GI diseases such as inflammatory bowel disease (IBD), but 
also to a number of extra-intestinal autoimmune and inflammatory diseases including 
multiple sclerosis and type 1 diabetes (Peterson and Artis 2014). The IECs are protected 
by the mucous layer and form a physical barrier between the lumen of the GI tract and the 
host. Adjacent IECs are connected by tight junctions, which are built up by transmembrane 
proteins such as occludins and claudins and cytosolic scaffold proteins like zonula 
occludins (Bischoff et al. 2014). Although most literature on intestinal permeability 
focusses on the colon, small intestinal permeability is increasingly attracting more interest. 
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For example, small intestinal permeability has been shown to be increased in humans 
diagnosed with non-alcoholic fatty liver disease (NAFLD) (Miele et al. 2009; Kwak et al. 
2014).  In the small intestinal epithelium, there is the added challenge of having a high 
cell turnover; this leads to consistent apoptotic and live cell extrusion which occurs to help 
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1.2 The gut microbiota 
The microorganisms living in our GI tract, collectively called the microbiota, have been 
studied extensively, with over 12,900 papers published in the last five years (Cani 2018). 
While the microbiota is present throughout the gut and consists of bacteria, archaea, 
viruses, phages, yeast and fungi, the majority of these publications focused on bacterial 
differences in the colon and faeces. Changes in the intestinal microbiota have been linked 
to a large variety of metabolic diseases including obesity and diabetes (reviewed in 
(Janssen and Kersten 2015)).  
 
Bacteria in the gut can influence host health via a variety of mechanisms, most importantly 
via their interaction with host cells and their secreted metabolites. Bacteria interaction with 
host cells initially occurs with cells of innate immune system via pattern recognition 
receptors (PRRs) like toll-like receptors (TLRs). These receptors can recognise pathogen-
associated molecular patterns (PAMPs) from microorganisms, for example 
lipopolysaccharide (LPS) derived most prominently from gram-negative species and can 
induce immune responses. Upon recognition of PAMPs by PRRs on immune cells, 
immunoregulatory signals are transduced to the large body of immune cells present in the 
lamina propria (Mowat and Agace 2014). Importantly, bacterial interaction with host cells 
(and consequent immunomodulatory responses) is a two way interaction; the innate 
immune system can respond to bacteria by initiating the immune response, however, the 
gut microbiota can also have an effect on GI immune system regulation which can depend 
on microbial composition (Hooper and Macpherson 2010). This interaction between host 
and microbes alters not only the immune response but also host metabolism. For example, 
LPS, has been shown to be linked to increase weight gain and insulin resistance 
development on a high fat (HF) diet (Everard et al. 2014). Additionally, increased 
circulating levels of LPS have been identified in obesity and diabetic patients (Lassenius 
et al. 2011; Pussinen et al. 2011) and small intestinal infusions of obese subjects with the 
microbiota of a lean donor has shown to increase insulin sensitivity (Vrieze et al. 2012).  
 
Outside their direct interaction with host cells, the microbiota also produces metabolites 
that can alter the wellbeing of the host. The large variety of metabolites produced by the 
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gut microbiota include secondary bile acids, trimethylamine-N-oxide (TMAO), 
neurotransmitters and short chain fatty acids (SCFAs). As an example of a metabolite that 
negatively influences host health, TMAO has been shown to be produced from choline 
and L-carnitine after conversion by both the gut microbiota and hepatic enzymes and has 
been linked to an increased risk of atherosclerosis (Koeth et al. 2013). Conversely, the 
production of SCFAs (acetate, propionate and butyrate) from non-digestible 
carbohydrates by the microbiota has been linked to a number of positive health effects 
(Makki et al. 2018). Additionally, the SCFA butyrate has long been known as an important 
energy source for colonocytes, however recently it has been shown that butyrate can also 
influence oxygen consumption in the colon and thereby protect against the colonization 
of potentially pathogenic bacteria (Byndloss et al. 2017; Cani 2017).  
 
Despite the large number of publications surrounding the gut microbiota, and the 
enormous progress made in the last years, a large part of the current evidence is correlative 
and additional research will be required in the coming years to establish causal effects 
(Cani 2018).   
 
1.2.1 The small intestinal microbiota  
The majority of scientific publications have focused on the microbiota in the colon and in 
excreted faeces which is mostly due to the ease and accessibility of these materials in 
humans. However, the major drawback of using faecal samples for microbiota analysis is 
that it only represents the excreted microbiota, leaving a large part of the microbiota 
unexplored. In more recent studies, the small intestinal microbiota has been explored and 
has been shown to be of importance for host health (El Aidy, van den Bogert, and 
Kleerebezem 2015). Comparatively with microbial populations in the colon, the 
microbiota in the small intestine is lower in both numbers and diversity and is closer in 
proximity to the host epithelium (and thereby underlying immune cells). The latter is due 
to a single thin mucus layer found in the small intestine (Mowat and Agace 2014) 
compared to the large intestine which comprises a thick mucus layer where bacteria reside 
at relatively further distances from host epithelial tissue. Importantly, close contact 
between the bacteria and the small intestine is limited by antimicrobial factors produced 
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by Paneth cells, such as defensins and REGIIIg (Moran, Sheehan, and Shanahan 2015; 
Mowat and Agace 2014). Zoetendal et al (Zoetendal et al. 2012) used healthy ileostomists 
patients that had their colon removed for over 20 years to study the small intestinal 
microbiota. They found that there is a decrease in diversity and an increase in carbohydrate 
metabolizing bacteria in the small intestinal microbiota compared to the colonic 
microbiota (Zoetendal et al. 2012). Additionally, the small intestinal microbiota fluctuates 
far more compared to the relatively stable faecal microbiota, most likely in response to 
dietary variation (Booijink et al. 2010).    
 
Small intestinal bacterial overgrowth 
Although the small intestine is not as sterile as has long been believed, an overgrowth of 
bacteria in the small intestine is still considered pathogenic. The most commonly 
described definition for small intestinal bacterial overgrowth (SIBO) is a concentration of 
105 or more colony forming units per millilitre (CFU/mL) of bacteria grown from a small 
intestinal aspirate (Khoshini et al. 2008). The prevalence of SIBO in the general 
population is unknown, but is estimated at 0-20% of the otherwise healthy population 
(Grace et al. 2013). The incidence of SIBO in both intestinal and liver disease has been 
found to be much higher. For example, great interest has been shown in the role of SIBO 
in irritable bowel syndrome, with SIBO incidences up to 80% (Aziz, Törnblom, and 
Simrén 2017). Additionally, a similar link is found between SIBO and non-alcoholic 
steatohepatitis (NASH) (Ferolla et al. 2014). However, more reliable and robust tests to 
diagnose SIBO are needed to progress the research in this area (Grace et al. 2013).   
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1.3 Liver biology 
The liver is the largest internal organ and is essential for a large number of metabolic 
activities, detoxification and nutrient storage (Robinson, Harmon, and O’Farrelly 2016). 
After this well-regulated absorption of nutrients in the SI, amino acids and carbohydrates 
are further metabolised in the liver. Where most nutrients are directly transported from the 
intestine to the liver after absorption, dietary fat bypasses the liver via the lymphatic 
system. Chylomicrons, produced and secreted by enterocytes into the lymph are exposed 
to other organs, like the heart and adipose tissue, before chylomicron remnants are taken 
up by the liver (Whitney and Rolfes 2008). However, most nutrients and other diet-derived 
components are directly transported to the liver via the portal vein (Welcome 2018). In 
order to maintain homeostasis, the liver and intestine both need to establish a bidirectional 
communication. Although rather complex, this communication is believed to primarily 
occur through signalling molecules produced by these organs and the microbiota living in 
the intestine. Bile acids play an important role in this enterohepatic communication (see 
chapter 1.4) (Kuipers, Bloks, and Groen 2014). Dietary chronic overloading of the 
intestine can disturb this enterohepatic communication, which might be an early cause of 
the metabolic syndrome and its hepatic manifestation, NAFLD (De Wit et al. 2012).  
 
1.3.1 NAFLD 
NAFLD, a co-morbidity of obesity and insulin insensitivity, is the most common hepatic 
disorder in Western countries and some Asian countries (Fan, Kim, and Wong 2017). At 
present 20-25% of people in the UK, and over 90% of obese individuals, have NAFLD. 
NAFLD has emerged as a common risk factor for heart disease, stroke and type two 
diabetes. If untreated, the milder form of NAFLD will lead to NASH, and in 20% of NASH 
cases (250,000 current cases) to eventual cirrhosis and liver cancer. Currently, there are 
no licensed drugs to treat NAFLD/NASH and the only effective treatment includes 
lifestyle changes (Nascimbeni et al. 2013). Therefore, the identification of an efficacious 
and affordable strategy for NAFLD management would be of relevance and benefit to a 
large and ever-increasing proportion of the UK population (British society of 
Gastroenterology, www.bsg.org.uk). 
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Dietary interventions have been put forward in the prevention and cure of NAFLD 
(Roman et al. 2015), for example a carbohydrate-restricted diet has been shown to improve 
localised fat metabolism in the liver in NAFLD patients (Mardinoglu et al. 2018). 
 
1.4 Bile acids 
Bile acids undergo enterohepatic circulation, forming a direct link between the liver and 
the intestine. Bile acids are natural occurring detergents that play an essential role in the 
digestion and uptake of dietary fat and fat-soluble vitamins. Bile acids are produced from 
cholesterol in the liver, conjugated to either taurine or glycine and excreted into the 
duodenal part of the small intestine. Bile acids have both a hydrophobic and a hydrophilic 
side which leads to spontaneous micelle formation in aqueous solution. In the lumen of 
the small intestine, in aqueous solution, Bile acids micelles mix with lipid products 
resulting from digestion to form mix micelles and subsequently enhance absorption. After 
most dietary fat is absorbed, around 95% of all bile acids are reabsorbed in the ileum. 
These bile acids are consequently transported back to the liver via the portal vein, closing 
the enterohepatic circulation (Schaap, Trauner, and Jansen 2014). 
 
1.4.1 Bile acid metabolism in the liver  
In the liver, where bile acids are produced, cholesterol 7 alpha-hydroxylase (CYP7A1) is 
the rate limiting enzyme in bile acid synthesis. An alternative pathway for bile acid 
synthesis is via sterol 27-hydroxylase (CYP27A1). Lastly, sterol 12-alpha-hydroxylase 
(CYP8B1) catalyses the last step in the conversion of cholesterol in cholic acid (CA). 
Thereby CYP8B1 plays an important role in balance of the two primary bile acids, CA 
and chenodeoxycholic acid (CDCA). In mice, a shift towards more CDCA leads to an 
increased production of muricholic acids (MCAs) (Kuipers, Bloks, and Groen 2014). In 
the small intestine, bile acids can be further metabolised by the gut microbiota, creating 
secondary bile acids, which is discussed in more detail in chapter 1.4.4. For an overview 
of the primary and secondary bile acids present in mice and man see table 1.1.  
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Table 1.1 Overview of bile acids present in the enterohepatic circulation of mice and humans. Colour 
coding indicates conjugation, white being tauro-conjugated, light grey being glyco-conjugated and dark grey 








T-a-MCA Tauro-α-muricholic acid Primary Mouse only 
T-b-MCA Tauro-β-muricholic acid Primary Mouse only 
TCA Taurocholic acid Primary Both (more in mouse) 
TCDCA Taurochenodeoxycholic acid Primary Both (more in mouse) 
TDCA taurodeoxycholic acid Secondary Both (more in mouse) 
TLCA taurolithocholic acid Secondary Both (more in mouse) 
GCA Glycocholic acid Primary Both (more in humans) 
GCDCA Glycochenodeoxycholic acid Primary Both (more in humans) 
GDCA glycodeoxycholic acid Secondary Both (more in humans) 
GLCA glycolithocholic acid Secondary Both (more in humans) 
a-MCA α-Muricholic acid Primary Mouse only 
b-MCA β-Muricholic acid Primary Mouse only 
CA Cholic acid Primary Both 
CDCA Chenodeoxycholic acid Primary Both 
DCA deoxycholic acid Secondary Both 
UDCA Ursodeoxycholic acid Secondary Both 
LCA Lithocholic acid Secondary Both 
-MCA -Muricholic acid Secondary Mouse only 
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In addition to the differences in bile acid pools between mice and humans, consisting of 
mostly hydrophobic bile acids in mice and more hydrophobic bile acids in humans, 
regulation of bile acid synthesis from the precursor cholesterol also differs (Chiang 2009). 
In rodents, the proximal promotor of the CYP7A1 gene binds the oxysterol activated liver 
X receptor (LXRα) while this binding does not exist in humans (Janowski et al. 1996).  
This binding leads to an increase in bile acid synthesis in mice on a high cholesterol diet, 
which could not be observed in LXR knockout mice (Peet et al. 1998). Further 
confirmation was found in transgenic mice carrying the human CYP7A1 gene, which did 
not show an increase in bile acid excretion in response to a high cholesterol diet (Chen et 
al. 2002). Taken together, this indicates different regulation of bile acids synthesis 
between mice and humans and a stronger influence of the cholesterol content of the diet 
on bile acid metabolism in mice. It is important to keep this in mind during the 
interpretation of bile acid differences observed in mouse studies.  
 
1.4.2 Bile acid metabolism in the ileum 
Reabsorption of bile acids in the ileum is largely the consequence of active uptake of bile 
acids via the apical sodium dependent bile acid transporter (ASBT). In ileal enterocytes, 
bile acids are sensed by the transcription factor farnesoid X receptor (FXR). FXR regulates 
the expression of genes that play a role in intracellular transport of bile acids (fatty acid 
binding protein 6 (FABP6)) and genes that regulate the transport of these bile acids into 
the bloodstream (Organic solute transporter alpha/ beta ( OSTα/β)) (Dawson and Karpen 
2015; Thomas et al. 2010). Furthermore, in 2005 it has been shown that FXR induces the 
expression of the signalling molecule fibroblast growth factor 19 (FGF19, with Fgf15 
being the homologue in mice) (Inagaki et al. 2005). FGF15/19 travels in the bloodstream 
to the liver where it binds to fibroblast growth factor receptor 4 (FGFR4) and via a cascade 
of reactions blocks the expression of CYP7A1, the rate limiting enzyme in de novo bile 
acid synthesis (Inagaki et al. 2005; T. Li and Chiang 2015). Additionally, re-absorbed bile 
salts that reach the liver activate hepatic FXR and block CYP7A1 via small heterodimer 
partner (SHP). For a basic overview of enterohepatic bile acid metabolism, please see 
figure 1.1.    
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Figure 1.1 Simplistic overview of bile acid metabolism in the liver and small intestine. Upper figure 
(chemical structures) is adapted from (Kuipers, Bloks, and Groen 2014). Bile acids are produced from 
cholesterol in the liver and excreted into the duodenal part of the small intestine. Here they play an essential 
role in the uptake of dietary fat and fat-soluble vitamins. In the ileum, bile acids are reabsorbed and activate 
the bile acid sensing transcription factor Farnesoid X Receptor (FXR). FXR induces the expression of 
fibroblast growth factor 15/19 (FGF15/19) which travels to the liver via the portal vein and inhibits the rate 
limiting enzyme in de novo bile acid synthesis: Cholesterol 7 alpha-hydroxylase (CYP7A1). (FA= fatty 
acid, ASBT= apical sodium dependent bile acid transporter, OSTα/= Organic solute transporter alpha/beta) 
Synthetic activation of FXR by GW4064 gives opposing results depending on its route of 
administration. If GW4064 is given via an IP injection, the activation of FXR is protective 
against diet induced obesity (DIO) and the development of NAFLD (Ma et al. 2013; Zhang 
et al. 2006). However, if GW4064 is given orally it increases DIO and hepatic triglycerides 
(TG) accumulation (Watanabe et al. 2011). This indicates that intestinal FXR activation 
provokes differential effects in comparison with hepatic FXR activation. In line with this, 
intestinal specific FXR knockout mice are protected against NAFLD on a 1% cholesterol 
diet in contrast to hepatic FXR knockout mice (Schmitt et al. 2014). Jiang et al even found 
that intestinal specific FXR knockout mice are less prone to develop NAFLD on a HF diet, 
most likely due to a reduction in circulating ceramides (Jiang et al. 2015). Contrastingly, 
intestine-specific FXR agonist fexaramine reduces DIO and insulin resistance while 
promoting browning of white adipose tissue. Intestinal FXR activation leads to a large 
increase in FGF19/15 expression and thereby alters the bile acids composition, possibly 
in a way that might explain these positive findings (Fang et al. 2015). In conclusion, 
although molecular mechanisms are partly unknown, FXR signalling in both the small 
intestine and the liver has strong implications for enterohepatic health. 
   
The importance of bile salt and FXR metabolism has recently been emphasized in bariatric 
surgery research (Penney et al. 2015). In bariatric surgery, positive metabolic changes 
occur even before weight loss. It is also known that bariatric surgery increases circulating 
bile salts (Myronovych et al. 2014). Recently, a study by Ryan et al (Ryan et al. 2014) 
showed that the beneficial effects of vertical sleeve gastrectomy (VSG) surgery are FXR 
dependent. FXR knockout mice regain weight within 8 weeks after the surgery and lose 
glycaemic improvement. Unfortunately, whole body FXR knockout mice were used in 
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this study, so it is impossible to distinguish between intestinal and hepatic FXR (Ryan et 
al. 2014). 
 
1.4.3 Bile acid metabolism in the rest of the body 
Besides activating FXR, bile salts are also capable of activating TGR5, a G-protein 
coupled receptor that is expressed throughout the body (Yuanyuan Li, Jadhav, and Zhang 
2013). In mice, bile acids activate TGR5 in brown adipose tissue leading to increased 
energy expenditure (Watanabe et al. 2006). In humans, TGR5 expression in subcutaneous 
adipose tissue correlates with resting metabolic rate (Svensson et al. 2013). Recently, 
Ullmer et al found that TGR5 activation leads to an increase in the gut derived hormones 
PYY and GLP-1 and exerts positive effects on glucose tolerance (Ullmer et al. 2013). This 
indicated that changes in bile acids and bile acid metabolism could provoke health effects 
beyond enterohepatic health. 
 
1.4.4 Bile acids and the microbiota 
There is a two-way interaction between the gut microbiota and bile acids. First, bile acids 
exert antimicrobial properties, with some bacterial species being more prone to these 
effects than other. Bile acid feeding increases the amount of Firmicutes while decreasing 
the amount of Bacteroides, a similar pattern as is observed after the consumption of a high 
fat diet (Murphy, Velazquez, and Herbert 2015). Second, bacteria are capable of 
deconjugating and altering the structure of bile acids, forming secondary bile acids (Ridlon 
et al. 2014). The enzyme bile salt hydrolase (BSH) is responsible for the conversion of 
primary bile salts (as produced by the liver) into secondary. BSH is a unique enzyme of 
the gut microbiota and is distributed across the major bacterial species in the gut (Jones et 
al. 2008). While most bile salts are FXR agonists, the primary bile salt Tauro-beta-
muricholic acid (T-β-MCA) is an FXR antagonist. Due to the lack of intestinal bacteria, 
no BSH is present in germ free mice. Consequently, T-β-MCA cannot be deconjugated 
and reaches the ileum where it blocks FXR. This results in reduced expression of Fgf15 
and an increase in bile acid synthesis in the liver (Sayin et al. 2013a). Administrating BSH 
to germ free mice counteracts these effects (Joyce et al. 2014). In humans, it was shown 
that 1 week of Vancomycin treatment decreases gram positive bacteria like Firmicutes. 
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These changes lead to a reduced conversion of primary bile salts into secondary bile salt 
and decreases circulating FGF19 (Vrieze et al. 2014). Besides antibiotics, nutritional 
compounds are also capable of changing the microbiota. Li et al showed that the 
antioxidant tempol alters the microbiota in a way that more T-β-MCA is present in the 
ileum (Li et al. 2013). Mice on tempol have decreased intestinal FXR expression and are 
protected against DIO. This is in consonance with the finding that intestine-specific FXR 
knockout mice are protected against NAFLD (Jiang et al. 2015). Conversely, 
conventionally raised mice administered with BSH show a dramatic reduction in T-β-
MCA and are also protected against DIO (Joyce et al. 2014). For an overview of the 
primary and secondary bile acids see table 1.  
The two-way interaction between the microbiota and bile acids is not only important in 
enterohepatic communication, but also in the rest of the body, as the gut microbiota 
modulation determines bile acid profiles throughout the body (heart, kidney). Here they 
can have signalling properties and influence cardiometabolic health (Swann et al. 2011). 
Additionally, microbiota changes by bile acids can also influence cardiometabolic health. 
Both via the altered production of SCFAs and by the production of atherosclerotic 
promoting molecules like trimethylamine (TMA) (Janssen and Kersten 2015). Increased 
serum concentrations of the liver metabolite of TMA, TMAO, are linked to atherosclerosis 
(Gregory et al. 2015). Furthermore, NAFLD and liver cirrhosis are associated with an 
altered microbiota. A recent study has found an increased presence of buccal derived 
bacteria in the gut in liver cirrhosis patients (Qin et al. 2014). It is known that bile acids 
are altered in NAFLD patients (Lake et al. 2013), which might be the cause of the 
alterations is microbiota composition.  
 
1.4.5 Bile acids and diets 
Bile acids play an essential role in the uptake of dietary fat, however, the effect of a high 
fat diet on the bile acid pool remains partly unclear. It is hypothesized that a HF diet 
increases the bile acid pool because of the crucial role of bile acids in lipid digestion. 
However, Ostα-/- mice have half the bile acid pool of wild type animals but only lose 
minimum amount of lipids in the faeces on a HF diet (Hammond et al. 2015). This may 
indicate that an excess of bile salts is present in wild type animals. In both humans and 
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mice, a HF diet increases faecal bile acids (Stenman, Holma, and Korpela 2012; Bianchini 
et al. 1989), but this is the small percentage of bile acids that is not reabsorbed in the ileum. 
Furthermore, these bile acids have travelled through the colon where microbiota have 
altered their structure. Arguably, finding out what happens to bile acid metabolism in the 
small intestine in response to a high fat diet might be more relevant.   
Another dietary component linked to bile acid metabolism is dietary fibre. Dietary fibres 
are known for their cholesterol-lowering effects, and have been hypothesized to bind bile 
acids and avoid their absorption leading to more conversion of cholesterol into bile acids 
(more in chapter 1.4.3).  
Additionally, the composition of the microbiota can be influenced by alterations in the 
diet. Switching between animal and plant-derived food shows large alterations in the 
microbiota and microbiota-derived signalling molecules. These effects can already be seen 
after 5 days in humans (David et al. 2014) and after 3.5 days in mice (Carmody et al. 
2014). In mice, diet is even found to be a more important determinant of the composition 
of the microbiome than genotype (Carmody et al. 2014). Since the microbiota plays a very 
important role in bile acid metabolism, it is not hard to speculate that this will also 
influence bile acids. Dietary fibres are known to alter the composition of the microbiota 
leading an increased production of short chain fatty acids (Lange et al. 2015).  
 
In both human and mice studies, a HF or animal-derived diet increases the presence of 
bile tolerant bacteria (mainly Firmicutes), while decreasing bacterial populations that 
produce SCFA (mainly Bacteroides) (David et al. 2014; O’Keefe et al. 2015; Turnbaugh 
et al. 2008; Hildebrandt et al. 2009). Only saturated fat seems to provoke these microbial 
changes, probably due to less efficient uptake and overflow of saturated fatty acids into 
the distal part of the intestine (N. de Wit et al. 2012; Patterson et al. 2014). Interestingly, 
bile acid feeding provokes similar changes in microbiota as a HF diet (Islam et al. 2011), 
supporting the theory that diet affects bile acid metabolism.   
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1.5 FGF15/19 
In humans, seven functional subfamilies of fibroblast growth factors (FGFs) have been 
identified (Beenken and Mohammadi 2009). Classically, FGFs are intracrine or paracrine 
factors, however the FGF19 subfamily (consisting of FGF19, FGF21 and FGF23) is an 
atypical group of FGFs that lack a heparin binding domain. This allows them to be secreted 
into the bloodstream. Therefore, FGF19 and FGF21 are endocrine factors that are often 
considered as metabolic hormones. All paracrine and endocrine FGFs bind to their 
receptors to exert their function. Four of these FGF receptors (FGFRs), namely FGFR1 to 
FGFR4, have been identified. FGF19 potently binds to FGFR4, but has also been shown 
to have affinity with FGFR1. Additionally, FGF19 needs a membrane-bound cofactor -
Klotho to successfully bind to and activate FGFRs (Markan and Potthoff 2016; Kliewer 
and Mangelsdorf 2015).  
 
The mouse homologue of FGF19 is called Fgf15. This difference in terminology is due to 
the lack of common amino acid identity; at the time of cloning it was found that the 
proteins only share 53% of amino acids (Nishimura et al. 1999). However, functional 
studies have shown that Fgf15 and FGF19 are orthologous proteins with a conserved FXR 
binding site in the promoter regions of the encoding genes (Kliewer and Mangelsdorf 
2015). For that reason, we will be referring to the FGF15/19 protein throughout this thesis.  
 
The highest expression of FGF15/19 is in the ileum, where bile acids are reabsorbed. Here, 
FGF15/19 is exclusively expressed in enterocytes (Haber et al. 2017). FGF15/19 secretion 
is often considered a postprandial response, with a peak of circulating FGF19 levels in 
humans found approximately 60 mins after consumption of a meal (Potthoff et al. 2011). 
Postprandially, FGF15/19 regulates bile acid, carbohydrate and protein metabolism. 
Although FGF15/19 is mostly known to inhibit bile acid synthesis by blocking hepatic 
CYP7A1 expression, FGF15/19 has also been shown to activate both protein and glycogen 
synthesis in the liver (Kir et al. 2011). FGF15/19 is capable of lowering blood glucose 
levels independent of insulin (Wu et al. 2010), via inhibiting the CREB-PGC-1a pathway 
in the liver (Potthoff et al. 2011).  
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1.5.1 FGF15/19 in health and disease 
Due to its nature as an metabolic hormone, many health effects have been linked to the 
over and under expression of FGF15/19 (Jahn et al. 2015). For example, a mouse model 
designed to express FGF19 via a myosin light chain promotor, expressing FGF19 mostly 
in muscle tissue, showed a decrease in body weight on both a chow and a HF diet. 
Additionally, lower fat mass, more brown adipose tissue and less triglyceride storage in 
the liver was observed (Tomlinson et al. 2011). Furthermore, mice fed with a HFD and 
injected with FGF19 had reduced body weight, were protected against diabetes and 
showed also decreased liver triglycerides (Fu et al. 2004). Additionally, Fgf15 knockout 
mice are high responders to high fat diets, gaining significantly more weight than their 
wild type litter mates while accumulating more triglycerides in the liver (Alvarez-Sola et 
al. 2017). Fgfr4 knockout mice, lacking the receptor for FGF15/19 signalling, develop 
signs of the metabolic syndrome while on a chow diet, including increased adipose tissue, 
glucose intolerance and hyperlipidaemia (Huang et al. 2007). In humans with NAFLD, 
type 2 diabetes and the metabolic syndrome FGF19 levels in serum are shown to be lower 
than in healthy controls (Barutcuoglu et al. 2011; Wojcik et al. 2012; Gallego-Escuredo et 
al. 2015; Eren et al. 2012).  
 
NAFLD 
Due to the response of both FGF19 overexpressing and Fgf15 KO mice to HF diets, 
interest has developed in the preventive and restorative role of FGF15/19 in NAFLD. 
Intestinal specific FXR activation via the FXR agonist fexaramine, which strongly induces 
the expression of Fgf15,  reduces insulin resistance while promoting browning of white 
adipose tissue in mice (Fang et al. 2015). Additionally, Fgf15 has been shown to repress 
the expression of Pparg2 in the liver, a transcription factor contributing to high fat induced 
hepatic steatosis (Alvarez-Sola et al. 2017). The biggest struggle in the development of 
FGF15/19 as a drug in NAFLD has been the carcinogenic properties of FGF15/19, as will 
be discussed in the next section. Recently, a non-carcinogenic engineered FGF19 
analogue, NMG282, has been developed (M. Zhou et al. 2014). NGM282 seems a very 
promising treatment for NAFLD as it has been shown to be effective at reversing NAFLD 
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in humans by reducing both liver fat content and markers of liver inflammation (Harrison 
et al. 2018). 
 
Hepatic carcinoma 
FGF15/19 binding to hepatic FGFR4 leads to an increase in cell proliferation in the liver 
(Repana and Ross 2015). This can be hepatoprotective during active liver injury, as has 
been shown after partial hepatectomy in mice (Uriarte et al. 2013). However, when 
FGF15/19 is chronically activated it is considered pro-carcinogenic (Repana and Ross 
2015). FGF19 expression in human hepatic tumour cells correlates with poor progression 
of liver cancer phenotypes (Miura et al. 2012; Hyeon et al. 2013; Hagel et al. 2015) and 
Fgf15 KO mice develop less hepatic carcinoma under treatment of diethyl nitrosamine. 
Furthermore, Fgf15 KO mice show less cell proliferation in the liver, as shown by Ki-67 
and AFP and less fibrosis as shown by SMA (Uriarte et al. 2015). Interfering with the 
FGF19 – FGFR4/KLB signalling pathway in liver cancer is regarded a new strategy in 
fighting this disease (Alvarez-Sola et al. 2017).  
 
Bile acid diarrhoea 
Bile acid diarrhoea (BAD) is described as chronic diarrhoea in response to excessive loss 
of bile acid in faeces (Walters 2014). BAD is often wrongly diagnosed as diarrhoea-
predominant irritable bowel syndrome (IBS-D) (Spiller and Thompson 2010), with around 
30% of IBS-D patients showing abnormal faecal bile acid loss (Wedlake et al. 2009).  
The role for enterohepatic communication via FGF15/19 has been emerging in BAD. In 
FGF15 KO mice an increase in faecal bile acid excretion was found (Inagaki et al. 2005), 
while monkeys treated with anti-FGF19 antibodies developed severe diarrhoea (Pai et al. 
2012). In humans, bile acid absorption seems to be unaffected in most BAD patients, and 
an increased bile acid pool has been shown. However, circulating FGF19 levels are 
decreased in BAD patients (Walters et al. 2009) and possible intervening by FGF19 
induction is considered a promising therapeutic approach for BAD patients (Walters 
2014). Interestingly, the previously-discussed non-carcinogenic FGF19 analogue 
NGM282 has recently been shown to increase gastro-intestinal transit time (Oduyebo et 
al. 2018).   
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Figure 1.2 Summary of health effects of FGF15/19 throughout the body. 
1.5.2 Regulation of FGF15/19 
As discussed previously, classically, FGF15/19 is regulated by the bile acid sensing 
transcription factor FXR and activity of FXR can be modulated by conversions of bile 
acids by the microbiota (Kuipers, Bloks, and Groen 2014). In this section, alternative 
regulation of FGF15/19 will be discussed.  
 
Firstly, the fat-soluble vitamins A and D have been linked to an increase in FGF15/19 
expression. Vitamin D KO mice show a decrease in Fgf15 expression, while wild type 
mice fed with vitamin D show increased expression of Fgf15. This effect was independent 
of FXR as shown by Fxr KO mice.  Additionally, vitamin A feeding also leads to an 
increased expression of Fgf15, however, this effect was obliterated in FXR KO mice 
(Schmidt et al. 2010).  
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Furthermore, the transcription factor PPAR influences FGF15/19 expression. PPAR in 
the small intestine regulates the expression of UDP-glucurosyltransferase (UGT) genes 
(Ugt1a1, Ugt1a7, Ugt2b35) which are proteins capable of glucuronidation of bile acids.  
This, when reaching the ileum, leads to lowered FXR activation and a corresponding 
decrease in Fgf15 expression.  Additionally, Ppara KO mice have increased ileal Fgf15 
expression and decreased hepatic Cyp7a1 expression (Zhou et al. 2014). The PPARA 
agonist clofibrate has been shown to increase bile acid excretion, decrease Fgf15 
expression and increase hepatic bile acid production via Cyp7a1 (Youcai Zhang et al. 
2017).  
Diet1 is a newly identified gene in the ileum that induces the expression of Fgf15. Mice 
with a mutation in the Diet1 gene have less Fgf15 expression and as a consequence higher 
Cyp7a1 expression and bile acid pools. DIET1 and FGF15 proteins are in close proximity 
from each other within the cell, suggesting a direct interaction (Vergnes et al. 2013).  
Lastly, bile acid production via Cyp7a1 is regulated by circadian rhythms and is highest 
in mice at the start of the dark phase. Circadian regulation is driven by the transcription 
factor Kruppel-like factor 15 (Klf15) in the ileum where it downregulates the expression 
of FGF15/19. The expression of Klf15 follows a pattern over 24h that is opposite to the 
expression pattern of Fgf15 and in Klf15 KO mice expression of Fgf15 is upregulated 
(Han et al. 2015).  
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1.6 Digestible carbohydrates: sugar and starch digestion  
Although the knowledge of the effect of diet on bile acid metabolism is limited (see 
chapter 1.4.5), the interaction between carbohydrates and bile acid metabolism is 
interesting. On the one hand Fgf15 has been shown to be able to alter glucose metabolism 
(Potthoff et al. 2011), while on the other hand the effects of mostly undigestible 
carbohydrates on the gut microbiota might alter bile acid metabolism (Li and Chiang 
2015). Because these effects will be studied further in this thesis, this and the following 
sub-chapter will give some background on digestible and undigestible carbohydrates and 
their effects on the gut and liver.  
  
1.6.1 The role of carbohydrates in human nutrition  
Carbohydrates generally form the biggest food group in the standard western diet, 
accounting for around 43% of total calories in European countries (Vergnaud et al. 2013). 
Digestible carbohydrates can be divided into simple carbohydrates (the sugars) and 
complex carbohydrates (starches). Both digestible and indigestible carbohydrates are 
polymers built up from monosaccharide units. Three monosaccharides important for 
human nutrition are glucose, fructose and galactose which all possess the same chemical 
formula C6H12O6. Structurally, the monosaccharides differ in taste perception with 
fructose being the sweetest. In nutrition, sugars are usually in disaccharide form, with the 
most important disaccharides being sucrose (glucose and fructose), maltose (glucose and 
glucose) and lactose (glucose and galactose). The most important form of complex 
digestible carbohydrate is starch, a long, branched or unbranched chain of hundreds or 
thousands of glucose molecules linked together. Starches can be found in plant-based 
foods, as they are a way of storing glucose. Animals store glucose as glycogen, a highly 
branched chain of glucose molecules, in the liver and muscle tissue. However, glycogen 
in animal muscle rapidly hydrolyses after slaughter, making it an insignificant dietary 
source of carbohydrates (Whitney and Rolfes 2008; Welcome 2018).   
 
1.6.2 Digestion of carbohydrates  
In order to be able to absorb dietary carbohydrates they are broken up into 
monosaccharides in the GI tract.  Mono- and disaccharide digestion is a fast process and 
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occurs mostly in the duodenum. Monosaccharides can be absorbed directly, while 
disaccharides and small oligosaccharides are cleaved into monosaccharides by enzyme 
complexes called -glucosidases (Rosak and Mertes 2012). -Glucosidases are membrane 
bound enzymes present in the epithelium throughout the small intestine. The most 
important -glucosidases present in the human small intestine are lactase, maltase-
glucoamylase (MGAM) and sucrase-isomaltase (SIS). Lactase is responsible for the 
breakdown of the disaccharide lactose, while MGAM breaks down maltose and glucose 
oligosaccharides, lastly SIS breaks down sucrose and glucose polymers (Tundis, Loizzo, 
and Menichini 2010; Quezada-Calvillo et al. 2008).  
 
More complex carbohydrate digestion starts in the mouth, where salivary amylase cleaves 
a small percentage of the present starches into smaller polysaccharides and the 
disaccharide maltose. Further cleavage of starch happens in the upper part of the small 
intestine, where pancreatic amylase is added to the food bolus. Amylase catalyses the 
hydrolysis of -1,4-glucan bonds present in starch and maltodextrins (Svensson 1988). 
When starch has broken into short enough chains of glucose, -glucosidases on the outer 
membrane of the intestinal cells break it down into monosaccharides which are 
consequently absorbed. A high starch (HS) diet has been shown to increase the activity of 
-glucosidases in the more downstream parts of the small intestine (Goda 2000).  
 
1.6.3 Glucose and fructose metabolism in the small intestine  
After starch and sucrose digestion, glucose is absorbed into the intestinal epithelial cells 
by the sodium-glucose linked transporter (SGLT1) which is localized in the apical brush 
border membrane (Gorboulev et al. 2012). Another glucose transporter, glucose 
transporter 2 (GLUT2), primarily mediates the lateral transport of glucose into the 
bloodstream, but deletion of GLUT2 has been shown to also decrease apical glucose 
absorption (Schmitt et al. 2017). After absorption into the enterocytes glucose is excreted 
into the portal vein by GLUT2. Although the glucose transporters SGLT1 and GLUT are 
not under direct control of insulin, intestinal deletion of the insulin receptor does decrease 
glucose absorption (Ussar et al. 2017), indicating a role for insulin. Additionally, under 
the control of insulin, the small intestine is capable of endogenous production of glucose, 
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making it a gluconeogenic organ like the liver and kidneys (Mithieux and Gautier-Stein 
2014; Croset et al. 2001).   
 
Fructose is absorbed into the intestinal epithelial cells via the transporter GLUT5 (Douard 
and Ferraris 2008). Although it was long believed that fructose is consequently transported 
to the liver, recently it has been shown that the small intestine converts around 90% of all 
fructose into glucose, galactose and glycerate if a low to medium dose of fructose is 
consumed (Jang et al. 2018).  
 
1.6.4 Glucose metabolism in the liver 
When glucose reaches the liver via the portal vein it is taken up into the hepatocytes via 
GLUT2 (Takeda et al. 1993). Consequently, all glucose is phosphorylated to glucose 6-
phosphate by glucokinase after which several metabolic pathways can be initiated. 
Postprandially, most glucose 6-phosphate is converted into glycogen. Alternatively, a 
surplus of glucose might be used to synthesize de novo fatty acids via acetyl-CoA 
conversion. Lastly, glucose can be used produce NADPH and 5-phosphate via the pentose 
phosphate pathway (Adeva-Andany et al. 2016).  
During short-term periods of fasting, the liver mainly uses its glycogen storages to provide 
other organs of glucose. During longer periods of fasting, the liver produces do novo 
glucose via gluconeogenesis (Rui 2014).   
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1.7 Undigestible carbohydrates: dietary fibres 
Dietary fibres (called fibres from hereon) are remnants of plant cells that cannot be 
degraded by enzymes produced by humans (Trowell 1976) and are also defined as 
undigestible carbohydrates. In the UK, the recommended daily intake is 30 grams, 
however the average consumption is only around 20 grams per day (Spencer et al. 2003).  
Fibres can be found in plant-based foods only and in the Western world total fibre 
consumption comes 50% from grains, 30-40% from vegetables, 16% from fruit and the 
remaining from minor sources (Dhingra et al. 2012). 
 
1.7.1 Soluble versus insoluble fibres 
Fibres can be roughly classified into insoluble and soluble fibre. Insoluble fibre, as the 
name suggests, cannot be dissolved in water. They mostly resist degradation by the 
microbiota and are therefore labelled less fermentable. Soluble fibres dissolve in water 
and form gel-like structures delaying nutrient absorption. Soluble fibres are fermented by 
the gut microbiota which leads to the production of short chain fatty acids (SCFAs) 
(Aleixandre and Miguel 2008; Cockburn and Koropatkin 2016). For an overview of 
insoluble and soluble fibres and their gradation of fermentability, see table 1.2.    
 
Table 1.2 Overview of selected dietary fibres. This table is based on the publication by Aleixandre et al 
(Aleixandre and Miguel 2008).  
Fibre Insoluble/soluble Fermentability 
Cellulose Insoluble Poor 
Hemicellulose Insoluble Intermediate 
Lignin Insoluble Poor 
Pectin Soluble Intermediate 
Guar gum Soluble High 




B-glucans Soluble High 
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1.7.2 Fibres and the microbiota 
Fibre consumption provokes changes in the gut microbiota and some fibres are classified 
as prebiotics. Prebiotics are defined as “a substrate that is selectively utilized by host 
microorganisms conferring a health benefit” (Gibson et al. 2017). Under this definition, 
almost all prebiotics are fibres, however not all fibres are prebiotics. A lack of dietary 
fibres can decrease the microbial diversity in the gut (Sonnenburg et al. 2016), something 
that also happens when in response to modernisation of hunter-gathers communities 
(Smits et al. 2017). Lange et al showed that four fermentable fibres (inulin, FOS, 
arabinoxylan and guar gum) provoke similar changes to the microbiota, which are 
different from mice fed less fermentable resistant starch. Host colonic gene expression 
was also similar in response to all fermentable fibres, caused by an activation of Pparg by 
the SCFAs produced (Lange et al. 2015). Over generations, the lack of dietary fibres, as 
can be found in a western style diet, can irreversibly alter the composition of the gut 
microbiota (Sonnenburg et al. 2016).  
Although to a lesser extent, SCFAs are also produced from soluble fibres by the 
microbiota of the small intestine. SCFAs are essential for the functionality of the SI as is 
shown by the importance of SCFA for proper vitamin A uptake (Goverse et al. 2017). A 
lack of dietary fibre and therefor of SCFA could potentially lead to malabsorption of 
vitamin A. 
 
1.7.3 Health effects of dietary fibres 
The health benefits of dietary fibres are indisputable. Fibre consumption has been shown 
to decrease all-cause mortality (Yang et al. 2015), protects against colon cancer (Ben et 
al. 2014) and decreases the incidence of cardiovascular disease and coronary heart disease 
(Threapleton et al. 2013). This is most likely due to the cholesterol lowering effects of 
soluble fibres, with oat products, psyllium, pectin and guar gum all linked to a decrease in 
both total and LDL cholesterol levels (Brown et al. 1999). The cholesterol-lowering 
effects of -glucans in oats were confirmed more recently in humans (Whitehead et al. 
2014) and pigs (Gunness et al. 2016).  
Most research addressing the molecular effects of fibres have been focused on the colon, 
showing alterations in the microbiota and SCFA production, colonic gene expression 
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(Lange et al. 2015), alterations in the colonic mucus layer (Schroeder et al. 2018) and the 
induction of IL-22 in colonic enterocytes (Zou et al. 2018). However, their role in the 
small intestine is less elucidated.  
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1.8 Healthy ageing  
Some of the most debilitating diseases, like cardiovascular disease, cancer and 
neurodegenerative diseases share age as a main risk factor (Niccoli and Partridge 2012). 
With healthy ageing arguably being a goal for all individuals, there is a lot of scientific 
interest in slowing the ageing process. This would delay both the onset and the progression 
of all age related diseases (Kaeberlein, Rabinovitch, and Martin 2015). The ageing 
process, here defined as the minimization of physical impairments, has an estimated 
genetic prediction of 30 to 60% with the remaining being determined by environmental 
factors (Foebel and Pedersen 2016). Since human environments are complex and 
potentially highly modifiable, much research focuses on influencing key environmental 
factors, one of which is nutrition.  
 
1.8.1 Expanding life span  
From the currently-available methods, calorie restriction (CR) is the most studied 
intervention for delaying the ageing process. CR is defined as a reduction in energy intake 
while preventing malnutrition and has been shown to increase the life-span of a wide range 
of species, from yeast to mice and primates (Fontana, Partridge, and Longo 2010; Fontana 
and Partridge 2015). Most likely due to the difficulty of studying long term CR in humans, 
the results in voluntary subjects are inconsistent. Cardiovascular health seems to benefit 
from long term CR in humans (Stein et al. 2012), while the delays in immune systems 
ageing cannot be replicated in humans (Tomiyama et al. 2017).   
Although CR shows some promising effects in humans, the dietary regime is demanding 
and difficult to maintain. However, the beneficial effects observed from CR has spurred 
research to search for alternatives, mainly in the form of small molecule CR mimetics. For 
example, some widely used anti-diabetes drugs, namely metformin and acarbose, have 
been put forwards as CR mimetics. These drugs both alter glucose metabolism, metformin 
in the liver and acarbose in the intestine, and thereby mimic CR. Metformin has been 
shown to increase healthy ageing in mice, especially in combination with other bioactive 
components (De Haes et al. 2014; Strong et al. 2016) and diabetic patients receiving 
metformin have reduced mortality (Bannister et al. 2014). Metformin is currently being 
tested in a large multicentre clinical trial with 3000 elderly subject to further investigate 
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its effects on ageing (Barzilai et al. 2016). Acarbose has been shown to increase life-spam 
in mice, with a large effect in male mice and modest effect in females (Harrison et al. 
2014). Other promising small molecules for healthy ageing include the mTOR inhibitor 
rapamycin (Ehninger, Neff, and Xie 2014) and sirtuin activators (Mitchell et al. 2014).  
 
1.8.2 Bile acids and ageing  
Ageing affects almost all metabolic systems in the body, so also bile acid metabolism. For 
example, during ageing the conversion of cholesterol to bile acids in the liver decreases 
(Einarsson et al. 1985). Which is most likely due to a lower activity of cholesterol 7 alpha-
hydroxylation, the rate limiting step in this conversion (Bertolotti et al. 1993). 
Additionally, bile acid excretion into the faeces decreases in ageing rats, which could be 
partially reversed by a 40% CR diet (Ferland et al. 1989). Conversely, an increase in tauro-
conjugated bile acid were found in the gallbladders of aged rats compared to their younger 
counterparts (Lee et al. 2016).   
 
Bile acids have also been studied for their influence on the ageing process (Krøll 2012). 
The conjugated secondary bile acid tauro-ursodeoxycholic acid (TUDCA) has been shown 
to have a number of beneficial health effects. For example, TUDCA normalizes the 
glucose intolerance associated with a HF diet (da-Silva et al. 2011). Additionally, during 
partial hepatectomy, TUDCA improves liver regeneration and reduces inflammation, 
apoptosis and necrosis (Mosbah et al. 2010). Additionally, unconjugated UDCA is often 
used in the treatment of cholestatic liver disease, a condition where bile acids accumulate 
in the hepatocytes (Paumgartner and Beuers 2002). Furthermore, TUDCA has been shown 
to alleviate myocardial contractile dysfunction in obese mice (Ceylan-Isik, Sreejayan, and 
Ren 2011). Taken together, both conjugated and unconjugated UDCA are capable of 
reducing the incidence of a number of age-related and metabolic diseases.  
 
Lastly, there are indications that specific bile acids can prolong life-span (Roux and 
Chartrand 2010). In yeast, the bile acid lithocholic acid (LCA) have been shown to 
increase life-span via an mTOR dependent pathway (Goldberg et al. 2010). Furthermore, 
the bile-acid like compound dafachronic acid has been shown to increase life span in C. 
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elegans via activation of the nuclear receptor DAF-12, which is similar to FXR in 
vertebrates (Gerisch et al. 2007). Later it has been shown that the C. elegans homologue 
of LXR (NHR-8) for this mechanism (Magner et al. 2013; Groen and Kuipers 2013). 
Ultimately, it has been hypothesized that the increased level of bile acids in the long-lived 
Ghrhr mutant mouse models contribute to its increased longevity (Gems 2007).  
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1.9 Mouse models in biomedical research 
Although research in humans is the preferred option, it is difficult to investigate causality 
in humans due to the difficulty of obtaining samples. As an alternative, murine models are 
heavily used in biomedical research. Mice provide a good, tractable animal experimental 
model of human intestinal biology with many of the key physiological features of the 
human GI-tract including the architecture, organisation and functions of the intestinal 
epithelium, microbiota and gut-associated lymphoid tissue faithfully reproduced in mice. 
Additionally, mice genetics have been widely studied and genetically modified mice are 
available for functional studies. Moreover, studies are relatively cheap due to the low 
maintenance cost and short life cycle of mice (Nguyen et al. 2015).  
 
1.9.1 Diets used in mouse studies 
While mice used in biomedical research are inbred and therefore genetically identical, 
reproducibility between murine studies is not optimal. This is at least in part due to the 
lack of good control diets. A common and arguably most employed chow diet is produced 
from unrefined plant products, which leads to large variations between vendors, seasons 
and even batches. The current alternative to the chow diet is a purified control diet, which 
is stable and defined in composition (Pellizzon and Ricci 2018). Unfortunately, the effects 
of the purified diet on the health of mice haven’t been properly investigated. The purified 
diet has been shown to lack in aryl hydrocarbon receptor (AHR) ligands, which is 
detrimental for SI health (Ying Li et al. 2011). Additionally, the purified diet does not 
contain any soluble fibre only cellulose, possibly leading to changes in the microbiota and 
mouse health. Although proper control diets are essential in any field of research, 
molecular nutrition research and research investigating the role of the intestinal microbiota 
might be extra sensitive.  
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1.10 Identifying research gaps  
As discussed previously, little is known about the effects of dietary patterns on bile acid 
metabolism. The indications that carbohydrates might predominantly influence bile acid 
metabolism are plentiful. First, it is well established that bile acid metabolisms, via the 
signalling molecule FGF15/19 influences carbohydrate metabolism in the liver (Kir et al. 
2011; Potthoff et al. 2011). Secondly, FGF15/19 is a postprandial signal (Potthoff et al. 
2011) indicating an opportunity for dietary regulation. Additionally, it is known that 
dietary components can alter the microbiota is such a way that it changes ileal bile acid 
metabolism (F. Li et al. 2013) and undigestible carbohydrates are known to severely 
influence the composition of the microbiota (Makki et al. 2018). Lastly, undigestible 
carbohydrates lower blood cholesterol levels, which has been previously been 
hypothesised to be due to alterations in bile acid metabolism (Gunness et al. 2016). 
Because of these indications that dietary patterns, and especially digestible and 
undigestible carbohydrates, could potentially influence bile acid metabolism, this is 
further investigated in this thesis.   
 
In order to investigate this, the aim of this thesis have been defined to:  
1. Investigate the effects of digestible carbohydrates on bile acid metabolism in the 
small intestine 
2. Investigate the effects of undigestible carbohydrates on bile acid metabolism in the 
small intestine  
3. Investigate the effects of digestible versus undigestible carbohydrates on the gut-
liver axis  
4. Investigate bile acid metabolism during healthy ageing, using CR as a model 
 
To study effects of diets on bile acid metabolism we first aim to study the role of digestible 
carbohydrates on bile acids metabolism in chapter 3. Here we compare the standard chow 
diet to a purified control diet with a high starch content and look at bile acid metabolism 
with a special interest in the ileum.  
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In the following chapter (chapter 4) the effects of indigestible carbohydrates, in this case 
soluble fibres, on FGF15/19 signalling in the ileum are investigated.  
 
In chapter 5 we broaden our view and investigate additional effects the HS diet has on the 
gut-liver axis and additionally investigate if adding soluble fibres to the HS diet can 
counteract some these effects on the gut-liver axis.  
 
In the last research chapter (chapter 6), we study bile acid metabolism during healthy 
ageing. In collaboration with the group of Dr Steegenga at Wageningen University small 
intestinal samples of a 24 months mouse aging study were received. Using these samples, 
we investigated bile acid metabolism in the small intestine during normal and healthy 
ageing.  
  





Chapter 2: Materials and Methods 
Thesis Britt Blokker  
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This chapter contains background information about the materials and methods used 
troughout this thesis. More detailed methods are discussed per chapter.  
 
2.1 Mice and organ collection 
For all murine studies male C57B6/J mice were used and mice were under 12 hours of 
light and dark cycles. Mice studies were either performed at Wageningen University 
(WUR) prior to the start of this PhD project, or by the PhD candidate at the Disease 
Modelling Unit (DMU) of the University of East Anglia (UEA). A table at the start of 
each chapter indicates where the studies were performed, if they were performed by the 
PhD candidate and if not, what was made available to the PhD candidate. All animal 
experiments were started at the age of 10-12 weeks, after stabilization of the microbiota 
(Schloss et al. 2012).  
 
All experimental procedures and protocols performed for this PhD thesis were reviewed 
and approved by the Animal Welfare and Ethical Review Body and were conducted 
according to the specifications of the United Kingdom Animals Scientific Procedures Act, 
1986.  
The animal experiments performed at WUR were in line with the Dutch guidelines. The 
study designs and the experiments described were approved by the Local Committee for 
Care and Use of Laboratory Animals at Wageningen University.  
 
Mice were sacrificed in the fed state in both UEA and WUR studies, unless indicated 
differently. UEA mice were sacrificed by cardiac puncture, a method in which animals are 
anesthetized with isoflurane gas and all blood is with drawled from the body via the heart. 
The small intestine of each mouse was transferred to a cold glass plate and divided into 
three equal pieces. The content of each piece was subsequently pushed out gently and 
collected into a separate Eppendorf tube (per part) which is immediately frozen in liquid 
nitrogen or dry ice. After pushing out the content, each part was cut into three small and 
three large pieces, as is depicted in figure 2.1. The most proximal large part was collected 
in a cassette and stored in 10% formalin (during 24 hours) for histology. The three small 
parts were collected together and put into an Eppendorf tube that was immediately snap-
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frozen in liquid nitrogen. These parts were later used for RNA isolation. The remaining 
two larger pieces were collected in a cryotube which was also snap-frozen in liquid 
nitrogen immediately. These parts were used for the remaining measurements like protein 
and bile acid extraction. From the liver of each mouse, two small pieces were collected 
into a cassette and stored in 10% formalin, while the rest of the liver was collected in a 
cryotube and snap-frozen in liquid nitrogen. Furthermore, cecum, colon, white adipose 
tissue (WAT) and brain were collected and snap-frozen in liquid nitrogen. Moments 




Figure 2.1 Visualization of the sample collection per part of the intestine. The segmentation was 
performed on each third of the small intestine, the duodenum, jejunum and ileum, at the time of sacrifice.  
 
Collection of the small intestine for the studies performed at WUR were similar, however 
the SI has been divided up in a variable number of equal pieces. For the IDEAL WUR 
mice (ageing study, see chapter 6) the SI was divided up into three equal parts, while for 
the 10 parts WUR mice (see chapter 3 and 5) the SI was divided into 10 equal parts. 
Additional organs (e.g. liver, cecum, colon, WAT, brain, faeces etc) were not available.  
    
 
Proximal Distal 
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2.3 Treatments   
A variety of dietary components and chemicals have been administered to mice in addition 
to either the chow and/or purified diet. Dietary component and chemicals were either 
administrated via the drinking water or oral gavage.  
 
2.3.2 Administrating substances via the drinking water 
C57B6/J mice drink an average of 5-6 ml of water per day (Bachmanov et al. 2002) and 
the dose of substances has been based on this consumption. Whenever substances were 
administrated via the drinking water, drinking water was renewed every three days to 
avoid breakdown of the product. Additionally, the taste of the substance was taken into 
account;  possible bitter-tasting substances were administrated via oral gavage to avoid 
dehydration.  
 
2.3.3 Oral gavage 
Whenever a substance was less suitable for administration via the drinking water, either 
because a very specific dose was needed, there was a possible bitter taste or the cost of the 
substance required was high, oral gavage was the suitable alternative.  
Oral gavage was performed by restraining the mouse and via a plastic, flexible catheter 
(FTP1830 18G x 30mm, Instech Solomon) adding 100 – 200 µL of liquid (usually 
substance dissolved in PBS) into the stomach.  The maximum volume for oral gavage in 
mice is 20 µL/g BW, however for the comfort of the mice adjusted the concentrations of 











Chapter 3: Glucose uptake into ileal enterocytes increases the 
expression of the signalling molecule Fgf15 independent of the 
microbiota 
Thesis Britt Blokker  
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Name study Where Performed by 
candidate? 
Samples available 
10 parts study WUR No Microarray data on intestinal 
tissue 
Feeding studies over time UEA Yes All 
Antibiotics study UEA Yes All 
Antifungal study UEA Yes All 
Fasting/refeeding study UEA Yes All 
FXR antagonist study UEA Yes All 
Cholestyramine study UEA Yes All 
Acarbose study UEA Yes All 
Glucose studies UEA Yes All 
 
3.1 Introduction  
A multitude of metabolic diseases, including diabetes mellitus type 2, have been linked to 
bile acid metabolism (Thomas et al. 2008; Prawitt, Caron, and Staels 2011; Boesjes and 
Brufau 2014). Within bile acid metabolism, the role of the metabolic hormone fibroblast 
growth factor (FGF) 19 and its mouse ortholog Fgf15 has emerged. Since bile acids are 
derived from cholesterol and Fgf15 blocks the production of bile acids via CYP7A1, an 
increased expression of Fgf15 reduces the conversion of cholesterol to bile acids. This 
effect has been linked to elevated blood levels of total and LDL cholesterol in both rodents 
and humans (Stroeve et al. 2010; Harrison et al. 2018).  
Outside of its role in bile acid and cholesterol metabolism, FGF15/19 has shown to 
activate both protein and glycogen synthesis in the liver (Kir et al. 2011). FGF15/19 is 
capable of lowering blood glucose levels (Wu et al. 2010) and regulates hepatic glucose 
metabolism in an insulin independent manner (Potthoff et al. 2011; Kir et al. 2011) Fasted 
mice treated with FGF15/19 showed a decreased expression of hepatic genes involved in 
glucose metabolism, regulated by proliferator-activated receptor  coactivator protein-1 
(PGC-1), of which gene expression is induced by cAMP regulatory element-binding 
protein (CREB) under fasting conditions (Herzig et al. 2001), showing that FGF15/19 
modulates hepatic glucose metabolism by inhibiting the CREB-PGC1a pathway (Potthoff 
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et al. 2011). FGF15/19 upregulation is known to be a postprandial response that follows 
the insulin response approximately 60 minutes after the consumption of a meal (Potthoff 
et al. 2011). The postprandial upregulation of FGF15/19 is hypothesized to be in response 
to the bile acids reaching the ileum. Interestingly, FGF15/19 drug trials are currently 
ongoing to investigate its possible use in diabetes mellitus treatment (Degirolamo, Sabbà, 
and Moschetta 2016). However, a substantial obstacle and concern is the potential 
carcinogenic effects of FGF15/19. The metabolic hormone induces cell division and has 
led to the development of hepatic carcinoma in mouse models (Uriarte et al. 2015; Uriarte 
et al. 2013). Currently, a non-carcinogenic engineered FGF19 analogue, NMG282, is 
being tested for human treatment (Harrison et al. 2018).  
Although it is clear that the signalling molecule FGF15/19 is biologically important, not 
much is known about the influence of nutrition on its regulation, even though it is widely 
accepted that FGF15/19 up-regulation is a postprandial response. Additionally, Fgf15 
expression is downregulated in both germ-free and antibiotic treated mice, indicating a 
link with the gut microbiota (Sayin et al. 2013b; Miyata et al. 2009; Wahlström et al. 
2016). This is also shown by the effects the antioxidant tempol that alters ileal FXR 
activity via alteration in the microbiota (Li et al. 2013). The link between FGF15/19 and 
the microbiota could suggest dietary regulation, as diet and environment are the main 
determinants of microbiota composition in both mice (Carmody et al. 2014) and humans 
(Rothschild et al. 2018).  
 
Because of the regulation of FGF15/19 expression by the microbiota and its newly 
discovered role in blood glucose regulation, we hypothesized that FGF15/19 might be 
upregulated by diets high in digestible carbohydrates, leading to increased ileal glucose 
levels. Here we show that starch intake, and thereby increased glucose concentrations in 
the ileum, are upregulating Fgf15 expression in C56BL6/J  mice, and that this effect is 
independent of the microbiota. On long term dietary intervention, this leads to disturbance 
of bile acid metabolism, increased cholesterol levels and even the development of hepatic 
carcinoma in mice.  
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3.2 Materials and methods 
3.2.1 Murine studies 
C56BL6/J mice bred in the DMU of the UEA were used for all murine studies (except 
WUR study, see below), starting at the age of 10-12 weeks, with a group size of minimum 
5 and maximum 10 mice. At the end of the experiments mice were sedated with a mixture 
of 4% isoflurane (IsoFlo, Abbott, ND), nitrous oxide (70%) and oxygen (30%) and blood 
samples were collected via cardiac puncture. The small intestine was collected and 
arranged in three equal parts, of which the last part was identified as the ileum. 
Additionally, the liver was collected. All samples were immediately snap-frozen in liquid 
nitrogen and stored at -80C until analysis or fixed in 10% formalin (include if you show 
histology).   
All experimental procedures and protocols used in these studies were reviewed and 
approved by the Animal Welfare and Ethical Review Body and were conducted according 
to the specifications of the United Kingdom Animals Scientific Procedures Act, 1986.  
The WUR study has been performed at the Nutrition, Metabolism and Genomics group of 
Wageningen University (WUR) in the Netherlands, previous to me commencing my PhD. 
Here the small intestine was divided into 10 equal parts on which microarrays (Affymetrix 
GeneChip Mouse Gene 1.1 ST array) were performed. Our group consequently analysed 
the data using Microsoft Excel.  
 
3.2.2 Diets 
Mice were fed either a standard chow diet (RM3-P, Special Diets Services, UK), a HS 
purified diet (D12450H, Research Diets, USA) for the indicated duration per experiment. 
WUR mice were fed a standard chow, a HS (D12450H) diet or a high fat (HF, 45 energy 
percent (En%) fat, D12451, Research Diets) diet for two weeks, however in the WUR 
diets lard is replaced by palm oil as a fat source. See table 3.1 for a description of the diets 
used.   
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Table 3.1 Dietary composition per kilogram of diet. The high starch (HS) diet contains more starch and 
sucrose and less fibre compared to the chow diet. In the purified diet (HS and high fat (HF) from Research 
Diets) starch is exchanged for fat. 
 Chow diet  
SDS diets RM3 




Energy content  3.35 kcal/g 3.82 kcal/g 4.4 kcal/g 
    
Protein  27.28 En% 20 En% 20 En% 
Carbohydrate 61.24 En% 70 En% 35 En% 
Fat 11.48 En% 10 En% 45 En% 
    
Corn Starch (g) 338.8 452.2  72.8  
Maltodextrin (g) 0 75  100  
Sucrose (g) 43.7 172.8  172.8  
Dietary fibre (g) 161.5  







See appendix 1 
Unknown mix 1 g V10001C  1 g V10001C  
Minerals 
See appendix 1 
Unknown mix 50 g S10026B  50 g S10026B  
 
3.2.3 Intervention experiments 
3.2.3.1 Studies performed at WUR 
As explained in Chapter 2, some of the results presented in this work were generated from 
samples of studies that were performed at WUR. Although these studies were not 
performed by the PhD candidate, a short summary of the methods used are explained 
below for the purpose of disclosing all information.  
 
10 Parts study  
Male C57B6/J mice were fed a standard chow, a low fat (LF, 10 En%) fat) or a high fat 
(HF, 45En% fat) diet for two weeks (Research Diets, see table 2.1). At the end of the two 
weeks mice were sacrificed in the fed state and the small intestine was transported to a 
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cold glass plate. Subsequently, the intestine was cut into 10 equal pieces which were 
opened and rinsed in phosphate buffered saline (PBS). The cells were scraped out, and 
RNA was isolated and converted into cDNA. A microarray (Affymetrix GeneChip Mouse 
Gene 1.1 ST array) was performed at the WUR and data was analysed by our group as 
outlined in chapter 2.4.  
 
3.2.3.2 Studies performed at UEA / Quadram Institute  
The studies outlined below were performed by the PhD Candidate in the DMU of the UEA 
and samples were analysed at the Quadram Institute. Body weight and food intake was 
measured once or twice a week for all experiments. Group size is between 5 to 10 mice 
per group for each experiment. Mice were transferred to a clean cage every week, unless 
stated otherwise, and were sacrificed in the fed state, unless stated otherwise (see below).  
 
Feeding studies over time  
Mice on a chow background diet were fed the chow or HS diet for a duration of 3 days, 1 
weeks, 2 weeks, 8 weeks or 6 months before sacrifice.  
 
Antibiotics study 
Mice on a chow background were switched to a clean cage and either remained on a chow 
diet or switched to the HS diet for 1 week. During this week mice were oral gavaged once 
daily with a cocktail of vancomycin (50mg/kg BW, Sigma-Aldrich, 94747), Neomycin 
(100mg/kg BW, Sigma-Aldrich, N6386), Metronidazol (100mg/kg BW, Sigma-Aldrich, 
M1547) in 0.9% saline. Additionally, mice received ampicillin (1g/L, Sigma-Aldrich, 
A0166) via drinking water. Mice were transferred to a clean cage every other day for the 
duration of this experiment. Similar protocol used in (Zarrinpar et al. 2018).  
 
Antifungal study  
Mice on a chow background were switched to a clean cage and either remained on a chow 
diet or switched to the HS diet for 1 week. During this week mice received fluconazole 
(Sigma-Aldrich, F8929) at a concentration of 0.5mg/ml in their drinking water. 
Additionally, there was a group of mice on both the chow and the HS diet that received 
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both the antibiotics treatment explained above and this antifungal treatment 
simultaneously during one week.  
 
Fasting/refeeding study 
Mice on a chow background were fasted overnight for a total of 12 hours (8pm-8am). At 
8am, mice were re-exposed to food, either the chow or the HS diet for a total of 3 hours 
before sacrifice.  
 
FXR antagonist study 
Mice were fed either the chow or HS diet and received the FXR antagonist Guggulsterone 
(Tocris, Bio-Techne, UK) via a daily oral gavage. Guggulsterone was given at a dose of 
20 mg/kg BW dissolved in PBS.  
 
Cholestyramine study 
Cholestyramine is a bile acid chelator and was administered twice daily via oral gavage 
(AM and PM) for the duration of one week to mice on either the chow or HS diet. Mice 
received a dose of 500mg/kg BW dissolved in PBS each time.  
 
Acarbose study 
To inhibit starch digestion, the competitive inhibitor acarbose (Sigma-Aldrich, A8980) 
was added to the drinking water of mice on both the chow and HS diet for two weeks. 
Acarbose was added to the drinking water because of it competitive nature, so that the 
mice received the acarbose throughout the day and night when they were also consuming 
their food. Acarbose was added to the drinking water at a concentration of 0.31g/L to reach 
a dose of approximately 50mg/kg BW/day.  
 
Glucose studies 
Glucose studies were based on glucose tolerance tests, where mice often receive a dose of 
D-Glucose (Sigma-Aldrich, G8270) at 2g/kg BW dissolved in PBS by either oral gavage 
or Intraperitoneal (IP) injection.   
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3.2.4 In vivo measurements 
 
Transit time  
Transit time from stomach to faeces was determined by Evans Blue. The Evans Blue dye 
(Sigma-Aldrich, E2129) was mixes with the original diet (either chow or HS diet) and 
PBS at a concentration of 5% Evans Blue, 10% chow/HS diet and 85% PBS. Mice were 
oral gavaged with 0.1mL of this semiliquid and overall transit time was determined by the 
time the first blue dye was determined in the faeces. Transit time was determined in mice 
that has been on the chow and HS diet for 12 weeks.  
 
Glucose measurements 
While most glucose was measured post-mortem, during the glucose studies some of the 
glucose measurements were performed in vivo.  Blood for in vivo glucose measurements 
was sampled via a tail prick with a 23G needle. Glucose was consequently measured using 
a glucose meter (AlphaTRAK 2 Abbott).  
 
3.2.5 Gene expression 
RNA of liver and intestinal scraping samples was isolated. Samples were homogenised in 
1 ml Trizol (Qiazol, Qiagen, UK) for 30 seconds at 6000 rpm in a Precellys®24 (Bertin 
Technologies, France). After homogenization samples were transferred to a new 
Eppendorf tube and 200 µl Chloroform was added. Samples were centrifuged for 15 
minutes at 12.000 RCF 4˚C and the clear layer was transferred to a new collection tube. 
Iso-propanol was added and after mixing, resting for 5-10 minutes and centrifugation for 
10 minutes at 12.000 RCF 4˚C an RNA pellet was left. The pellet was washed in 85% 
ethanol and dissolved in 100 µl RNase Free water. RNA concentration was measured with 
a Nanodrop (Thermo Scientific, Wilmington, USA). cDNA was synthesized from 2 µg of 
RNA which was first treated with DNase (DNase kit, Invitrogen, 18068-015) and 
subsequently reverse transcription was performed. A quantitative polymerase chain 
reaction (Q-PCR) was performed using SYBR green master mix (Applied Biosystems, 
Thermo Fisher Scientific, UK) according to the producer’s instructions. Reactions were 
performed using 384 wells (Applied Biosystems, Thermo Fisher Scientific, UK) using 
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5µL of SYBR green and primer mix (for a list of the primers used, see table 3.2) and 1.5µL 
of cDNA. The reaction was initialized at 50°C for 5 minutes and 95°C for 2 minutes, after 
which 40 cycles of denaturation (95°C 15 seconds) and annealing/extension (59°C 1 min) 
were performed. Afterwards, a melting curve was created and checked for a single product 
per gene. ΔCT values were calculated by subtracting the CT value of the housekeeping 
gene TBP from the gene CT value. ΔΔCT was calculated relative to control samples 
(Livak and Schmittgen 2001).  
 
Table 3.2 Primers used for q-PCR measurements in small intestine and liver. 
Gene Forward  Reverse 
TBP (hk) GAAGCTGCGGTACAATTCCAG CCCCTTGTACCCTTCACCAAT 
GAPDH (hk) AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
FXR  GGCCTCTGGGTACCACTACA AAGAAACATGGCCTCCACTG 
OSTA TTGTGATCAACCGCATTTGT CTCCTCAAGCCTCCAGTGTC 
ASBT TGGAATGCAGAACACTCAGC GCAAAGACGAGCTGGAAAAC 
FABP6 CACCATTGGCAAAGAATGTG AACTTGTCACCCACGACCTC 
SHP TCTGCAGGTCGTCCGACTATT AGGCAGTGGCTGTGAGATGC 
FGF15 CAGTCTTCCTCCGAGTAGCG TGAAGACGATTGCCATCAAG 
CYP7A1 GAGCGCTGTCTGGGTCACGG GCCAGCCTTTCCCGGGCTTT 
CYP27A1 TGTGGACAACCTCCTTTGGG CCATAGGTGAGGCCCTTGTG 
CYP8B1 TTGCAAATGCTGCCTCAACC TAACAGTCGCACACATGGCT 
 
Selected samples went for microarray analysis. After RNA isolation as described before, 
samples were send to WUR for microarray analysis. At WUR RNA quality was assessed 
with a Bioanalyzer (Aligent 2100 Bioanalyzer, Santa Clara, USA), and microarrays were 
performed using the Mouse gene Chip 1.1 array from Affymetrix (Thermo Fisher 
Scientific, Santa Clara, USA). After normalization process, ~22 k genes were included in 
the data set.  The limma R library was used to analyse the significant differential 
expression between the diets. Log2FC of 1.5 and a p-value of 0.05 were used as cut-off 
points and the rate discovery false for the p-value was calculated. Ingenuity Pathways 
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Analysis (IPA) web-based software application was used to analyse, integrate and 
interpret the data 
 
3.2.6 Histology 
From each UEA mouse, a small part of the liver and a piece of each of the three parts of 
the small intestine was collected in 10% formalin. 24 hours after collection, these samples 
were transferred into 50% ethanol and within a week were processed on the Leica ASP 
300, program overnight no formalin. The samples were embedded in wax and cut into 
5µm sections. Sections were stained with a haematoxylin and eosin (H&E) staining and 
pictures were taken with an Olympus BX60 microscope.  
 
3.2.7 Western blot 
Whole cell extracts were fractionated by SDS-PAGE and transferred to a polyvinylidene 
difluoride membrane using a transfer apparatus according to the manufacturer’s protocols 
(Bio-Rad). After incubation with 5% non-fat milk in TBST (10 mM Tris, pH 8.0, 150 mM 
NaCl, 0.5% Tween 20) for 60 min, the membrane was washed once with TBST and 
incubated with antibodies against FXR (1:1000 dilution, Santa-Cruz, sc-25309), GAPDH 
(1:5000 dilution, Abcam, AB8245) at 4 °C for 12 h. Membranes were washed three times 
for 10 min and incubated with a 1:3000 dilution of horseradish peroxidase-conjugated 
anti-mouse or anti-rabbit antibodies for 2 h. Blots were washed with TBST three times 
and developed with the ECL system (Amersham Biosciences) according to the 
manufacturer’s protocols 
 
3.2.8 Bile acid measurements 
As no bile acid measurements were performed in house at the time of arrival, we set up 
our own method in collaboration with the metabolomics unit of the Quadram Institute. A 
special thanks go to Mark Philo, who was a tremendous help in this process. Bile acids 
were measured in the scrapings and content of the three different parts of the small 
intestine, liver, colon faeces and serum. Here for, 50 mg (liver), 25 mg (intestine) or 50 
µL (serum) of tissue was homogenised in 1 ml of cold 70% methanol for 30 seconds at 
6000 rpm in a Precellys®24 (Bertin Technologies, France). After centrifugation (5 min, 
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3000g, 4˚C) the supernatant was transferred to a new collection tube and MeOH content 
was removed by rotary evaporation (70 min, 50˚C). Volume was restored to 1ml by adding 
5% MeOH. To clean up the samples they were loaded onto Waters OASIS PRIME HLB 
1 30mg SPE cartridges, washed with 5% MeOH and eluted in 500 µl 100% MeOH. 
Internal standards were added at the following time points: before homogenisation, before 
rotary evaporation, before loading onto cartridges, after elusion.  
Cleaned-up extracts were analysed using HPLC – mass spectrometry operated in multiple 
reaction monitoring (MRM) mode.  
Each sample (5 µl) was analysed using an Agilent 1260 binary HPLC couples to an AB 
sciex 4000 QTrap triple quadrupole mass spectrometer. HPLC was achieved using a 
binary gradient of solvent A (Water + 5mM Ammonium Ac + 0.012% Formic Acid) and 
solvent B (Methanol + 5 mM Ammonium Ac + 0.012% Formic Acid) at a constant flow 
rate of 600 µl/min. Separation was made using a Supelco Ascentis Express C18 150 x 4.6, 
2.7µm column maintained at 40˚C. Injection was made at 50% B and held for 2 min, 
ramped to 95%B at 20 min and held until 24 minutes. The column equilibrated to initial 
conditions for 5 minutes.  
The mass spectrometer was operated in electrospray negative mode with capillary voltage 
of -4500V at 550˚C. Instrument specific gas flow rates were 25ml/min curtain gas, GS1: 
40ml/min and GS2: 50ml/min.  
See appendix 2 for liquid chromatography-mass spectrometry (LC-MS) conditions and 
mass fragmentation monitoring values. Quantification was applied using Analyst 1.6.2 
software to integrate detected peak areas relative to the deuterated internal standards.  
 
3.2.9 Microbiota analysis  
3.2.9.1 microbial DNA isolation from SI content 
The content of each part of the small intestine was gently pushed out of the intestine at the 
time of sacrifice and rinsed out using 200µ of PBS. 150µL of this was used to isolate 
microbial DNA from. In collaboration with the Hall lab (Quadram Institute, Norwich 
Research Park, UK), for DNA isolation we used the Qiagen DNA mini kit following an 
improved protocol with additional steps to ensure breakage of all bacterial samples kindly 
provided by Dr. M Lawson. Briefly, the samples were homogenised using glass beads for 
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4x 30 seconds at 6000 rpm in a Precellys®24 (Bertin Technologies, France) and heated to 
95°C for 5 minutes in the middle. Additionally, samples were incubated with a lysis buffer 
containing 20mg/ml lysozyme after which the homogenising was repeated. Consequently, 
DNA was isolated using the Qiagen DNA mini kit following instruction from the 
producer. DNA quantity was assessed using both a nanodrop and a Qubit reader.  
 
3.2.9.2 16S sequencing of the SI microbiota  
A minimum of 50 ng of DNA was sent to the Earlham Institute (Norwich Research Park, 
UK) for quality assessment and 16S sequencing using the Illumina platform. Results were 
further analysed in collaboration with Wiktor Jurkoswki, PhD and Sarah Bastkoswki, PhD 
from the Earlham Institute.   
The microbiome composition was established using QIIME version 1.9.0 (Caporaso et al. 
2010). Paired reads were merged during the Quantitative Insights into Microbial Ecology 
Qiime 1.9.0 illumina workflow employed on a high performance computing cluster. The 
mapping file includes the forward and reverse linker primer sequence and was used for 
demultiplexing. Demultiplexing, quality filter and mapping file validation was carried out 
as described in the Qiime illumina workflow manual.  Operational Taxonomic Units 
(OTUs) were picked within Qiime using the closed-reference OTU picking protocol with 
the RDP classifier by searching reads against the Greengenes database version gg_13_8 
to the 97% level, and reads were aligned with PyNAST.  A representative sequence tree 
was gained after clustering using Uclust version 1.2.22. 
We calculated richness as defined through Chao1 (Chao A, (2000)) and diversity as 
defined by Shannon (Shannon C, (1948)) using the R package Phyloseq (version 1.18.0) 
(McMurdie P et al., (2013)). The Shapiro-Wilk test was used to assess normality and 
showed that the alpha diversity values are not normally distributed. We tested if diets had 
a significant impact on the mouse microbiomes alpha diversity using the Kruskal-Wallis 
test. A modified one way ANOVA as implemented in lmPerm (version 2.1.0, Wheeler R 
E, (2010)) was employed, which uses permutation tests instead of normal theory test, and 
was used to test for effects diet as covariates.   
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We used the fitZig function of the R package Metagenomeseq (Paulson et al. 2013) to 
establish significant differences in abundances of OTUs between groupings including 
covariates. We considered OTUs that were present in at least 25% of all samples.   
 
3.2.9.3 Quantification of the microbiota using Q-PCR 
Quantification of the microbiota was performed to analyse the effectiveness of 
administrating antibiotics. A standard curve was created by growing E. Coli until an 
optical density of 2 as measured on a spectrophotometer. Microbial DNA was isolated 
from this growth medium using the same method as described above and diluted into a 
standard curve. Total 16S DNA was quantified by q-PCR using the Eub primers (table 
3.3), relating the quantifiable samples to the produced standard curve.  
 
Table 3.3 Primers used for microbial DNA.  
Microbial 
DNA 
Forward  Reverse 
Eub  ACTCCTACGGGAGGCAGCAG ATTACCGCGGCTGCTGG 
Bacteroides GGARCATGTGGTTTAATTCGATGAT AGCTGACGACAACCATGCAG 
Firmicutes GGAGYATGTGGTTTAATTCGAAGCA AGCTGACGACAACCATGCAC 
 
3.2.10 Glucose and starch quantification in intestinal content  
Glucose in the content of the ileum was determined in mice that were oral gavaged with a 
high dose of glucose to determine if the glucose reached the ileum. Glucose quantification 
was performed using a glucose assay kit (Sigma-Aldrich GAG020). 20mg of content was 
homogenized in 500 µL deionized water, heated at 70C for 15 minutes and centrifuged 
for 10 minutes at 3000g. The supernatant was used in the glucose assay kit using the 
manufactures instructions.  
 
Starch was quantified in the content of the ileum and caecum in order to determine starch 
digestion higher up in the small intestine using the total starch assay (Megazyme, K-
TSTA-50A). 20mg of content was homogenized in 1 mL of 80% Ethanol and centrifuged 
for 10 minutes at 1800g. After wash steps, starch was digested by alpha-amylase according 
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to the manufactures protocol. Finally, glucose is measured in an absorbance plate reader 
at 510 nm.  
 
3.2.11 Serum and liver measurements 
Transaminases Alanine transaminase (ALT) and Aspartate transaminase (AST) were 
tested in the serum using a routine colorimetric ILAB 650 assay to determine normal liver 
function.   
 
Cholesterol was determined in the serum using the corresponding liquicolor kits (Human 
GmbH, Germany) following the manufactures protocol.  
 
Cholesterol and triglycerides were also analysed in the livers using the same kits. 
Proceeding this, the lipid fraction was extracted following an adjusted version of the Bligh 
and Dyer method (Bligh and Dyer 1959). In short, 50 mg of liver tissue was homogenized 
in 200 L chloroform and 400 L methanol. 200 L distilled water was added and the 
sample was homogenized again after which the sample was centrifuged for 10 minutes at 
3000g. The lower layer was subsequently transferred to a clean Eppendorf tubes and dried 
overnight. The dried pellet was dissolved in 250 L 2% Triton X-100 and this was used 
to perform the colorimetric assay.  
 
3.2.12 Statistics 
Statistics have been performed using Graphpad Prism. The statistical tests used are 
indicated in each figure legend. Power calculations were based on Fgf15 results observed 
in the 10 parts study and led to a minimum of 5 mice per group being used in each 
experiment (indicated per figure). Analysis of variance (ANOVA) provides a statistical 
test of whether the means of groups are equal. When groups were compared over time, a 
2-way ANOVA with Bonferroni post-hoc test was used. When three or more groups were 
compared at a single time point, a 1-way ANOVA was used with Bonferroni post-hoc. 
Lastly, when two groups were compared at one time point, an unpaired t-test was used to 
test for significance. p<0.05 was considered overall as statistically significant and 
significance was indicated as ***= p<0.001 **= p<0.01 *= p<0.05. 
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3.3 Results 
To investigate the effects of diets on bile acid metabolism and the regulation of the 
signalling molecule Fgf15, a standard chow diet and a purified HS diet were compared 
over time. As expected, no changes in body weight or food intake were observed between 
the two groups over a six-month period (figure 3.1A and B). More information about the 




Figure 3.1 The high starch (HS) diet does not lead to changes in body weight in mice. Mice were fed a 
standard chow diet or a purified HS diet for up to six months. During this time, no differences in either body 
weight (A) or calorie intake (B) were observed. Significance was tested using 2-way ANOVA with Bonferroni 
post-hoc test (A) and an unpaired t-test (B)  
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3.3.1 A HS diet increased the expression of the signalling molecule Fgf15 in the ileum 
independent of bile acids  
Despite the lack of difference in body weight, aspects of bile acid metabolism were found 
to be differentially regulated in the two diet groups. The most striking change was a 2-6 
fold increase in the expression of the signalling molecule Fgf15 in the HS fed mice. Fgf15 
expression was increased on all measured time-points (3 days to 6 months, figure 3.2A) 
and this difference in gene expression was confirmed in an independent study performed 
at Wageningen University (WUR, NL). The WUR study was performed with mice on a 2 
week-intervention with chow, HS and HF-diets.  Both the HF and HS diet are purified 
diets, the only difference being that a large part of the starch (379.4g / 84%) is replaced 
by saturated fat in the HF diet. Changes in gene expression have been studied by using 
whole genome microarrays over the course of the small intestine. Fgf15 expression 
showed an expected increase toward the ileal part of the small intestine in chow fed mice 
and showed also a pronounced upregulation on the HS diet compared to the chow diet 
(figure 3.2B). The HF-fed mice show Fgf15 expression pattern more similar to the chow 
group, suggesting that potentially the amount of starch may play a role in ileal Fgf15 
expression levels.  
Since bile acids are known to be the major regulator of Fgf15 expression, bile acids present 
in the ileal tissue at the time of sacrifice were analysed via HPLC and LC-MS. No 
differences in total bile acids and no consistent differences in individual bile acids were 
observed between the two diets (figure 3.2C, D and table 3.4). The minor differences in 
individual bile acids observed were not consistent over the different time point and would 
not easily explain the difference in Fgf15 expression. Overall, most differences would 
suggest higher FXR activity on the chow diet, which would lead to the opposite effect of 
that observed in the current study. For example, after 3 days of feeding tauro conjugated 
beta muricholic acid (T-b-MCA) is significantly higher on the HS diet compared to the 
chow diet, while it has been known to be a FXR antagonist (Sayin et al. 2013b; Gonzalez 
et al. 2017) and should lead to a decrease in Fgf15 expression. Taken together, these results 
indicate that dietary starch increases the expression of Fgf15 in the ileum independent of 
changes in bile acids.   
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Table 3.4 Ileal bile acid profiles show no consistent alteration between chow and HS fed mice. Bile acid were 
quantified in ileal tissue by HPLC and are given in µmol/g tissue after 3 days, 2 weeks and 6 months of feeding the 
chow and HS diet. Significance was calculated using a 2-way ANOVA with Bonferroni post-hoc test between chow 
and HS (***= p<0.001, **= p<0.01, *= p<0.05) n≤5 for all groups Color coding indicated conjugation, white being 
tauro-conjugated, light grey being glyco-conjugated and dark grey being unconjugated bile acids  
 
Figure 3.2 A high starch diet increases the expression of Fgf15 in two independent studies while no 
differences in ileal bile acids are observed. Fgf15 expression in the ileum is increased in mice on a HS 
diet at all measured time points, from 3 days to 6 months (A). An independent study performed at 
Wageningen University shows Fgf15 expression levels over the course of the small intestine, confirming 
the increase of Fgf15 of mice on a HS diet in the ileum compared to both a control chow diet and a high fat 
(HF) diet (B). Bile acids were measured in ileal tissue and show no differences in total bile acids after 3 
days, 2 weeks and 6 months of feeding (C) and the major bile acid groups after 6 months of feeding the 
chow versus HS diet (D). Significance was tested using or 2-way ANOVA with Bonferroni post-hoc test 
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3.3.2 Dietary regulation of Fgf15 modulates hepatic bile acid and cholesterol metabolism  
After production, the signalling molecule Fgf15 is excreted into the portal vein and is 
transported to the liver to block de novo bile acid production via blocking Cyp7a1 (figure 
3.3A). To test the biological effects of the increased Fgf15 expression on the HS diets 
Cyp7a1 gene expression was measured in the liver. In line with the known effects of 
Fgf15, Cyp7a1 expression was decreased on all time point in the HS fed mice and this 
effect increased in significance over time (figure 3.3B). Hence, starch-mediated dietary 
regulation of Fgf15 is capable of affecting hepatic bile acids metabolism.  
Cyp7a1 converts cholesterol in bile acids, which for the bile acids that escape reabsorption 
in the ileum, is one of the only known ways of cholesterol excretion in mammals. Since 
the previously observed decrease in Cyp7a1 expression could influence cholesterol 
metabolism, both serum cholesterol and hepatic cholesterol were quantified.  An increase 
in both hepatic and circulating cholesterol levels, that became significant in the long term 
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was observed (figure 3.3C). This indicates a HS diet can increase the expression of the 




Figure 3.3 A HS diet decreases Cyp7a1 expression and increases cholesterol levels. FGF15 produced in 
the ileum travels to the liver to block Cyp7a1 expression (A), which explains the decrease in Cyp7a1 
expression observed in mice fed the HS diet (B). Cholesterol level were measured in both the serum and the 
liver (C). Significance was tested using 2-way ANOVA with Bonferroni post-hoc test between chow and HS 
diet (***= p<0.001, *= p<0.05) n≤5 for all groups 
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3.3.3 Involvement of the microbiota 
It has been shown previously that the colonic microbiota is vastly different between a 
standard chow and a purified HS diet showing both a decrease in diversity and a large 
alteration in the kind of bacteria present (Dalby et al. 2017). Since the peak abundance of 
FGF15/19 expression is in the ileum, we decided to sequence the small intestinal 
microbiota to investigate its potential role in the regulation of Fgf15 expression under HS 
diet conditions. Microbial DNA was isolated from the content of the small intestine after 
two weeks of feeding and the 16S gene loci was sequenced. As expected, major 
differences in the small intestinal microbiota were identified, with switch from 
Bacteroidetes being the dominant phyla to Firmicutes being dominant in the HS fed mice 
(figure 3.4A). Additionally, microbial diversity was found to be lower in the HS fed mice 
as calculated by Shannon diversity (figure 3.4B).  
To investigate causality of the differences in microbiota in the dietary regulation of Fgf15, 
mice were treated with a cocktail of broad spectrum of antibiotics to deplete the number 
of bacteria significantly in the intestine. Additionally, a group of mice was treated with 
the antifungal agent fluconazole (0.5mg/ml in drinking water) to abolish the fungal part 
of the microbiome, and another group of mice received both treatments in combination. 
Subsequently, Fgf15 expression was measured in the ileum and showed increased 
expression in all of the HS fed mice independent of the treatment (figure 3.4C). In line 
with literature (Miyata et al. 2009), Fgf15 expression was found to be significantly 
decreased after antibiotic treatment in chow fed mice (10 fold decrease, p=0.03 for chow 
versus chow+ab, figure 3.4C). To confirm that the antibiotics treatment successfully 
decreased the number of bacteria in the ileum, microbiota was quantified via q-PCR 
showing a significant depletion in both diet groups after antibiotics treatment (figure 
3.4D).  Furthermore, the microbiota changes of mice fed the HS diet are very similar to 
the microbiota  changes in mice fed the HF diet (data not shown, similar results published 
(Dalby et al. 2017)), while Fgf15 expression is only upregulated on the HS diet and not 
the HF diet. This underlines the independency on the microbiota for the purified diets.        
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Figure 3.4 The small intestinal microbiota is vastly different between the chow and HS diet but is not 
causal in the observed changes in Fgf15 expression. Microbial DNA was isolated from the content of the 
small intestine and showed a switch from Bacteroidetes to Firmicutes as the predominant phyla in HS fed 
mice (A). Additionally, microbial diversity was found to be decreased (B). Mice were treated with a cocktail 
of broad spectrum antibiotics, fluconazole as an antifungal agent or a combination of both treatments to test 
the causality of the microbiota on the different Fgf15 expression. None of the treatments decreased Fgf15 
expression on the HS diet (C). Microbiota was quantified to test the effectiveness of the antibiotic treatments 
(D). Significance was tested using an unpaired t-test (A, B, C) or a 2-way ANOVA with Bonferroni post-hoc 
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3.3.4 Direct effects of HS diet on FGF15 expression   
The potential exclusion of causality of the microbiota in the starch regulation of Fgf15 
insinuated a direct effect of components of the HS diet. To investigate this, mice were 
exposed to the diets for a very short time. 12 week old mice that had been receiving the 
chow diet since weaning were fasted for 12 hours overnight and consequently refed with 
either the chow or HS diet for 3 hours before sacrifice, in order to investigate the direct 
effects of the diet on Fgf15 expression. The overnight fast ensured food consumption 
during these 3 hours and digested food was found in the small intestine after sacrifice. 
Anticipating this experiment, transit time from stomach to faeces was determined to be 
around 2.5 hours and not significantly different between diet groups (figure 3.5A) 
indicating that 3 hours of refeeding the diets will allow the diets to pass through the 
intestine. Others have used labelled activated charcoal to show that passage through the 
small intestine takes place in approximally 1 hour in mice (Padmanabhan et al. 2013). 
After refeeding, a trend (p=0.06) towards higher Fgf15 expression in mice fed the HS diet 
was observed indicating a direct effect of the HS diet on Fgf15 expression (figure 3.5B).  
To investigate the amount of starch reaching the ileum, both starch (figure 3.5C) and 
glucose levels (figure 3.5D) were quantified in the ileum and were found to be 
significantly higher in mice fed the HS diet compared to chow fed mice. A positive 
correlation was observed between both starch and glucose with Fgf15 (figure 3.5E) 
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Figure 3.5 The HS diet has a direct effect on Fgf15 expression, most likely due to ileal exposure to 
starch and glucose. Transit time was tested using Evans Blue mixed with the corresponding diets in mice 
that had been fed the chow or HS diet for three months (A). To test the direct effects of the HS diet, mice 
on a chow background were fasted for 12 hours overnight before being refed for 3 hours with either chow 
or the HS diet (B). In mice fed the chow or HS diet for 3 days to 2 weeks, glucose was determined in the 
luminal content of the ileum, showing to be increased in the HS group and correlating with Fgf15 expression 
(C). Significance was tested using an unpaired t-test between chow and HS diet (*= p<0.05), correlation 
was tested using Pearson correlation n≤4 for all groups.  
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3.3.5 Inhibiting starch digestion by acarbose treatment  
To determine the causality of starch and starch digestion in the observed increase in ileal 
Fgf15 expression, mice were treated with acarbose in addition to the HS diet. Acarbose is 
an alpha-glucosidase inhibitor that is commonly used in the management of 
hyperglycaemia. It is a noninsulinotropic oral antidiabetic agent that competitively blocks 
alpha-glucosidases and thereby inhibits the digestion of di, oligo- and polysaccharides. -
Glucosidases are enzymes located in the brush border membrane of the small intestine that 
cleave di- and oligosaccharides into monosaccharides to enable their uptake into the 
enterocytes. Acarbose is a pseudotetrasaccharide and similar to that of natural 
oligosaccharides, however it has a 104 to 105 times higher affinity for -glucosidases and 
can therefore decrease the number of available enzymes for the digestion of starch-derived 
oligosaccharides (Rosak and Mertes 2012). Thus, under acarbose treatment, starch 
digestion is decreased which leads to less glucose uptake into epithelial cells.   
In this experiment, mice were treated with acarbose at a dose of 50mg per kg of body 
weight per day for 2 weeks, and this was administered via the drinking water (figure 3.6A). 
To confirm the decreased uptake of starch in the small intestine, starch was quantified in 
the caecum showing an increase in the acarbose treated mice (figure 3.6B). Subsequently, 
Fgf15 expression was quantified in the ileum and showed a dramatic decrease in the 
acarbose-treated mice (figure 3.6C), which correlated with an increase in Cyp7a1 
expression in the liver (figure 3.6D). Additionally, a trend towards decreased serum 
cholesterol levels in acarbose-treated mice was seen (figure 3.6E). This effect is in line 
with the previous observation that Fgf15 and Cyp7a1 expression have effects on 
cholesterol levels. Taken together, these data indicate that the conversion of starch to 
glucose is causal in the upregulation of the signalling molecule Fgf15 in the ileum.  
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Figure 3.6 Inhibiting starch digestion by acarbose decreases Fgf15 expression and consequently 
increases hepatic Cyp7a1 expression. To inhibit starch digestion one group of mice was treated with 
acarbose (50mg / kg BW) for two weeks (A), shown to be effective by an increase in starch found in the 
caecum thus escaping digestion the in small intestine (B). Fgf15 expression in the ileum is downregulated 
by acarbose treatment (C) which correlated with an upregulation of hepatic Cyp7a1 expression (D) and a 
trend towards lower serum cholesterol levels (E). Significance was tested using 1-way ANOVA with 
Bonferroni post-hoc test between chow and HS diet (*= p<0.05) n≤5 for all groups   
 
  
PhD thesis Britt Blokker 77
3.3.6 Intracellular Glucose in the epithelial cells after uptake from the intestinal lumen 
increases Fgf15 expression 
Since starch digestion into glucose was determined to be essential for the starch-induced 
increase in Fgf15 expression, the direct effects of glucose were investigated. Although 
glucose is normally absorbed in the duodenum and jejunum, overloading the mouse small 
intestine with glucose has been shown to induce glucose uptake in the ileum (Bode et al. 
1981). Therefore, mice on a chow diet were treated with a one-time dose of glucose (2 
gram / kg BW, a concentration often used in glucose tolerance tests (Andrikopoulos et al. 
2008)) via oral gavage and the response in ileal Fgf15 expression was tested over time 
(Appendix 3A). Blood glucose levels were measured 15, 30, 60, 90 and 120 minutes after 
OG and showed an expected initial increase and consequent normalization (Appendix 3B). 
Two mice per time point were sacrificed 30, 60, 90 and 120 minutes after OG to measure 
intestinal and hepatic gene expression. Fgf15 expression showed a time-dependent 
increase after glucose OG with a peak at 90 minutes (Appendix 3C), and this timepoint 
was selected for further experiments. Additionally, hepatic Cyp7a1 decreased over time 
(Appendix 3D) and, as previously described, hepatic glucose metabolism genes responsive 
to Fgf15 (Potthoff et al. 2011) show a decrease at the same time that Fgf15 expression 
increases (Appendix 3E).  
 
To gain sufficient significance in the increase of Fgf15 after glucose OG the experiment 
was repeated with 5 mice per group both before and 90 minutes after OG. Additionally, a 
third group of mice received the same dose of glucose (2g/ kg BW) via intraperitoneal (IP) 
injection to test if glucose needed to reach the ileum via the intestinal lumen in order to 
increase Fgf15 expression (figure 3.7A). In line with the preliminary results, Fgf15 
expression was found to be significantly higher 90 minutes after glucose OG (figure 3.7B). 
Mice who received the glucose load via IP injection, circumventing the intestinal lumen, 
did not show a similar increase (figure 3.7B). As a proof of concept, glucose levels in the 
intestinal lumen of the ileum were measured and show an increase in OG treated mice 
(figure 3.7C). Hepatic Cyp7a1 expression was decreased in both OG and IP mice (figure 
3.7D), which might be explained by an increase in hepatic FXR activity in response to 
increased blood glucose levels (Berrabah et al. 2014).   
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Figure 3.7 Glucose reaching the ileal enterocytes via the apical membrane induces Fgf15 expression. 
Mice were treated either by oral gavage (OG) or intraperitoneal injection (IP) and sacrificed before or 90 
minutes after treatment (A). Fgf15 expression in the ileum was significantly higher after OG but not IP (B). 
Glucose from OG treated mice reaches the ileum (C). Hepatic Cyp7a1 expression is downregulated in both 
OG and IP treated mice (D). Significance was tested using 1-way ANOVA with Bonferroni post-hoc test 
between chow and HS diet ( *= p<0.05) n≤5 for all groups  
3.3.8 Bile acids are essential for Fgf15 expression, independent of diet  
As mentioned previously, bile acid profiles in the ileum were not found to be consistently 
different between chow and HS fed mice (figure 3.1E and table 3.1). Therefore, we 
designed an experiment to investigate the requirement of bile acids for the observed 
difference in Fgf15 expression. Hence, mice were treated with the bile acid sequestrant 
cholestyramine twice daily via oral gavage. Cholestyramine is a positively charged non-
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digestible resin that binds to bile acids in the intestine to form insoluble complexes that 
leave the body via the faeces (Scaldaferri et al. 2013). Thus, cholestyramine inhibits the 
reabsorption of bile acids in the ileum. Mice on both the chow and the HS diet were treated 
with cholestyramine and Fgf15 expression was found to be abolished on both diets (figure 
3.8B). This indicates that bile acids are essential for the expression of Fgf15 in the ileum, 
independent of the starch content of the diet.  
 
3.3.9 The farnesoid X receptor is involved in the increase of Fgf15 by starch and glucose  
The most well-known regulation of Fgf15 is via the transcription factor FXR, which can 
be activated by bile acids (Dawson and Karpen 2015). Since bile acids were found to be 
essential in the regulation of Fgf15 in mice on both the chow and the HS diet, the role of 
FXR was determined further. To investigate the role of FXR in the regulation of Fgf15 a 
natural FXR antagonist, guggulsterone, was used. Guggulsterone is a steroid that can be 
found in the guggul plant and has been used in Ayurvedic medicine since 600 BC to treat 
a wide variety of diseases including lipid disorders. Mice on the chow and HS diet were 
treated with 20 mg/kg BW via daily oral gavage and showed a decrease in ileal Fgf15 
expression for both diets (figure 3.8C). Another ileal FXR target gene, Fabp6, showed a 
similar decrease under guggulsterone treatment indicating that guggulsterone inhibited 
FXR activity in our experiment (figure 3.8D).  
To investigate the posttranscriptional effects of glucose on FXR protein expression, 
western blots were performed on protein extracts of ileal tissue at time-points after glucose 
oral gavage showing an increase in FXR protein over time (figure 3.8E), while no increase 
was observed at gene expression level (data not shown). Other ileal FXR target genes, Shp 
and Fabp6, were quantified after glucose treatment by OG and IP, showing a significant 
increase in OG treated mice only (figure 3.8F). Taken together, these data indicate a role 
for the transcription factor FXR in the upregulation of Fgf15 expression by starch and 
glucose.  
In combination with the cholestyramine results this confirms that glucose, bile acids and 
FXR are needed to achieve the observed increase in Fgf15 expression, leading us to 
speculate that FXR undergoes glucose-hexosamine-derived O-linked B-N-
acetylglucosamine modification (GlcNAcylation). O-GlcNAcylation leads to an increase 
PhD thesis Britt Blokker 80
of FXR protein stability, transcriptional activity, and chromatin binding through SMRT 
inactivation, which afterwards would lead to increased target gene expression after 
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Figure 3. 8 Both bile acids and the transcription factor FXR are involved in the upregulation of Fgf15 
by starch and glucose. Mice were treated with cholestyramine (A), a bile acid sequestrant, which abolishes 
Fgf15 expression in both chow and HS fed mice (B). To investigate the role of FXR mice were treated with 
the natural FXR antagonist guggulsterone (A), and Fgf15 expression was downregulated under both dietary 
conditions (C). Additionally, Fabp6, another ileal FXR target gene was also downregulated by 
guggulsterone (D), indicating that it successfully depressed FXR activity. FXR protein was quantified in 
response to an OG glucose load and showed upregulation over time (E). Furthermore, the ileal FXR target 
genes Shp and Fabp6 were upregulated by an oral glucose load but not if the glucose was administrated via 
IP injection (F). Significance was tested using 2-way ANOVA (B, C, D) or 1-way ANOVA (F) with Bonferroni 
post-hoc test between chow and HS diet (***= p<0.001, **= p<0.01, *= p<0.05). 
 
3.3.11 Long term effects of increased FGF15 expression on circulating bile acids 
As shown before, the starch induced increase in Fgf15 leads to an increase of cholesterol 
levels, however also other long-term health effects were observed. Firstly, we investigated 
the effects of the changes of both ileal Fgf15 and hepatic Cyp7a1 expression on circulating 
bile acids. Serum bile acids were determined via HPLC-MS and large differences were 
found between the diet groups after 6 months of feeding (figure 3.9A). Notably, these 
differences were not observed at the shorter time points (3 days – 2 weeks, data not 
shown). This disturbance in circulating bile acids could potentially have wide-spread 
health effects by these bile acids activating the ubiquitously expressed bile acid sensing 
transcription factor TGR5 (Kawamata et al. 2003).  
 
3.3.12 Long-term glucose induction of FGF15 potentially leads to hepatic carcinoma 
development  
Furthermore, in our long-term experiment (6 months), we encountered hepatic carcinoma 
in 2 out of 9 HS fed mice (figure 3.9B) while no carcinoma was encountered in the chow 
fed mice (0/10). Induction of FGF15/19 has previously been linked to the development of 
hepatic carcinoma (Uriarte et al. 2015; Uriarte et al. 2013); here we show that glucose-
dependent induction of Fgf15 can contribute to the development of liver cancer in mice. 
Additionally, the alanine aminotransferase (ALT) was found to be higher in the serum of 
mice exposed to the HS diet for 6 months (figure 3.9C), indicating liver damage. At the 
shorter time points (3 days and 2 weeks) no significant differences in transaminases were 
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observed (data not shown), however a trend toward more cell division, as measured by 
Ki67, Cyclin D (gene Ccdn1) and Survivin (bene Birc5) gene expression is already 
observed at these time points (figure 3.9D). Further, gene expression in these cell 
proliferation genes was found to be significantly upregulated after 6 months of feeding 
even though the mice with hepatic carcinoma were excluded from the gene expression 
data set (figure 3.9D). Taken together, this indicates that the glucose induction of Fgf15 is 
substantial enough to contribute to the development of hepatic carcinoma in mice.   
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Figure 3.9 Long term overexpression of Fgf15 leads to alterations in circulating bile acids and 
increases the chances of developing hepatocarcinoma in mice. After 6 months of feeding chow versus 
HS diet large differences in circulating bile acids are observed (A). Furthermore, hepatic carcinoma was 
encountered in 2/9 HS fed mice (B), compared to 0/10 chow fed mice, and serum ALT levels were found to 
be increased in HS fed mice (C). Trends towards more cell proliferation and collagen production in mice 
fed the HS diet can be found at early time points (3 days – 2 weeks, D) and these differences become 
significant after 6 months even though the mice with profound liver cancer are excluded from gene 
expression data set (D). Significance was tested using 2-way ANOVA with Bonferroni post-hoc test between 
chow and HS diet (*= p<0.05) n≤5 for all groups 
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3.4 Discussion 
Here, for the first time, we show that dietary starch can increase the expression of the 
important signalling molecule FGF15/19 in the ileum. A HS diet can lead to an increase 
in glucose absorption in ileal enterocytes which in turn provokes an increased expression 
of FGF15/19, possibly via GlcNAcylation of the bile-sensing transcription factor FXR. 
Since FGF15/19 is involved in blood glucose homeostasis by activating relevant pathways 
in the liver (Kir et al. 2011; Wu et al. 2010; Potthoff et al. 2011), this speculatively may 
be a response of the body to an overload of starch.  
Although we are, to the best of our knowledge, the first to highlight this effect, indications 
have surfaced in previous scientific papers. Most research groups compare the HS diet to 
a purified HF diet, as was also used in the WUR studies. De Wit et al (De Wit et al. 2008) 
previously identified a difference in Fgf15 expression (by performing microarray analysis 
of the ileum) in mice on the HS and HF diet, but assumed a downregulation of Fgf15 by 
dietary fat. Here we show that rather than the dietary fat decreasing Fgf15 expression, a 
surplus of dietary starch is increasing its expression. The biological activities surrounding 
the increase in Fgf15 are shown by its effect on both Cyp7a1, the rate limiting enzyme in 
de novo bile acid synthesis, and on blood and liver cholesterol levels. In this regard, 
regulation of FGF15/19 expression has shown to affect cholesterol levels in both mouse 
models (Stroeve et al. 2010) and human intervention studies (Harrison et al. 2018).  
The combination of scientific literature showing a reduction in Fgf15 expression both after 
antibiotic treatment (Miyata et al. 2009) and in germ free mice (Sayin et al. 2013b), and 
the major differences in the small intestinal microbiota we identified led us to a 
hypothesized role for the microbiota in the regulation of Fgf15 expression. Conversely, 
antibiotic-treated mice on the HS diet, in which the small intestinal microbiota was 
successfully abolished, showed no decrease in Fgf15 but a slightly greater increase in 
Fgf15 expression compared to conventionally raised HS-fed mice. Since we determined 
starch to be responsible for the Fgf15 alterations, this difference could potentially be due 
to the quantity of available starch present in the ileum, as it has been shown that the 
microbiota can ferment digestible starch (McBurney, Cuff, and Thompson 1990). So, 
potentially the small intestinal microbiota negatively influences the amount of starch 
reaching the ileal enterocytes and depleting the microbiota leads to an increase in ileal 
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starch exposure. Of note, our results are in line with previous literature, as in chow fed 
mice we observed a decrease in Fgf15 expression.  
Acarbose is an antidiabetic drug that inhibits the hydrolysis of complex carbohydrates and 
thereby reduces glucose uptake in the small intestine. Acarbose treatment, therefore, was 
used to show the role of starch digestion in Fgf15 gene expression regulation. Recently, 
the effects of acarbose on the microbiota and bile acid profiles in humans have been 
studied showing an increase in circulating unconjugated bile acids. As a result of the bile 
acid profiles, an increase in FGF19 would be expected, however a significant decrease in 
circulating FGF19 was observed (Gu et al. 2017). This, in line with our findings and 
proposed mechanism, could be explained by the decreased digestion of starch and other 
oligosaccharides in the ileum. Additionally, a slight decrease in blood cholesterol levels 
was observed in the acarbose treated participants (Gu et al. 2017), similar to the effects 
we observe in our mouse model. Further emphasizing the human relevance of the here 
elucidated mechanism of FGF15/19 upregulation by glucose is given in a postprandial 
study (Morton et al. 2014). Here, participants were given a fat, protein or carbohydrate 
drink in a cross-over design and their response in circulating FGF19 was measured. The 
carbohydrate drink consisted of mostly glucose and increased circulating FGF19 levels in 
blood significantly compared to both the fat and protein drink, which is consistent with 
the here observed increase of Fgf15 expression after glucose OG in mice. Together with 
previously discussed human acarbose study (Gu et al. 2017), this indicates that the 
upregulation of Fgf15 expression after ileal exposure to starch and/or glucose is most 
likely also relevant for humans.  
 
To further elucidate the molecular mechanism behind the regulation of FGF15/19, the 
involvement of both bile acids and FXR were identified as essential in the increase of 
Fgf15 expression by glucose. This would be in line with a study performed at Groningen 
University by Herrema et al (unpublished), where they fed wild type (WT) and intestinal 
specific FXR knockout mice a high dextrose diet (consisting of mostly glucose) or chow 
diet and observed an increase in Fgf15 expression in the ileum only in WT mice fed the 
dextrose diet. Additionally, they observed an even higher increase in WT mice fed the 
dextrose diet in the morning compared to the evening which could be explained by mice 
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consuming most of their food during the night time (Vanderlip 2001); hence more glucose 
being present in the ileum in the morning. For all murine studies conducted for this thesis, 
sacrifices took place in the morning.  
 
Although not much is known about ileal FXR regulation by glucose, glucose has been 
shown to increase hepatic FXR in a dose-dependent manner in rats on both gene and 
protein expression and activity (Duran-Sandoval et al. 2004).  Glucose is capable of 
altering FXR activity via glucose-hexosamine-derived O-linked B-N-acetylglucosamine 
modification (GlcNAcylation). O-GlcNAcylation leads to an increase of FXR protein 
stability, transcriptional activity, and chromatin binding through SMRT inactivation 
(Benhamed et al. 2014). This has shown to regulate hepatic FXR in vivo during fasting 
and refeeding cycles (Berrabah et al. 2014). So, higher glucose levels can stabilize FXR 
protein via GlcNAcylation, however activation of FXR is still needed to show this 
increased activity. This is in line with our results where we need both FXR and its natural 
activator, bile acids, to induce the increased expression of Fgf15 in starch fed mice (figure 
3.12).  
 
Surprisingly, in our model Fgf15 is the most responsive FXR target gene after the possible 
stabilization of FXR protein. Only after glucose OG we were able to show other FXR 
target genes to be upregulated in the ileum (figure 3.9F). We hypothesize that Fgf15 
expression is particularly sensitive to alteration in FXR stability, however more research 
will be required to reveal the molecular mechanism behind this.  
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Figure 3.10 Hypothesis on the molecular mechanism by which starch increases the expression of 
FGF15/19. In addition to bile acid reabsorption taking place in the ileum, under high starch conditions 
glucose is also absorbed into ileal enterocytes. Increased intracellular glucose levels can lead to 
GlcNAcylation of FXR, stabilizing the protein. Bile acids activate FXR in both the control and the high 
starch conditions, but due to the increase in protein stabilization in the high starch fed group, there is more 
production of the important signalling molecule FGF15/19 in the high starch fed group. This consequently 
leads to more inhibition of CYP7A1, the rate limiting enzyme in de novo bile acid synthesis, and therefor 
to less bile acid production and a rise in cholesterol levels, among other health effects. This figure was 
produced using and adapting figures from  (“SMART - Servier Medical ART” 2018).  
 
Long term overexpression of FGF15/19 has a number of detrimental health effects; one 
being higher blood cholesterol levels due to a reduced conversion of cholesterol into bile 
acids by hepatic CYP7A1 (S. A. Harrison et al. 2018; Dawson 2015). Here, we show 
dietary regulation of Fgf15 by starch can increase cholesterol levels, and most likely by 
the same mechanism. Furthermore, serum bile acid profiles were significantly altered after 
6 months of feeding, which can influence other organs via the bile acid sensing G-coupled 
protein receptor TGR5. TGR5 is expressed ubiquitously in both mice and humans, and its 
expression has been shown in a wide distribution of organs including endocrine glands, 
adipocytes, muscles, intestine, spleen and lymph nodes (Kawamata et al. 2003). LCA is 
the most potent agonist of TGR5 (Duboc, Taché, and Hofmann 2014), and is 
downregulated in mice fed the HS diet for 6 months, however a slightly less potent agonist, 
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TCA, is upregulated under these conditions. Further research is needed to identify the 
effects of LCA and TCA in modifying bile acid profiles on TGR5 activation in other 
organs and its health effects.  
 
FGF15/19 has shown to be hepatoprotective during acute liver injury; while it is pro-
carcinogenic if chronically activated. Consequently, interfering with the FGF19 – 
FGFR4/KLB signalling pathway in liver cancer is regarded a new strategy in fighting this 
disease (Alvarez-Sola et al. 2017; Miura et al. 2012; Hyeon et al. 2013; Hagel et al. 2015). 
Additionally, Fgf15 KO mice develop less hepatocellular carcinoma and fibrosis under 
the treatment of diethylnitrosamine compared to their wildtype littermates. Fgf15 KO mice 
show less cell proliferation in the liver, as shown by Ki-67 and less fibrosis as shown by 
aSMA (Uriarte et al. 2015). Furthermore, Fgf15 has previously been shown to induce 
cyclin D expression in a partial hepatectomy mouse model (Li et al. 2018). In the current 
feeding studies, chronic overexpression of Fgf15 is induced in the HS mice and after 6 
months hepatic carcinoma was observed in 2 out of 9 HS fed mice while no hepatic 
carcinoma was observed in the chow fed animals. After only 3 days and 2 weeks of feeding 
of the HS diet, a small trend towards more cell proliferation (shown by Ki-67 gene 
expression) and fibrosis, (shown by aSMA expression) could already be observed. This 
correlates with the higher levels of Fgf15 in these animals. Taken together this emphasizes 
the severity of the chronic diet-induced induction of Fgf15.  
 
In conclusion, we demonstrate that ileal exposure to glucose, either directly or in the form 
of starch, increases the expression of the important signalling molecule Fgf15, 









Chapter 4 Soluble fibres suppress the production of signalling 
molecule Fgf15 in the ileum most likely independent of the 
microbiota 
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Name study Where Performed by 
candidate? 
Samples available 
FOS study UEA Yes All 
FOS + antibiotics study UEA Yes All 
Soluble fibre study UEA Yes All 
 
As briefly discussed in the last chapter, starch content is not the only difference between 
the chow and HS diet. Another important factor is the lack of (soluble) fibres in the HS 
diet. Therefore, in this chapter, the role of dietary soluble fibres on (the gut-liver axis and 
in particular on) Fgf15 expression will be discussed.  
 
4.1 Introduction 
Fibres are non-digestible carbohydrates that can be found in mainly plant-based foods and 
can be divided into two broad groups; insoluble and soluble fibres. Insoluble fibres are, as 
the name suggests, not soluble in water and are poorly fermentable by the gut microbiome. 
Soluble fibres are soluble in water and are fermented by bacteria in our GI tract, leading 
to the production of short chain fatty acids (SCFAs) (Dhingra et al. 2012; Slavin 2013). 
Epidemiological studies have found an inverse correlation between dietary fibre intake 
and blood cholesterol levels (Brown et al. 1999) and the risk of cardiovascular disease 
(Threapleton et al. 2013). The cholesterol lowering effect of soluble fibres has also been 
shown in multiple animal models, e.g.  mice (S. Han et al. 2015a) and pigs (P. Gunness et 
al. 2016).  
 
While some hypotheses exist, to this day it is not completely understood how soluble fibre 
can decrease blood cholesterol levels. One of the proposed mechanisms is via modulation 
of bile acid metabolism, as this is a major determinant of cholesterol metabolism (Purnima 
Gunness and Gidley 2010). As discussed in detail in the introduction of this thesis, bile 
acids are produced from cholesterol in the liver, and bile acid that escape reabsorption in 
the ileum are an important pathway of cholesterol excretion in mammals (Kuipers, Bloks, 
and Groen 2014). Additionally, dietary fibres are known to have a large influence on the 
gut microbiota and the production of SCFAs in both rodents and humans (David et al., 
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2014; Lange et al., 2015). A change in the microbiota could infleunce bile acid metabolism 
via the enzyme BSH which is uniquely produced by bacteria and leads to deconjugation 
of bile acids and eventually the formation of secondary bile acids (Ridlon et al. 2014; 
Jones et al. 2008). Changes in the microbiota and deconjugation of bile acids has 
previously been linked to changes in the expression of Fgf15 (Li et al., 2013; Sayin et al., 
2013) 
Combining the cholesterol-lowering and microbiota altering effects of dietary fibres with 
the known influence of the microbiota on Fgf15 expression led us to our research question; 
how do dietary fibres regulate Fgf15 expression in the small intestine and how does this 
effect cholesterol levels? Here we show that bile acid metabolism is involved in the 
cholesterol-lowering effects of soluble fibres via regulation of Fgf15 expression in the 
ileum which leads to a decrease in bile acid production in the liver. Interestingly, we 
demonstrate that this effect is most likely independent of the microbiota.   
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4.2 Materials and methods 
4.2.1 Murine studies 
C56BL6/J mice bred in the DMU of the UEA were used for all murine studies (except 
WUR study, see below), starting at the age of 10-12 weeks, with a group size of minimum 
5 and maximum 10 mice. At the end of the experiments mice were sedated with a mixture 
of 4% isoflurane (IsoFlo, Abbott, ND), nitrous oxide (70%) and oxygen (30%) and blood 
samples were collected via cardiac puncture. The small intestine was collected and 
arranged in three equal parts, of which the last part was identified as the ileum. 
Additionally, the liver was collected. All samples were immediately snap-frozen in liquid 
nitrogen and stored at -80C until analysis or fixed in 10% formalin (include if you show 
histology).   
All experimental procedures and protocols used in these studies were reviewed and 
approved by the Animal Welfare and Ethical Review Body and were conducted according 
to the specifications of the United Kingdom Animals Scientific Procedures Act, 1986.  
 
4.2.2 Diets 
Mice were fed either a standard chow diet (RM3-P, Special Diets Services, UK), a HS 
purified diet (D12450H, Research Diets, USA) for the indicated duration per experiment 
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Table 4.1 Dietary composition per kilogram of diet. The high starch (HS) diet contains more starch and 
sucrose and less fibre compared to the chow diet. In the purified diet (HS and high fat (HF) from Research 
Diets) starch is exchanged for fat. 
 Chow diet  
SDS diets RM3 
HS diet  
D12450H 
Energy content  3.35 kcal/g 3.82 kcal/g 
   
Protein  27.28 En% 20 En% 
Carbohydrate 61.24 En% 70 En% 
Fat 11.48 En% 10 En% 
   
Corn Starch (g) 338.8 452.2  
Maltodextrin (g) 0 75  
Sucrose (g) 43.7 172.8  
Dietary fibre (g) 161.5  





See appendix 1 
Unknown mix 1 g V10001C  
Minerals 
See appendix 1 
Unknown mix 50 g S10026B  
 
 
4.2.3 Intervention studies 
 
FOS study 
In addition to the chow and HS diet, mice received the soluble fibre fructo-
oligosaccharides (FOS, Sigma-Aldrich, F8052) via the drinking water for the duration of 
one week. FOS was added to the drinking at a concentration of 30g/L to reach a daily 
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FOS and antibiotics study 
Mice on a chow background were switched to a clean cage and to the HS diet for 1 week 
with added FOS in the drinking water at a concentration of 30g/L. During this week mice 
were oral gavaged once daily with a cocktail of vancomycin (50mg/kg BW, Sigma-
Aldrich, 94747), Neomycin (100mg/kg BW, Sigma-Aldrich, N6386), Metronidazol 
(100mg/kg BW, Sigma-Aldrich, M1547) in 0.9% saline. Additionally, mice received 
ampicillin (1g/L, Sigma-Aldrich, A0166) via drinking water. Mice were transferred to a 
clean cage every other day for the duration of this experiment. Similar antibiotics protocol 
used in (Zarrinpar et al. 2018).  
 
Soluble fibre studies 
In collaboration with Research Diets Inc (New Brunswick, USA), new diets were 
designed. Firstly, a new HS diet was constructed containing less sucrose compared to the 
original HS diet. Secondly, diets containing soluble fibre were also made, as no soluble 
fibres were present in the semi-purified HS diets. Thirdly, three different soluble fibre 
diets were designed, containing either 75 gram of pectin, inulin or fibersol. Calorie intake 
was normalized to the HS diet by slightly decreasing the starch content. For the full 
contents of these diets please see table 4.2.  
Mice were fed these diets for a duration of two weeks, and additionally a group of mice 
fed the chow diet was added to this experiment.  
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Table 4.2 Dietary composition of the added soluble fibres diets. Rodent diets with 10 En% fat with 50g 
Cellulose and added with 75g inulin, pectin or soluble corn fibre (Fibersol).  
 
4.2.3 Gene expression 
RNA of liver and intestinal scraping samples was isolated. Samples were homogenised in 
1 ml Trizol (Qiazol, Qiagen, UK) for 30 seconds at 6000 rpm in a Precellys®24 (Bertin 
Technologies, France). After homogenization samples were transferred to a new 
Eppendorf tube and 200 µl Chloroform was added. Samples were centrifuged for 15 
minutes at 12.000 RCF 4˚C and the clear layer was transferred to a new collection tube. 
Iso-propanol was added and after mixing, resting for 5-10 minutes and centrifugation for 
Product #
gm% kcal% gm% kcal% gm% kcal% gm% kcal%
Protein 19 20 18 20 18 20 18 20
Carbohydrate 67 70 62 70 62 70 62 70
Fat 4 10 4 10 4 10 4 10
Total 100 100 100 100
kcal/gm 3.85 3.68 3.68 3.69
Ingredient gm kcal gm kcal gm kcal gm kcal
Casein 200 800 200 800 200 800 200 800
L-Cystine 3 12 3 12 3 12 3 12
Corn Starch 506.2 2024.8 478 1912 478 1912 476.2 1905
Maltodextrin 10 125 500 125 500 125 500 125 500
Sucrose 68.8 275 68.8 275 68.8 275 68.8 275
Cellulose, BW200 50 0 50 0 50 0 50 0
Inulin, Orafti HP 0 0 75 113 0 0 0 0
Pectin, Tic Gums 1400 0 0 0 0 75 113 0 0
Fibersol-2 (Resistant Maltodextrin) 0 0 0 0 0 0 75 120
Lard 20 180 20 180 20 180 20 180
Soybean Oil 25 225 25 225 25 225 25 225
Mineral Mix S10026 10 0 10 0 10 0 10 0
Dicalcium Phosphate 13 0 13 0 13 0 13 0
Calcium Carbonate 5.5 0 5.5 0 5.5 0 5.5 0
Potassium Citrate, 1 H2O 16.5 0 16.5 0 16.5 0 16.5 0
Vitamin Mix V10001 10 40 10 40 10 40 10 40
Choline Bitartrate 2 0 2 0 2 0 2 0
Yellow Dye #5, FD&C 0.04 0 0.025 0 0 0 0 0
Red Dye #40, FD&C 0 0 0.025 0 0 0 0.025 0
Blue Dye #1, FD&C 0.01 0 0 0 0.05 0 0.025 0
  Total 1055.05 4057 1101.85 4057 1101.85 4057 1100.05 4057
gm
Total Fiber 50.0 125.0 125.0 125.0
Insoluble Fiber 50.0 50.0 50.0 50.0
Soluble Fiber 0.0 75.0 75.0 75.0
gm%
Total Fiber 4.7 11.3 11.3 11.4
Insoluble Fiber 4.7 4.5 4.5 4.5
Soluble Fiber 0.0 6.8 6.8 6.8
Fiber contents listed above are estimates based on these fiber sources containing 100% fiber and either 100% as soluble or insolu
Assayed levels: Cellulose = 93%, Inulin = 96%, Pectin = 93%. Fibersol-2 = 90% (m anufacturer data)  
Inulin contains 1.5 kcal/gm as per Roberfroid, 1999 (J. Nutr. 129: 1436S–1437S, 1999) 
Pectin doesn't have a specified kcal/g value, so have chosen 1.5 kcal/g to match inulin. MAP




50 g Cellulose 50 Cell/75 Inulin 50 Cell/75 Pectin
D18012101 D18012102 D18012103
10 kcal% Fat Modified w/ Modified w/
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10 minutes at 12.000 RCF 4˚C an RNA pellet was left. The pellet was washed in 85% 
ethanol and dissolved in 100 µl RNase Free water. RNA concentration was measured with 
a Nanodrop (Thermo Scientific, Wilmington, USA). cDNA was synthesized from 2 µg of 
RNA which was first treated with DNase (DNase kit, Invitrogen, 18068-015) and 
subsequently reverse transcription was performed. A quantitative polymerase chain 
reaction (Q-PCR) was performed using SYBR green master mix (Applied Biosystems, 
Thermo Fisher Scientific, UK) according to the producer’s instructions. Reactions were 
performed using 384 wells (Applied Biosystems, Thermo Fisher Scientific, UK) using 
5µL of SYBR green and primer mix (for a list of the primers used, see table 4.3) and 1.5µL 
of cDNA. The reaction was initialized at 50°C for 5 minutes and 95°C for 2 minutes, after 
which 40 cycles of denaturation (95°C 15 seconds) and annealing/extension (59°C 1 min) 
were performed. Afterwards, a melting curve was created and checked for a single product 
per gene. ΔCT values were calculated by subtracting the CT value of the housekeeping 
gene TBP from the gene CT value. ΔΔCT was calculated relative to control samples 
(Livak and Schmittgen 2001).  
 
Table 4.3 Primers used for q-PCR measurements in small intestine and liver. 
Gene Forward  Reverse 
TBP (hk) GAAGCTGCGGTACAATTCCAG CCCCTTGTACCCTTCACCAAT 
GAPDH (hk) AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
FGF15 CAGTCTTCCTCCGAGTAGCG TGAAGACGATTGCCATCAAG 
CYP7A1 GAGCGCTGTCTGGGTCACGG GCCAGCCTTTCCCGGGCTTT 
 
 
4.2.4 Bile acid measurements 
As no bile acid measurements were performed in house at the time of arrival, we set up 
our own method in collaboration with the metabolomics unit of the Quadram Institute. A 
special thanks go to Mark Philo, who was a tremendous help in this process. Bile acids 
were measured in the scrapings and content of the three different parts of the small 
intestine, liver, colon faeces and serum. Here for, 50 mg (liver), 25 mg (intestine) or 50 
µL (serum) of tissue was homogenised in 1 ml of cold 70% methanol for 30 seconds at 
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6000 rpm in a Precellys®24 (Bertin Technologies, France). After centrifugation (5 min, 
3000g, 4˚C) the supernatant was transferred to a new collection tube and MeOH content 
was removed by rotary evaporation (70 min, 50˚C). Volume was restored to 1ml by adding 
5% MeOH. To clean up the samples they were loaded onto Waters OASIS PRIME HLB 
1 30mg SPE cartridges, washed with 5% MeOH and eluted in 500 µl 100% MeOH. 
Internal standards were added at the following time points: before homogenisation, before 
rotary evaporation, before loading onto cartridges, after elusion.  
Cleaned-up extracts were analysed using HPLC – mass spectrometry operated in multiple 
reaction monitoring (MRM) mode.  
Each sample (5 µl) was analysed using an Agilent 1260 binary HPLC couples to an AB 
sciex 4000 QTrap triple quadrupole mass spectrometer. HPLC was achieved using a 
binary gradient of solvent A (Water + 5mM Ammonium Ac + 0.012% Formic Acid) and 
solvent B (Methanol + 5 mM Ammonium Ac + 0.012% Formic Acid) at a constant flow 
rate of 600 µl/min. Separation was made using a Supelco Ascentis Express C18 150 x 4.6, 
2.7µm column maintained at 40˚C. Injection was made at 50% B and held for 2 min, 
ramped to 95%B at 20 min and held until 24 minutes. The column equilibrated to initial 
conditions for 5 minutes.  
The mass spectrometer was operated in electrospray negative mode with capillary voltage 
of -4500V at 550˚C. Instrument specific gas flow rates were 25ml/min curtain gas, GS1: 
40ml/min and GS2: 50ml/min.  
See appendix 2 for LC-MS conditions and mass fragmentation monitoring values. 
Quantification was applied using Analyst 1.6.2 software to integrate detected peak areas 
relative to the deuterated internal standards.  
 
4.2.5 Serum and liver measurements 
Cholesterol was determined in the serum using the corresponding liquicolor kits (Human 
GmbH, Germany) following the manufactures protocol.  
 
Cholesterol and triglycerides were also analysed in the livers using the same kits. 
Proceeding this, the lipid fraction was extracted following an adjusted version of the Bligh 
and Dyer method (Bligh and Dyer 1959). In short, 50 mg of liver tissue was homogenized 
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in 200 L chloroform and 400 L methanol. 200 L distilled water was added and the 
sample was homogenized again after which the sample was centrifuged for 10 minutes at 
3000g. The lower layer was subsequently transferred to a clean Eppendorf tubes and dried 
overnight. The dried pellet was dissolved in 250 L 2% Triton X-100 and this was used 
to perform the colorimetric assay.  
 
4.2.6 Statistics 
Statistics have been performed using Graphpad Prism. The statistical tests used are 
indicated in each figure legend. Power calculations were based on Fgf15 results observed 
in the 10 parts study and led to a minimum of 5 mice per group being used in each 
experiment (indicated per figure). Analysis of variance (ANOVA) provides a statistical 
test of whether the means of groups are equal. When groups were compared over time, a 
2-way ANOVA with Bonferroni post-hoc test was used. When three or more groups were 
compared at a single time point, a 1-way ANOVA was used with Bonferroni post-hoc. 
Lastly, when two groups were compared at one time point, an unpaired t-test was used to 
test for significance. p<0.05 was considered overall as statistically significant and 
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4.3 Results 
4.3.1 Fructo-oligo saccharides (FOS) decrease ileal Fgf15 expression  
In order to investigate the effects of soluble fibres on Fgf15 expression in the ileum, fructo-
oligo saccharides (FOS) were added to the drinking water of HS fed mice for the duration 
of one week (figure 4.1A). No differences were observed in either body weight (figure 
4.1B) or food intake (figure 4.1C). However, a downregulation of Fgf15 expression was 
observed in the ileum of these animals (figure 4.1D). This corresponded with a trend 
toward an increase of hepatic Cyp7a1 expression (figure 4.1E) and a significant decrease 
in circulating cholesterol (figure 4.1F).  
 
PhD thesis Britt Blokker 100
Figure 4.1 FOS in drinking water decreases the expression of Fgf15 in the ileum and consequently 
lowers blood cholesterol levels. FOS was added into to the drinking water of mice fed the HS diet at a 
concentration of 30 g/L (A), which did not lead to any changes in either body weight (B) or food intake (C). 
However, a decrease in Fgf15 was observed in the ileum of FOS treated mice (D), corresponding to a slight 
trend towards increased Cyp7A1 expression (E) and a significant decrease in blood cholesterol levels (F). 
Significance was tested using 1-way ANOVA with Bonferroni post-hoc test between chow and HS diet (*= 
p<0.05) n≤4 for all groups 
 
4.3.2 FOS decreases Fgf15 expression independent of the microbiota 
To investigate the role of the microbiota in the downregulation of Fgf15 expression by 
FOS, a group of mice was added to the experiment that received the HS diet with FOS in 
the drinking water and were simultaneously treated with broad spectrum antibiotics for 1 
week. Although slightly less pronounced, we observed a similar downregulation of Fgf15 
expression in the antibiotic-treated group compared to conventional mice treated with FOS 
only (figure 4.2A). Differences in Fgf15 expression between the non-treated HS group 
and both FOS treated (with and without antibiotics) groups were statistically significant, 
differences between the FOS groups were non-significant. Cyp7a1 expression in the liver 
was increased in the antibiotic-treated mice compared to all other groups (figure 4.2B), 
suggesting an additional effect of antibiotics on Cyp7a1 expression. Taken together, FOS 
seems to decrease the expression of ileal Fgf15 independent of the microbiota.  
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Figure 4.2 The downregulation of Fgf15 by FOS is independent of the microbiota. An additional group 
of mice was treated with both FOS and broad-spectrum antibiotics on top of the HS diet and showed a 
similar downregulation of Fgf15 expression (A). In addition, hepatic Cyp7a1 expression was significantly 
increased in these mice (B). Significance was tested using a 1-way ANOVA with Bonferroni post-hoc test 
between all groups (** = p<0.001, **= p<0.01, *= p<0.05). n≤5 for all groups 
 
4.3.3 Pectin, inulin and fibersol significantly decrease the expression of ileal Fgf15 
To further investigate the effects that different soluble fibres have on the expression of 
Fgf15, diets were designed containing 75g of soluble fibres per kg of food (figure 4.3A). 
The first added fibre was inulin, which can be extracted from chicory root and consists of 
polymers of fructose linked by -2,1 bonds (Wilson and Whelan 2017). The previously 
used FOS is similar structurally but contains a shorter chain length than inulin. The second 
soluble fibre added to the HS diet was pectin, a heteropolysaccharide that can be found 
ubiquitously in plant cell walls (Naqash et al. 2017). Lastly, fibersol was added to the 
diets, a non-viscous highly digestion resistant maltodextrin based on corn (Ye et al. 2015). 
After two weeks of feeding the diets, Fgf15 expression was quantified in the ileum using 
q-PCR and was found to be downregulated by all tested fibres (figure 4.3B). A consequent 
trend towards increased hepatic Cyp7a1 expression was observed for both pectin and 
inulin but not fibersol (figure 4.3C). This correlated with a decrease of circulating 
cholesterol levels, which was only found to be significant for mice fed the pectin diet but 
a trend towards decreased cholesterol levels was observed for all fibres (figure 4.3D).  
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Figure 4.3 All tested soluble fibres decrease ileal Fgf15 expression. Diets were designed to contain 75g 
of soluble fibres per kg of food, with the different soluble fibres being pectin, inulin and fibersol (A). All 
diets with added soluble fibres significantly decreased the expression of ileal Fgf15 (B), while hepatic 
Cyp7a1 was only significantly upregulated by inulin (C). Circulating cholesterol showed a lowering trend 
on all soluble fibres but was only found significant for pectin (D). Significance was tested using a 1-way 
ANOVA with Bonferroni post-hoc test between the HS diet and the other groups (** = p<0.001, **= p<0.01, 
*= p<0.05) n≤10 for all groups 
 
4.3.4 Ileal bile acids are unchanged when soluble fibres are added to the diets 
To elucidate the molecular mechanisms underpinning the decrease of Fgf15 expression in 
mice treated with soluble fibres, we measured bile acids present in ileal tissue. No 
differences in total bile acids (figure 4.4A) were observed. Upon closer inspection, 
individual bile acids were also not found to be altered by adding soluble fibres to the HS 
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diet, although a trend towards increased bile acid content was observed in the fibersol 
group (figure 4.4B). However, such increases does not easily explain the differences 
observed in Fgf15 expression, as an increase in bile acids would lead to an increased 
expression of Fgf15 expression (Kuipers, Bloks, and Groen 2014). Additionally, the bile 
acids are only found to be different in fibersol treated mice, while mice under treatment 
of all soluble fibres (pectin, inulin and fibersol) showed a decrease in Fgf15 expression 
compared to HS fed mice. Therefore, we carefully conclude that the decrease of Fgf15 
expression by soluble fibres is not due to changes in bile acid levels.  
 
 
Figure 4.4 Bile acid in the ileum after soluble fibre treatment. No differences were observed in total bile 
acids present in the ileal tissue after treatment with pectin, inulin or fibersol (A). Individual bile acids also 
show no significant differences between the diets (B). Significance was tested using a 1-way ANOVA with 
Bonferroni post-hoc test between the HS diet and the other groups (** = p<0.001, **= p<0.01, *= p<0.05) 
n≤10 for all groups   
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4.3.5 Bile acid excretion does not increase in response to soluble fibres 
Dietary fibres are often hypothesized to prevent the reabsorption of bile acids in the ileum, 
and thereby increase bile acid excretion (Purnima Gunness and Gidley 2010). To 
investigate this in the current feeding study, bile acids were quantified in fresh faeces, 
collected at the time of sacrifice. A trend towards a decrease in bile acids in the soluble 
fibres diets was observed, mainly for inulin (p=0.07) and pectin (p=0.15, figure 4.5A). 
However, no significant differences were observed. A closer look at the individual bile 
acids revealed a significant decrease in the secondary bile acid DCA after adding pectin 
or inulin to the diet (figure 4.5B). Since primary bile acids are converted into secondary 
bile acids by the microbial enzyme BSH (Ridlon et al. 2014), this could indicate an 
alteration in the microbiota. Although the effect of soluble fibres on Fgf15 expression 
seems to be independent of the microbiota, the known effects of fibres on the intestinal 
microbiota might still be of impact on bile acid profiles. The formation of secondary bile 
acids mostly takes place in the ceacum and colon (Di Ciaula et al. 2017), and therefor 
might not influence ileal Fgf15 expression.   
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Figure 4.5 Bile acid in the faeces after soluble fibre treatment. No differences were observed in total bile 
acids present in the faeces tissue after treatment with pectin, inulin or fibersol (A). Individual bile acids 
show a significant decrease in DCA when pectin or inulin is added to the diet (B). Significance was tested 
using a 1-way ANOVA with Bonferroni post-hoc test between the HS diet and the other groups (** = p<0.001, 
**= p<0.01, *= p<0.05) n≤10 for all groups  
 
4.3.6 Effects of soluble fibres on glucose metabolism in the ileum 
In the previous chapter of this thesis, we outlined how glucose absorption in the ileum can 
influence Fgf15 expression. Since soluble fibres have been shown to influence glucose 
uptake from the intestine (Russell et al. 2016), and have recently even been shown to 
inhibit intestinal sucrase, an alpha-glucosidase (Neyrinck et al. 2016), soluble fibres could 
affect Fgf15 expression by altering glucose absorption. To investigate whether soluble 
fibres are influencing starch digestion and glucose absorption in the small intestine, we 
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tested the effects of fibres on glucose metabolism-related genes in the ileum. As a positive 
control, a group of mice treated with the known -glucosidase inhibitor acarbose (Rosak 
and Mertes 2012) was added to the experiment. Mice in this group received the HS diet 
supplemented with 50 mg of acarbose per kg of BW administered via the drinking water. 
As acarbose competitively blocks -glucosidases, we hypothesized a higher gene 
expression of glucose metabolism-related gene was present in this group.   
Glucose uptake from the intestinal lumen into the enterocytes was tested via the expression 
of glucose transporter 2 (Glut2, Slc2a2 gene) and sodium-glucose linked transporter 1 
(Sglt1, Slc5a1 gene) (figure 4.6A and B) and the transcriptional induction of -
glucosidases sucrose isomaltase (Sis) and maltase glucoamylase (Mgam) were tested by 
q-PCR (figure 4.6C and D). As expected, acarbose treated mice showed increase 
expression in all glucose metabolism related genes in the ileum. From the fibres, fibersol 
showed a significant increase in all glucose-related genes (Mgam marginal with p=0.05); 
while the other fibres show and trend towards a minor increase in Sis, Sglt1 and Glut2, but 
not Mgam. Activity measurements of the -glucosidases will be needed to make stronger 
conclusions, but for now the results indicate a modest competitive effect of soluble fibres, 
mostly fibersol, on -glucosidases activity in the ileum.  
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Figure 4.6 Glucose metabolism in the ileum might be affected by soluble fibres. Acarbose was used a 
positive control for -glucosidase inhibition. Gene expression the glucose transporters Glut2 (A) and Sglt1 
(B) and the -glucosidases Sis (C) and Mgam (D) was tested via Q-PCR. Significance was tested using a 1-
way ANOVA with Bonferroni post-hoc test between the HS diet and the other groups (** = p<0.001, **= 
p<0.01, *= p<0.05) n≤10 for all groups   
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4.4 Discussion 
Here we show that the soluble fibres FOS, inulin, pectin and fibersol decrease the 
expression of the signalling molecule Fgf15 in the ileum, and this is most likely 
independent of the ileal microbiota as shown by the results in the antibiotic-treated mice. 
The decrease in Fgf15 expression correlates with an increased expression of Cyp7a1 in 
the liver, the enzyme responsible for the conversion of cholesterol to bile acids. Hence, 
the decreased expression of ileal Fgf15 might contribute to the known cholesterol-
lowering properties of soluble fibres.  
FOS are short to medium chain fructose oligosaccharides, and can be produced by the 
degradation of inulin (Flores-Maltos et al. 2016). FOS and other inulin type of fructans 
are known to lower total and LDL cholesterol levels (Liu et al. 2017), which we confirm 
in this study. Additionally, we demonstrate that FOS inhibits the expression of the Fgf15 
in the ileum, and that this effect is more likely independent on the microbiota. Fransen et 
al (Fransen et al. 2017) recently reported a similar decrease of Fgf15 following FOS intake 
in germ free animals, supporting that FOS decreases Fgf15 expression independent of the 
microbiota. In their experiment, the authors tested both short and medium chain FOS 
molecules. Although not further investigated by these authors, they reported Fgf15 being 
the strongest responding gene to FOS, decreasing its expression by 4-6 fold in germ-free 
mice. Such effects were observed in conventionally raised mice treated with FOS, 
however, this could be explained by the small dose used (10mg/day) in combination with 
bacterial fermentation of FOS. They show by NMR that none of the administered FOS 
reaches the caecum in conventionally-raised mice (Fransen et al. 2017). Furthermore, 
Catry et al (Catry et al. 2017) found an increase in Cyp7a1 expression after treating 
apolipoprotein E knockout mice with inulin like fructans in the drinking water. Although 
they did not investigate Fgf15 expression in the ileum, the changes in Cyp7a1 expression 
are in line with the results presented in this chapter.  
 
Additionally, other soluble fibres were found to decrease the expression of Fgf15 in a 
similar manner. Due to the differences in chemical structure of the fibres, these findings 
were unexpected. Inulin and pectin are both known to reduce blood cholesterol levels ( 
Jiang et al. 2016; Liu et al. 2017); while not much is known about the digestion resistant 
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maltodextrin fibersol. Here, we show a trend towards a serum cholesterol-lowering effect 
of fibersol but would suggest longer feeding studies with fibersol to confirm these 
observations.  
Multiple mechanisms have been suggested on how soluble fibres decrease total and LDL 
cholesterol levels. One of which is the bile acid binding property of soluble fibres. 
However, this should lead to an increased excretion of bile acids via the faeces, which we 
did not observe. Others have also questioned the direct binding of bile acids by soluble 
fibres (Grundy et al. 2016). Furthermore, bile acid excretion from the ileum in ileostomy 
subjects was not influenced by the addition of inulin or FOS to the diet when compared to 
sucrose (Ellegård, Andersson, and Bosaeus 2018).  
The link between fibres and glucose absorption has been made several times before, with 
soluble fibres decreasing the uptake of glucose and thereby reducing sugar spikes in the 
blood (Russell et al. 2016). In addition to this, inulin has been shown to directly inhibit 
the -glucosidase sugar isomerase (SIS) in the small intestine (Neyrinck et al. 2016). Mice 
fed a 5% inulin diet (the diets used in the current study contain 7.5% soluble fibre), showed 
a significant decrease in SIS activity in the jejunum. This effect was found both in vivo 
and in vitro suggesting a microbiota independent effect (Neyrinck et al. 2016). SIS is 
located on the brush border membranes and is responsible for the conversion of di- and 
oligosaccharides into monosaccharides to facilitate uptake into the small intestinal 
enterocytes. The most important substrates for SIS are maltose, isomaltose and sucrose 
(Zagalak and Curtius 1975). 
Since Fgf15 expression was found to be very sensitive to the glucose uptake into the ileum 
(chapter 3, this thesis), we hypothesize that soluble fibres might inhibit the uptake of 
glucose from starch in the ileum and thereby decrease the expression of Fgf15 compared 
to the HS diet. Unfortunately, we were unable to perform activity test for the -
glucosidases due to shortage of available sample. However, we have tried to obtain some 
indications by investigating the expression of genes involved in glucose metabolism in the 
small intestine. If soluble fibres are capable of blocking -glucosidases, we hypothesized 
that this would be via competitive inhibition. So, to test this we used an established -
glucosidases inhibitor, acarbose, as our positive control. In the acarbose-treated mice, a 
clear upregulation of the tested genes (Sis, Mgam, Sglt1 and Glut2) involved in intestinal 
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glucose metabolism was observed. In line with literature (Toshinao Goda 2018), the 
expression of these genes was also increased in mice fed a HS diet. When the additional 
effect of soluble fibres was tested, we observed an increase in all genes for fibersol and a 
trend towards a minor upregulation for Sis, Sglt1 and Glut2 for both pectin and inulin, 
which could indicate a slight competitive inhibition. Further research will be needed, 
mostly activity assays, to determine the precise role for dietary fibres on -glucosidases 
and thereby starch digestion in the ileum.  
 
In conclusion, soluble fibres decrease the expression of the signalling molecule Fgf15 in 
the ileum, which might contribute to the cholesterol-lowering effects of soluble fibres. 
More research will be needed to further elucidate the molecular mechanisms underlying 
this inhibition, which should focus on the effects of fibres on glucose absorption in the 
ileum.   





Chapter 5: The role of dietary fibres in the small intestine: impact 
on the gut-liver axis  






PhD thesis Britt Blokker 112
Name study Where Performed by 
candidate? 
Samples available 
10 parts study WUR No Microarray data on intestinal tissue 
Soluble fibre study UEA Yes All 
Long term study UEA Yes All 
 
In this thesis, we have been comparing a standard chow diet to a semi-purified high starch 
low fibre diet (HS) and identified major differences in the regulation of the signalling 
molecule Fgf15 in the ileum. However, during the course of the experiment, many 
additional differences were observed in health status pertaining to the gut and liver of these 
mice. In this chapter, the differences in gut and liver health between the diets are discussed 
further. Additionally, we try to identify which of these differences are due to the lack of 
soluble fibres in the HS diet.  
 
5.1 Introduction  
In molecular metabolism research there is an increasing number of preclinical studies 
aiming at identifying the molecular mechanisms underlying the impact of natural and 
chemical compounds on improving health (Collins and Tabak 2014). Unfortunately, the 
results of these studies are often not reproducible (Collins and Tabak 2014), at least in part 
because of the lack of comparable control diets.  Currently, the most commonly used 
control diet is the standard chow diet, a diet composed of partially processed but mostly 
unrefined plant and animal products. The composition of chow diets can be highly variable 
which is influenced by factors such as vendor/distributor as well as seasonal and batch 
variation. Over the years, the chow diet has been proven to be a healthy diet for mice, but 
its large variability makes it a poor diet for scientific experiments (Pellizzon and Ricci 
2018). Furthermore, the chow diet is often used as a control diet in DIO models, after 
which the effects of the semi-purified high fat diet (HF) are contributed to the fat content 
of the diet. However, the effects of dietary fat will be confounded by other components, 
for example the lack of soluble fibres, that differ between diets (Warden and Fisler 2008). 
This has been demonstrated in the gut microbiota, where it was long believed that the fat 
content of the diet provoked a switch from primarily Bacteroidetes in the gut of chow fed 
PhD thesis Britt Blokker 113
mice to mostly Firmicutes in HF fed mice (Murphy, Velazquez, and Herbert 2015a; 
Murphy et al. 2010). However, recently it has been shown that this switch in phyla is due 
to a lack of certain components in the purified diets and not the actual fat content (Dalby 
et al. 2017).  
 
This problem has been assessed by creating a semi-purified control diet, of which there 
are several alternatives developed. In 1993, the American Institute of Nutrition developed 
the AIN-93 diet, an improved version of the original purified control diet developed in 
1973 (Reeves, Nielsen, and Fahey 1993). For the AIN-93 diet, dietary fibre content was 
discussed and set at 50g per kg, with the most important remark being that it should come 
from a reliable source and that the use of cellulose is suggested. Most purified control diets 
on the market are based on this diet, and in almost all purified control diets, the dietary 
fibre content is 50 grams of cellulose per kg. Purified control diets are well defined and 
consistent in their composition making them suitable control diets. However, it is 
becoming clear that purified control diets might be detrimental for the mice’s health in 
particular on the long-term, leading to other confounding factors (Pellizzon and Ricci 
2018).  
 
The purified diets are composed of sucrose, starch, protein (usually casein) and fat (usually 
animal-derived lard or plant derived palm oil) with added vitamins and minerals. We 
hypothesize that one of the most important components missing from the purified diets 
are soluble fibres. Additionally, we postulate that the amount of sucrose (7-35% versus 
5.75% in chow) needs to be reduced to make the control diet more suitable as a healthy 
control in mouse studies. Previous studies have also indicated that the semi-purified diet 
lacks a stimulus for the Aryl-Hydrocarbon Receptor (AhR), leading to a decrease 
in intraepithelial lymphocytes (Ying Li et al. 2011). Furthermore, the AhR has recently 
been shown to be an important determiner of the metabolic syndrome (Natividad et al. 
2018).   
 
Soluble fibres are known to alter the microbiota (Holscher 2017), and a healthy microbiota 
has been linked to an array of health benefits  (Janssen and Kersten 2015). In addition to 
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alterations in the microbiota, a diet lacking in dietary fibres can alter gut morphology. A 
low fibre diet has been shown to decrease both the length of the colon and the weight of 
the ileum in mice. The length of the colon could be restored with short chain fatty acids 
(SCFAs) feeding, while the caecum weight seemed to be independent of SCFAs 
production (Chassaing et al. 2015). Although most known effects of fibres are on the colon 
and colonic microbiota, recently the production of SCFAs from fibres in the small intestine 
has been reported to be of major importance for the uptake of vitamin A (Goverse et al. 
2017).  
 
In this chapter, the aim is to further investigate the effects of the different control diets on 
the health of mice, with a special interest in the small intestine-liver axis. After feeding 
the different diets for up to six months, we report alterations in the small intestinal 
microbiota, gene expression and histology as well as gene expression and histology of the 
liver.  
The second aim of this chapter was to investigate if the negative effects of the purified 
diet could be counteracted by soluble fibres. A short term study shows promising effects 
including a less drastic change in the small intestinal microbiota.  
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5.2 Materials and methods 
5.2.1 Murine studies 
C56BL6/J mice bred in the DMU of the UEA were used for all murine studies (except 
WUR study, see below), starting at the age of 10-12 weeks, with a group size of minimum 
5 and maximum 10 mice. At the end of the experiments mice were sedated with a mixture 
of 4% isoflurane (IsoFlo, Abbott, ND), nitrous oxide (70%) and oxygen (30%) and blood 
samples were collected via cardiac puncture. The small intestine was collected and 
arranged in three equal parts, of which the last part was identified as the ileum. 
Additionally, the liver was collected. All samples were immediately snap-frozen in liquid 
nitrogen and stored at -80C until analysis or fixed in 10% formalin (include if you show 
histology).   
All experimental procedures and protocols used in these studies were reviewed and 
approved by the Animal Welfare and Ethical Review Body and were conducted according 
to the specifications of the United Kingdom Animals Scientific Procedures Act, 1986.  
The WUR study has been performed at the Nutrition, Metabolism and Genomics group of 
Wageningen University (WUR) in the Netherlands, previous to me commencing my PhD. 
Here the small intestine was divided into 10 equal parts on which microarrays (Affymetrix 
GeneChip Mouse Gene 1.1 ST array) were performed. Our group consequently analysed 
the data using Microsoft Excel.  
 
5.2.2 Diets 
Mice were fed either a standard chow diet (RM3-P, Special Diets Services, UK), a HS 
purified diet (D12450H, Research Diets, USA) for the indicated duration per experiment. 
WUR mice were fed a standard chow or a HS (D12450H) diet diet for two weeks, however 
in the WUR diets lard is replaced by palm oil as a fat source. See table 5.1 for a description 
of the diets used.   
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Table 5.1 Dietary composition per kilogram of diet. The high starch (HS) diet contains more starch and 
sucrose and less fibre compared to the chow diet. In the purified diet (HS and high fat (HF) from Research 
Diets) starch is exchanged for fat. 
 Chow diet  
SDS diets RM3 
HS diet  
D12450H 
Energy content  3.35 kcal/g 3.82 kcal/g 
   
Protein  27.28 En% 20 En% 
Carbohydrate 61.24 En% 70 En% 
Fat 11.48 En% 10 En% 
   
Corn Starch (g) 338.8 452.2  
Maltodextrin (g) 0 75  
Sucrose (g) 43.7 172.8  
Dietary fibre (g) 161.5  





See appendix 1 
Unknown mix 1 g V10001C  
Minerals 
See appendix 1 
Unknown mix 50 g S10026B  
 
5.2.3 Intervention experiments 
5.2.3.1 Studies performed at WUR 
As explained in Chapter 2, some of the results presented in this work were generated from 
samples of studies that were performed at WUR. Although these studies were not 
performed by the PhD candidate, a short summary of the methods used are explained 
below for the purpose of disclosing all information.  
 
Male C57B6/J mice were fed a standard chow, a low fat (LF, 10 En%) fat) or a high fat 
(HF, 45En% fat) diet for two weeks (Research Diets, see table 2.1). At the end of the two 
weeks mice were sacrificed in the fed state and the small intestine was transported to a 
cold glass plate. Subsequently, the intestine was cut into 10 equal pieces which were 
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opened and rinsed in phosphate buffered saline (PBS). The cells were scraped out, and 
RNA was isolated and converted into cDNA. A microarray (Affymetrix GeneChip Mouse 
Gene 1.1 ST array) was performed at the WUR and data was analysed by our group as 
outlined in chapter 2.4.  
 
5.2.3.2 Studies performed at UEA / Quadram Institute  
The studies outlined below were performed by the PhD Candidate in the DMU of the UEA 
and samples were analysed at the Quadram Institute. Body weight and food intake was 
measured once or twice a week for all experiments. Group size is between 5 to 10 mice 
per group for each experiment. Mice were transferred to a clean cage every week, unless 
stated otherwise, and were sacrificed in the fed state, unless stated otherwise (see below).  
 
Mice on a chow background diet were fed the chow or HS diet for a duration of 3 days, 1 
weeks, 2 weeks, 8 weeks or 6 months before sacrifice.  
 
Antibiotic-treated mice were oral gavaged once daily with a cocktail of vancomycin 
(50mg/kg BW), Neomycin (100mg/kg BW), Metronidazol (100mg/kg BW) in 0.9% 
saline. Additionally, mice received ampicillin (1g/L) via drinking water and were 
transferred to a clean cage daily. This protocol eradicated the microbiota in the ileum, as 
is shown in figure 3.4D.  
 
The diets used to study the effects of soluble fibres on the small intestine and liver were 
designed in collaboration with Research Diets Inc (New Brunswick, USA). Briefly, the 
HS diet (D12450H) was used as a basis from which sucrose levels were reduced to reach 
similar levels as present in chow (reduced from 172.8 g/kg to 68.8 g/kg, compared to 
43.7g/kg in chow). Additionally, 3 more diets were designed containing the soluble fibres 
pectin, inulin or fibersol (a digestion resistant form of maltodextrin) at a concentration of 
7.5%. For more information on the diets see table 5.2. 
 
A concentration of 7.5% was chosen to get close to the amount of soluble fibres present 
in the chow diet (see appendix 1). The different fibres were selected for their known 
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prebiotic properties (Wilson and Whelan 2017; Naqash et al. 2017; Ye et al. 2015). While 
more is known about the properties of both inulin and pectin, Fibersol was selected for its 
delayed fermentation properties (Ye et al. 2015).  
 
Table 5.2 Dietary composition of the added soluble fibres diets. Rodent diets with 10 En% fat with 50g 
Cellulose and added with 75g inulin, pectin or soluble corn fibre (Fibersol).  
 
Product #
gm% kcal% gm% kcal% gm% kcal% gm% kcal%
Protein 19 20 18 20 18 20 18 20
Carbohydrate 67 70 62 70 62 70 62 70
Fat 4 10 4 10 4 10 4 10
Total 100 100 100 100
kcal/gm 3.85 3.68 3.68 3.69
Ingredient gm kcal gm kcal gm kcal gm kcal
Casein 200 800 200 800 200 800 200 800
L-Cystine 3 12 3 12 3 12 3 12
Corn Starch 506.2 2024.8 478 1912 478 1912 476.2 1905
Maltodextrin 10 125 500 125 500 125 500 125 500
Sucrose 68.8 275 68.8 275 68.8 275 68.8 275
Cellulose, BW200 50 0 50 0 50 0 50 0
Inulin, Orafti HP 0 0 75 113 0 0 0 0
Pectin, Tic Gums 1400 0 0 0 0 75 113 0 0
Fibersol-2 (Resistant Maltodextrin) 0 0 0 0 0 0 75 120
Lard 20 180 20 180 20 180 20 180
Soybean Oil 25 225 25 225 25 225 25 225
Mineral Mix S10026 10 0 10 0 10 0 10 0
Dicalcium Phosphate 13 0 13 0 13 0 13 0
Calcium Carbonate 5.5 0 5.5 0 5.5 0 5.5 0
Potassium Citrate, 1 H2O 16.5 0 16.5 0 16.5 0 16.5 0
Vitamin Mix V10001 10 40 10 40 10 40 10 40
Choline Bitartrate 2 0 2 0 2 0 2 0
Yellow Dye #5, FD&C 0.04 0 0.025 0 0 0 0 0
Red Dye #40, FD&C 0 0 0.025 0 0 0 0.025 0
Blue Dye #1, FD&C 0.01 0 0 0 0.05 0 0.025 0
  Total 1055.05 4057 1101.85 4057 1101.85 4057 1100.05 4057
gm
Total Fiber 50.0 125.0 125.0 125.0
Insoluble Fiber 50.0 50.0 50.0 50.0
Soluble Fiber 0.0 75.0 75.0 75.0
gm%
Total Fiber 4.7 11.3 11.3 11.4
Insoluble Fiber 4.7 4.5 4.5 4.5
Soluble Fiber 0.0 6.8 6.8 6.8
Fiber contents listed above are estimates based on these fiber sources containing 100% fiber and either 100% as soluble or insolu
Assayed levels: Cellulose = 93%, Inulin = 96%, Pectin = 93%. Fibersol-2 = 90% (m anufacturer data)  
Inulin contains 1.5 kcal/gm as per Roberfroid, 1999 (J. Nutr. 129: 1436S–1437S, 1999) 
Pectin doesn't have a specified kcal/g value, so have chosen 1.5 kcal/g to match inulin. MAP




50 g Cellulose 50 Cell/75 Inulin 50 Cell/75 Pectin
D18012101 D18012102 D18012103
10 kcal% Fat Modified w/ Modified w/
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5.2.4 Intestinal permeability 
In both the 6 months feeding study and the soluble fibre study, intestinal permeability was 
determined via fluorescein isothiocyanate (FITC) dextran. FITC dextran with a molecular 
weight of approximately 4 kDa (Sigma-Aldrich, FD4) was administered to the mice via 
oral gavage at a concentration of 44mg per 100g body weight 2 hours before sacrifice. 
Mice were sacrificed via cardiac puncture as discussed previously (section 2.1) and whole 
blood was collected in an Eppendorf tube and kept on ice in the dark. 30 minutes later, the 
blood was centrifuged for 30 minutes at 3,000g in a refrigerated microcentrifuge and 
serum was separated out into a clean Eppendorf tube. An aliquot of the serum was 
subsequently diluted in an equal volume of PBS and 100 μl of diluted serum was added to 
a 96-well microplate in duplicate. Additionally, a standard serial dilution of FITC-dextran 
(0, 125, 250, 500, 1,000, 2,000, 4,000, 6,000, 8,000 ng/ml) was added to the 96-wells 
plate. FITC concentration was determined in a spectrophoto-fluometry with an excitation 
of 485 nm and an emission wavelength of 528 nm. Serum from mice not administered 
with FITC-dextran was used to determine the background.  
 
5.2.5 Gene expression 
RNA of liver and intestinal scraping samples was isolated. Samples were homogenised in 
1 ml Trizol (Qiazol, Qiagen, UK) for 30 seconds at 6000 rpm in a Precellys®24 (Bertin 
Technologies, France). After homogenization samples were transferred to a new 
Eppendorf tube and 200 µl Chloroform was added. Samples were centrifuged for 15 
minutes at 12.000 RCF 4˚C and the clear layer was transferred to a new collection tube. 
Iso-propanol was added and after mixing, resting for 5-10 minutes and centrifugation for 
10 minutes at 12.000 RCF 4˚C an RNA pellet was left. The pellet was washed in 85% 
ethanol and dissolved in 100 µl RNase Free water. RNA concentration was measured with 
a Nanodrop (Thermo Scientific, Wilmington, USA). cDNA was synthesized from 2 µg of 
RNA which was first treated with DNase (DNase kit, Invitrogen, 18068-015) and 
subsequently reverse transcription was performed. A quantitative polymerase chain 
reaction (Q-PCR) was performed using SYBR green master mix (Applied Biosystems, 
Thermo Fisher Scientific, UK) according to the producer’s instructions. Reactions were 
performed using 384 wells (Applied Biosystems, Thermo Fisher Scientific, UK) using 
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5µL of SYBR green and primer mix (for a list of the primers used, see table 5.3) and 1.5µL 
of cDNA. The reaction was initialized at 50°C for 5 minutes and 95°C for 2 minutes, after 
which 40 cycles of denaturation (95°C 15 seconds) and annealing/extension (59°C 1 min) 
were performed. Afterwards, a melting curve was created and checked for a single product 
per gene. ΔCT values were calculated by subtracting the CT value of the housekeeping 
gene TBP from the gene CT value. ΔΔCT was calculated relative to control samples 
(Livak and Schmittgen 2001).  
 
Table 5.3 Primers used for q-PCR measurements in small intestine and liver. 
Gene Forward  Reverse 
TBP (hk) GAAGCTGCGGTACAATTCCAG CCCCTTGTACCCTTCACCAAT 
GAPDH (hk) AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
FXR  GGCCTCTGGGTACCACTACA AAGAAACATGGCCTCCACTG 
OSTA TTGTGATCAACCGCATTTGT CTCCTCAAGCCTCCAGTGTC 
ASBT TGGAATGCAGAACACTCAGC GCAAAGACGAGCTGGAAAAC 
FABP6 CACCATTGGCAAAGAATGTG AACTTGTCACCCACGACCTC 
SHP TCTGCAGGTCGTCCGACTATT AGGCAGTGGCTGTGAGATGC 
FGF15 CAGTCTTCCTCCGAGTAGCG TGAAGACGATTGCCATCAAG 
CYP7A1 GAGCGCTGTCTGGGTCACGG GCCAGCCTTTCCCGGGCTTT 
CYP27A1 TGTGGACAACCTCCTTTGGG CCATAGGTGAGGCCCTTGTG 
CYP8B1 TTGCAAATGCTGCCTCAACC TAACAGTCGCACACATGGCT 
 
Selected samples went for microarray analysis. After RNA isolation as described before, 
samples were send to WUR for microarray analysis. At WUR RNA quality was assessed 
with a Bioanalyzer (Aligent 2100 Bioanalyzer, Santa Clara, USA), and microarrays were 
performed using the Mouse gene Chip 1.1 array from Affymetrix (Thermo Fisher 
Scientific, Santa Clara, USA). After normalization process, ~22 k genes were included in 
the data set.  The limma R library was used to analyse the significant differential 
expression between the diets. Log2FC of 1.5 and a p-value of 0.05 were used as cut-off 
points and the rate discovery false for the p-value was calculated. Ingenuity Pathways 
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Analysis (IPA) web-based software application was used to analyse, integrate and 
interpret the data 
 
5.2.6 Histology 
From each UEA mouse, a small part of the liver and a piece of each of the three parts of 
the small intestine was collected in 10% formalin. 24 hours after collection, these samples 
were transferred into 50% ethanol and within a week were processed on the Leica ASP 
300, program overnight no formalin. The samples were embedded in wax and cut into 
5µm sections. Sections were stained with a haematoxylin and eosin (H&E) staining and 
pictures were taken with an Olympus BX60 microscope.  
 
5.2.7 Caspase 3 activity 
For protein extraction, approximately 3 mg of frozen tissue was homogenised on ice in 
600 µL AFC lysis buffer (see table 5.4). The homogenate was centrifuged for 10 minutes 
at 12000 rpm and 4°C. The supernatant was transferred into a new tube and stored at -
20°C until used.  
 
Table 5.4 AFC lysis buffer composition for caspase 3 activity. 
AFC-Lysis buffer Volume Final concentration 
Hepes 1M pH 7.4 100 µL 10 mM 
Chaps 10% 100 µL 0.1% 
EDTA 0.5mM pH 8 40 µL 2 mM 
DTT 1M 50 µL 5 mM 
dH2O 9.71 ml  
 
Caspase 3 is a key enzyme for the induction of the apoptotic cascade and is therefore used 
as a marker of apoptosis. This assay works with a Caspase-3 specific substrate DEVD and 
a fluorochrome AFC. Active caspase specifically cleaves the substrate DEVD-AFC, thus 
releasing the fluorogenic AFC which can be quantified by U.V. spectrofluorometry. These 
tetrapeptide substrates are used to identify and quantify Caspase-3 activity in apoptotic 
protein lysates.  
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Per reaction tube, 480 µL mastermix and 20 µL proteins were mixed. Of this mixture 
200µL was pipetted into a 96-wells plate in duplicate and incubated at 37°C while gently 
shaking. Mastermix with AFC-lysis buffer was taken as a blank. AFC-release was 
measured at 0h, 1h and 2h.  
 
Table 5.5 Mastermix and reaction buffer composition for caspase 3 activity. 
Mastermix Volume/reaction 
25x Reaction buffer 20 µL 
Ac-DEVD-AFC substrate 2.5 µL 
dH2O 457.5 µL 




5.2.8 Serum and liver measurements 
Cholesterol and triglycerides were determined in the serum using the corresponding 
liquicolor kits (Human GmbH, Germany) following the manufactures protocol.  
 
Cholesterol and triglycerides were also analysed in the livers using the same kits. 
Proceeding this, the lipid fraction was extracted following an adjusted version of the Bligh 
and Dyer method (Bligh and Dyer 1959). In short, 50 mg of liver tissue was homogenized 
in 200 L chloroform and 400 L methanol. 200 L distilled water was added and the 
sample was homogenized again after which the sample was centrifuged for 10 minutes at 
3000g. The lower layer was subsequently transferred to a clean Eppendorf tubes and dried 
overnight. The dried pellet was dissolved in 250 L 2% Triton X-100 and this was used 
to perform the colorimetric assay.  
 
25x Reaction buffer Final  
concentration 
Pipes 1M pH 7.4 2.5 ml 
EDTA 0.5mM pH 8 1 ml 
Chaps 10% 2.5 ml 
DTT 1M 1.25 ml 
dH2O 2.75 ml 
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5.2.9 Bile acid measurements 
As no bile acid measurements were performed in house at the time of arrival, we set up 
our own method in collaboration with the metabolomics unit of the Quadram Institute. A 
special thanks go to Mark Philo, who was a tremendous help in this process. Bile acids 
were measured in the scrapings and content of the three different parts of the small 
intestine, liver, colon faeces and serum. Here for, 50 mg (liver), 25 mg (intestine) or 50 
µL (serum) of tissue was homogenised in 1 ml of cold 70% methanol for 30 seconds at 
6000 rpm in a Precellys®24 (Bertin Technologies, France). After centrifugation (5 min, 
3000g, 4˚C) the supernatant was transferred to a new collection tube and MeOH content 
was removed by rotary evaporation (70 min, 50˚C). Volume was restored to 1ml by adding 
5% MeOH. To clean up the samples they were loaded onto Waters OASIS PRIME HLB 
1 30mg SPE cartridges, washed with 5% MeOH and eluted in 500 µl 100% MeOH. 
Internal standards were added at the following time points: before homogenisation, before 
rotary evaporation, before loading onto cartridges, after elusion.  
Cleaned-up extracts were analysed using HPLC – mass spectrometry operated in multiple 
reaction monitoring (MRM) mode.  
Each sample (5 µl) was analysed using an Agilent 1260 binary HPLC couples to an AB 
sciex 4000 QTrap triple quadrupole mass spectrometer. HPLC was achieved using a 
binary gradient of solvent A (Water + 5mM Ammonium Ac + 0.012% Formic Acid) and 
solvent B (Methanol + 5 mM Ammonium Ac + 0.012% Formic Acid) at a constant flow 
rate of 600 µl/min. Separation was made using a Supelco Ascentis Express C18 150 x 4.6, 
2.7µm column maintained at 40˚C. Injection was made at 50% B and held for 2 min, 
ramped to 95%B at 20 min and held until 24 minutes. The column equilibrated to initial 
conditions for 5 minutes.  
The mass spectrometer was operated in electrospray negative mode with capillary voltage 
of -4500V at 550˚C. Instrument specific gas flow rates were 25ml/min curtain gas, GS1: 
40ml/min and GS2: 50ml/min.  
See appendix 2 for LC-MS conditions and mass fragmentation monitoring values. 
Quantification was applied using Analyst 1.6.2 software to integrate detected peak areas 
relative to the deuterated internal standards.  
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5.2.10 Metabolomics 
Faecal extracts were prepared for NMR analysis by mixing thoroughly 20 mg of frozen 
faecal material with 1 mL of saline phosphate buffer (1.9 mM Na2HPO4, 8.1 mM 
NaH2PO4, 150 mM NaCl, and 1 mM TSP (sodium 3-(trimethylsilyl)-propionate-d4)) in 
D2O (deuterium oxide), followed by centrifugation (18,000g, 1 min). Supernatants were 
removed, filtered through 0.2 μm membrane filters, and stored at −20 °C until required. 
Serum samples were diluted 1:12 with NMR buffer and stored at -20 °C until further 
analysis. Samples were thawed, and 600 μL of each filtrate was transferred to a 5 mm o.d. 
NMR tube for analysis. 
  
High resolution 1H NMR spectra were recorded on a 600 MHz Bruker Avance 
spectrometer fitted with a 5 mm TCI cryoprobe and a 60 slot autosampler (Bruker, 
Rheinstetten, Germany). Sample temperature was controlled at 300 K. Each spectrum 
consisted of 128 scans of 32 768 complex data points with a spectral width of 14 ppm 
(acquisition time 1.95 s). The noesypr1d presaturation sequence was used to suppress the 
residual water signal with low power selective irradiation at the water frequency during 
the recycle delay (D1 = 2 s) and mixing time (D8 = 0.15 s). A 90° pulse length of 8.8 μs 
was set for all samples. Spectra were transformed with 1 Hz line broadening and zero 
filling, manually phased, and baseline corrected using the CHENOMX software. 
Metabolites were identified using information found in the literature or on the web 
(Human Metabolome Database, http://www.hmdb.ca/) and by use of the 2D-NMR 
methods, COSY, HSQC, and HMBC (Le Gall et al. 2011). 
 
5.2.11 Microbiota analysis  
5.2.11.1 microbial DNA isolation from SI content 
The content of each part of the small intestine was gently pushed out of the intestine at the 
time of sacrifice and rinsed out using 200µ of PBS. 150µL of this was used to isolate 
microbial DNA from. In collaboration with the Hall lab (Quadram Institute, Norwich 
Research Park, UK), for DNA isolation we used the Qiagen DNA mini kit following an 
improved protocol with additional steps to ensure breakage of all bacterial samples kindly 
provided by Dr. M Lawson. Briefly, the samples were homogenised using glass beads for 
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4x 30 seconds at 6000 rpm in a Precellys®24 (Bertin Technologies, France) and heated to 
95°C for 5 minutes in the middle. Additionally, samples were incubated with a lysis buffer 
containing 20mg/ml lysozyme after which the homogenising was repeated. Consequently, 
DNA was isolated using the Qiagen DNA mini kit following instruction from the 
producer. DNA quantity was assessed using both a nanodrop and a Qubit reader.  
 
5.2.11.2 16S sequencing of the SI microbiota  
A minimum of 50 ng of DNA was sent to the Earlham Institute (Norwich Research Park, 
UK) for quality assessment and 16S sequencing using the Illumina platform. Results were 
further analysed in collaboration with Wiktor Jurkoswki, PhD and Sarah Bastkoswki, PhD 
from the Earlham Institute.   
The microbiome composition was established using QIIME version 1.9.0 (Caporaso et al. 
2010). Paired reads were merged during the Quantitative Insights into Microbial Ecology 
Qiime 1.9.0 illumina workflow employed on a high performance computing cluster. The 
mapping file includes the forward and reverse linker primer sequence and was used for 
demultiplexing. Demultiplexing, quality filter and mapping file validation was carried out 
as described in the Qiime illumina workflow manual.  Operational Taxonomic Units 
(OTUs) were picked within Qiime using the closed-reference OTU picking protocol with 
the RDP classifier by searching reads against the Greengenes database version gg_13_8 
to the 97% level, and reads were aligned with PyNAST.  A representative sequence tree 
was gained after clustering using Uclust version 1.2.22. 
We calculated richness as defined through Chao1 (Chao A, (2000)) and diversity as 
defined by Shannon (Shannon C, (1948)) using the R package Phyloseq (version 1.18.0) 
(McMurdie P et al., (2013)). The Shapiro-Wilk test was used to assess normality and 
showed that the alpha diversity values are not normally distributed. We tested if diets had 
a significant impact on the mouse microbiomes alpha diversity using the Kruskal-Wallis 
test. A modified one way ANOVA as implemented in lmPerm (version 2.1.0, Wheeler R 
E, (2010)) was employed, which uses permutation tests instead of normal theory test, and 
was used to test for effects diet as covariates.   
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We used the fitZig function of the R package Metagenomeseq (Paulson et al. 2013) to 
establish significant differences in abundances of OTUs between groupings including 
covariates. We considered OTUs that were present in at least 25% of all samples.   
  
5.2.11 Statistics 
Statistics have been performed using Graphpad Prism. The statistical tests used are 
indicated in each figure legend. Power calculations were based on expected differences on 
gene expression (based on previous differences observed in Fgf15 expression) and led to 
a minimum of 5 mice per group being used in each experiment (indicated per figure). 
Analysis of variance (ANOVA) provides a statistical test of whether the means of groups 
are equal. When groups were compared over time, a 2-way ANOVA with Bonferroni post-
hoc test was used. When three or more groups were compared at a single time point, a 1-
way ANOVA was used with Bonferroni post-hoc. Lastly, when two groups were 
compared at one time point, an unpaired t-test was used to test for significance. p<0.05 
was considered overall as statistically significant and significance was indicated as ***= 
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5.3 Results 
The macronutrient composition of the two diets is relatively similar, however there are 
some major variances in sucrose content (3 times higher in HS), starch content (88 gram 
higher in HS) and fibre content (no fermentable fibre in the HS diet, figure 5.1A). 
Additionally, previous studies have pointed towards the lack of AhR ligands in the HS 
diet  (Ying Li et al. 2011). Mice receiving these diets for up to six months showed no 
difference in body weight gain (figure 5.1B) or any other obvious phenotypic differences. 
However, as will be outlined in this chapter, significant health-relevant differences in the 
gut and in particular in the liver of these animals were observed.  
 
Figure 5.1 Mice fed a chow or semi-purified high starch (HS) diet no not differ in body weight over 
time. The most important differences between the chow and HS diet are the increase in starch and sucrose 
and the lack of soluble fibres in the HS diet (A). Body weight gain is not different between the two diet 
groups over a total of 6 months period of feeding (B). n=5 for all groups 
 
5.3.1 Gene expression in the small intestine 
Significant differences in small intestinal gene expression were detected between mice fed 
the chow or purified diet, with 499 genes having a fold change >1.5 and adjusted p-value 
< 0.05, as found by microarray gene expression analysis. The differentially-regulated 
genes are both up and downregulated with a higher number of differentially regulated 
genes at the duodenal part of the small intestine compared to the jejunum and ileum (figure 
5.2A). Datamining using the Ingenuity Pathway Analysis software resulted in the 
prediction of a number of upstream regulators / transcription factors to be down and 
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upregulated in their activities across the different regions of the small intestine (figure 
5.2B and C). Most of these transcription factors we analysed did not show changes in gene 
expression but likely have a reduced transcriptional activity on one diet or increased on 
the other diet (chow) because of differences in the corresponding ligands resulting in less 
or more expression of their target genes. Among the transcription factors with a reduced 
transcriptional activity on the HS diet is the metabolically important Ppar receptor in the 
duodenum, involved in lipid metabolism, a number of transcription factors involved in 
cell growth (Foxf2), oxidative stress (Nfe2l2), detoxification (Nr1i2, Nr2i3) and immune 
response (Stat1). Transcription factors with increased activity and target gene expression 
on the HS diet include immune-related (Irf5, Irf7, NfatC2), cell-cell adhesion in the 
duodenum (Ctnnb1), cell cycle (Srf, Foxm1, Tp53), histone acetylation (Ncoa2) and 
gluconeogenesis in the ileum (Foxo1). The number and importance of the transcription 
factors differentially regulated (both increased and decreased) between the two diets 
emphasises the major effects these diets have on small intestinal health.   
Individual gene expression analysis showed that glucose uptake genes are higher 
expressed under HS conditions, an adaptive and physiological response that is in line with 
the increased sucrose and starch content of the diet. Additionally, genes involved in 
vitamin A metabolism are differentially regulated, Ppar target genes are downregulated, 
inflammation related genes like TNF- and NF are upregulated and barrier function 
and mucus-related genes are differentially regulated between the diets (Figure 5.2D). 
Lastly, we observed the downregulation of AhR target gene Cyp1a1 which is in line with 
the literature (Ying Li et al. 2011) and a down regulation of an important gene in the 
kynurenine pathway (Indoleamine 2,3-dioxigenase 1 (Ido1)) (figure 5.2E).  
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Figure 5.2 Gene expression over the course of the small intestine is dramatically different between 
chow and HS fed mice.  After two weeks of feeding a chow or HS diet, 499 genes were significantly altered 
over the course of the small intestine, with most genes upregulated in the duodenum of mice fed the HS diet 
(A). IPA predicted a large number of upstream regulators / transcription factors to be decreased (B) and 
increased (C) in their activity on the HS diet, and within the pathways individual gene expression was 
differentially regulated between the diets as shown in expression heatmaps with darker colours indicating 
higher expression (D). Cyp1a1 expression and Ido1 expression are shown over the course of the small 
intestine (E).  Significance was tested using or 2-way ANOVA with Bonferroni post-hoc test between chow 
and the test diets (***= p<0.001, *= p<0.05) n=5 for all groups 
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 5.3.2 Microbiota in the small intestine 
After two weeks of feeding, a switch in microbiota from Bacteroidetes to Firmicutes was 
observed in the HS fed mice (figure 5.3A), an alteration that is usually linked to a Western 
style diet and obesity (Komaroff 2017). Additionally, -diversity was found to be lower 
on mice fed the HS diet as shown by a decreased Shannon diversity score (figure 5.3B), 
indicating less richness in the bacterial community of HS fed animals. Furthermore, on 
the genus level, a vastly different microbiota profile was found (figure 5.3A), with six 
significantly different genera between the two diets after multiple testing correction of 
which five were increased and one was decreased after HS feeding (figure 5.3C). Similar 
changes were found in a purified HF diet compared to the chow data, indicating that these 
changes are due to the purification of the diets (data not shown).  
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Figure 5.3 Small intestinal microbiota is vastly different after feeding the chow and HS diet. After two 
weeks of feeding we observed a switch from Bacteroidetes to Firmicutes in the small intestine at phylum 
level and different genus profiles were found between the diet, as shown for each individual mouse (A). -
Diversity was calculated via Shannon diversity score and was lower in HS compared to chow fed mice (B). 
The genera Allobaculum, Mogibacteriaceae, Dorea, Turicibacterm, Lactococcus and S24-7 were 
significantly different in abundance between the diets (D). Significance was tested using a student’s t-test 
(**= p<0.01, *= p<0.05) n=5 for all groups 
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5.3.3 Metabolomic profiles in the ileum  
In addition to 16S-sequencing the microbiota, broad spectrum metabolomics was 
performed on content from the ileum and caecum of mice fed the chow and HS diet for 
one week (figure 5.4A). Principle Component Analysist (PCA) revealed a clear difference 
in specific metabolite concentrations according to diet (figure 5.4B). In particular, large 
differences in the amino acids present, with an increase of almost all amino acids in the 
HS fed animals (figure 5.4C) which could indicate a malabsorption of amino acids in the 
small intestine. Additionally, large variations were found in carbohydrate profiles, with 
more glucose on the HS diet, but lower amounts of complex carbohydrates (figure 5.4D) 
which is in line with the absence of soluble fibres in the HS diet. In the caecal content, the 
increase in amino acids of HS fed mice was also observed (figure 5.4E), stressing the 
possible malabsorption of amino acids. Furthermore, SCFAs were elevated in the caecum 
of chow fed mice (figure 5.4F).  
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Figure 5.4 Different metabolite profiles isolated from ileum and caecum content between the chow 
and HS fed mice. After 1 week of feeding, the content from the ileum and caecum was used to extract 
water-soluble metabolites (A). PCA plot show clear separation of metabolite profiles between the diets (B). 
In the ileum more amino acids were found in HS fed mice (C), in addition to more glucose and less complex 
carbohydrates (D). In the caecum, a similar increase in amino acids was observed (E) and a decrease in 
SCFAs in HS fed mice compared to chow fed mice (F). Significance was tested using a student’s t-test with 
multiple correction using the Sidak-Bonferroni method (***=p<0.001, **= p<0.01, *= p<0.05) n=5 for all 
groups 
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5.3.4 Ileum metabolite profiles independent of the microbiota 
Since large differences in both the microbiota and the metabolite profiles were found 
between chow and HS fed mice, we investigated the role of the microbiota in influencing 
ileal metabolite profiles using 1H NMR analysis of the ileal contents of mice treated with 
broad spectrum antibiotics (figure 5.5A). Here, we observe that also after antibiotic 
treatment there is a significant alteration of metabolite profiles between chow and HS fed 
mice (figure 5.5B), indicating direct effects of the diets on the metabolites present in the 
ileum. In addition, a similar increase in amino acids on the HS fed mice was found (figure 
5.5C). Lastly, glucose was still increased in HS fed mice, while other carbohydrates were 
increased on the chow diet (figure 5.5D). This links back to chapter 3 of this thesis, where 
glucose reaching the ileum was found to increase the expression of Fgf15 independently 
of the microbiota. Different from conventionally-raised mice, no increase in tri-, di- or 
oligosaccharides was found in antibiotic-treated chow mice, indicating a role of the 
microbiota in carbohydrate metabolism.   
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Figure 5.5 Antibiotics treated mice show similar metabolites profiles.  Mice were treated with broad 
spectrum antibiotics while being fed the chow or HS diet, and metabolites were isolated from the content of 
the ileum (A). PCA plot show an extreme separation between the two diets (B). Again, amino acids were 
found to be higher in HS fed mice (C), in addition to an increase in glucose and a decrease in more complex 
carbohydrates (D) Significance was tested using a student’s t-test with multiple correction using the Sidak-
Bonferroni method (***=p<0.001, **= p<0.01, *= p<0.05) n=10 for all groups 
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5.3.5 Small intestine physiology 
To determine the long-term consequences of the observed metabolic changes in the small 
intestine, a long-term study was performed to compare the effects of the chow and HS diet 
after six months of feeding. Due to the previously observed alteration in gene expression 
and microbiota profiles, we hypothesized alterations on small intestinal physiology. 
Consequently, H&E staining was performed on ileum samples (figure 5.6A) and a shorter 
villi length was observed in the ileum (figure 5.6B), which is most likely due to the lack 
of fibres in the LF diet (figure 4A and B) (Sigleo, Jackson, and Vahouny 1984). This 
difference was only found for the ileum, but not in the duodenum nor in the jejunum, and 
only after six months of feeding the diets (data not shown). Because of the previously 
observed differences in barrier function and mucus-related genes, intestinal permeability 
was tested using FITC-dextran. FITC-dextran was administered via oral gavage two hours 
before sacrifice and the appearance of fluorescence was measured in the serum. A higher 
fluorescence indicated an increase in membrane permeability in the intestinal epithelial 
layer, as FITC dextran is absorbed (see methods 2.4.3). An increase in intestinal 
permeability was observed in mice fed the HS diet for six months (figure 5.6C), which is 
linked to a variety of gut and metabolic conditions including obesity and the metabolic 
syndrome (Bischoff et al. 2014). Additionally, microarray analysis was performed on the 
ileum of these mice. Genes found to be differentially regulated in the two-week 
experiment were investigated and mostly also differentially expressed in this long-term 
experiment. The decrease in Ido1 and Cldn3 could be confirmed, as well as the increase 
in Nos2 expression (figure 5.6D). Further, glucose metabolism genes were analysed and 
found to be upregulated in the ileum of HS fed mice (figure 5.6E). This is in line with the 
previously observed increase in these genes on the HS diet, however, after two weeks the 
increase seemed to be mostly in the duodenum and jejunum while after six months they 
could also be observed in the ileum.  
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Figure 5.6 Long term feeding of the HS diet decreases villus length and leads to more intestinal 
permeability. After 6 months of feeding the two control diets, we investigated the small intestinal 
physiology by H&E staining (A) and found a decrease in villus length in the ileum (B). Additionally, long 
term feeding if the HS diet increased intestinal permeability as measured by FITC dextran (C). Gene 
expression, as measured via microarray, showed that similar effects can be found long term on intestinal 
gene expression as were previously identified short term (D) and additionally glucose metabolism genes are 
upregulated in the ileum of HS fed mice (E) Significance was tested using a student’s t-test or a t-test with 
multiple correction using the Sidak-Bonferroni method (***=p<0.001, **= p<0.01, *= p<0.05) n≤9 for all 
groups 
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5.3.6 Consequences for the liver 
The intestine and liver together form the gut-liver axis, linked though the enterohepatic 
circulation of diverse metabolites, which is critical in the development of a variety of 
health problems including metabolic and liver diseases (Wiest et al. 2017). To investigate 
the effects of the diets on the liver, H&E staining was performed on livers of mice on these 
diets over time (figure 5.7A). Short-term and long-term histological differences were 
observed, showing hepatocyte ballooning which coincided with increased triglyceride 
levels on the HS diet (figure 5B). In rodents, this coincides cholesterol levels (shown in 
figure 3.2), while this link is not present in humans and nonhuman primates (Khovidhunkit 
et al. 2004).  In addition, liver damage was quantified by apoptosis determination via 
caspase 3 activity measurements and showed a trend (p=0.1 at 1 week) towards an increase 
on the HS diet (figure 5.7C). The changes in fat accumulation and tissue damage were also 
reflected on the gene expression level on the short (figure 5D) and long term (figure 5E). 
Genes increased in livers of HS fed mice include the fatty acid synthase (Fasn), SMA  
(gene name Acta2) as an early indicator of fibrosis and tumor necrosis factor  (Tnf) as an 
indicator of inflammation. On the long term the HS diet even led to the development of 
hepatic carcinoma in 2 out of 9 animals, compared to 0 out of 10 chow fed animals (chapter 
3, figure 3.10). Interestingly, the diets seemed to have an initial metabolic stress effect on 
the livers (3 days and 1 week), after which the phenotypes would modestly recover; while 
on the long term (6 months) the detrimental phenotypes would become more obvious. This 
is reflected in the liver histology, liver triglyceride quantification and in the gene 
expression profiles (data not shown).  
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Figure 5.7 The HS diet induces triglyceride accumulation and apoptosis in the liver. H&E pictures of 
livers of mice fed the chow or HS diets for 3 days to 6 months show more fat accumulation and tissue 
damage in the HS fed mice (A). The accumulation of triglycerides is significant short term (1 week) and 
long term (6 months) (C). Apoptosis was measured by caspase 3 activity and shows a trend towards and 
increase on the HS diet (D). The changes in liver phenotype are also reflected in gene expression profiles 
after 3 days (E) and 6 months (F). Significance was tested using a 2-way ANOVA with a Bonferroni post-
hoc test or a student’s t t-test with multiple correction using the Sidak-Bonferroni method (***=p<0.001, 
**= p<0.01, *= p<0.05) n≤5 for all groups 
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5.3.7 Effects of soluble fibres on the gut-liver axis  
As discussed previously, we hypothesized that the lack of soluble fibres in the HS diet 
may be a major contributor to the phenotypes observed in both the small intestine and the 
liver. Additionally, we suspected that the sucrose content of the HS diet may also 
contribute to the pathological liver phenotypes. To test these hypotheses, new diets were 
designed in collaboration with Research Diets Inc, based on the original HS diet.  Firstly, 
sucrose content was decreased by over 60% to simulate sucrose levels found in the chow 
diet.  Additionally, 75 grams of soluble fibres was added to the HS diet. Firstly, inulin was 
added, a fibre that can be extracted from chicory root and is a polymer comprising fructose 
residues linked by -(2,1) bonds (Wilson and Whelan 2017). The second soluble fibre 
added to the HS diet was pectin, a hetero-polysaccharide that can be found ubiquitously 
in plant cell walls (Naqash et al. 2017). Lastly, fibersol was added to the diets, a non-
viscous and highly digestion-resistant maltodextrin (Ye et al. 2015). A summary of the 
compositions of the diets can be found in table 5.6 while a more detailed description is 
given in the materials and methods table 5.2.  
 
Table 5.6 Dietary composition of diets designed in collaboration with Research Diets.  
 
In order to detangle the role of soluble fibres, the HS diet used in this experiment is the 
low sucrose HS diet. The low sucrose HS diet and the corresponding fibre diets only differ 
in soluble fibre content, corrected for caloric intake by a slight decrease in starch. No 
significant differences in body weight or food intake were observed between the diets 
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(figure 5.8A and B). To investigate the morphology of the gut, we measured the length of 
the small intestine and colon and the weight of the caecum. In line with previous reports 
(Chassaing et al. 2015), an increase in caecum weight was observed in the fibre rich diets, 
however, no differences in small intestinal or colon length were evident (figure 5.8C). 
To further investigate which of the previously observed intestinal dysregulations were 
caused by a lack of dietary fibres, targeted gene expression across the small intestine was 
investigated using q-PCR. Cyp1a1 was tested in the duodenum as a target gene of the 
AhR, which did not respond to the addition of soluble fibres to the diet. Vitamin A 
metabolism was tested via Beta-Carotene Oxygenese 1 (Bco1) expression in the jejunum 
and showed an improvement in response to soluble fibres, with inulin and pectin 
normalizing Bco1 expression completely and fibersol being less potent. Lastly, ileal Ido1 
expression was tested in the ileum and did not show any differential response to the fibres. 
Intestinal permeability was also tested using oral gavage of FITC dextran as previously 
described, but no differences between the groups were observed (data not shown).  
To investigate the role of soluble fibres on the gut-liver axis, liver histology was 
performed. To determine the effects of the newly-designed diets on liver histology, a 
group of mice on the original high sucrose HS diet were included. As predicted, the 
reduced sucrose content of the new HS diet improved the liver phenotype considerably. 
The soluble fibres pectin and inulin were found to further improve the phenotype, while 
fibersol did not appear to have any beneficial effect on liver phenotypes. It has to be 
considered that this was a short-term study and longer feeding studies are necessary to 
further decipher the effect of the soluble fibres on liver health.   
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Figure 5.8 Adding soluble fibres to the HS diet partly counteracts its detrimental effects on the gut-
liver axis. Body weight did not change when the soluble fibres were added to the HS diet (A) and neither 
did food intake (B). Length of the small intestine and colon and weight of the caecum were measured during 
sacrifice (C). Gene expression of genes previously found to be differentially expression between the chow 
and HS diet were tested via Q-PCR in the duodenum, jejunum and ileum (D). Lastly, liver phenotypes were 
studied by histological H&E staining (E). Significance was tested using a 2-way ANOVA (A) or 1-way 
ANOVOA (rest) with a Bonferroni post-hoc test for differences against the HS diet group (***=p<0.001, **= 
p<0.01, *= p<0.05) n=10 for all groups 
 
5.3.8 Effects of soluble fibres on the ileal microbiota  
Since soluble fibres are known to alter the gut microbiota, 16S sequencing was performed 
on the content of the ileum to identify changes in the ileal microbiota between the diets. 
Firstly, -diversity as calculated by Shannon score was again found to be lower in HS fed 
mice compared to chow fed mice (also see figure 5.3B), and here it is shown that adding 
soluble fibres to the HS diet does not increase the microbial diversity in the ileum (Figure 
5.9A). Additionally, in figure 5.3A we show that there is a switch from predominantly 
Bacteroidetes in chow fed animals to predominantly Firmicutes in HS fed animals. Here, 
the percental abundance of Bacteroidetes is shown to increase after adding pectin and 
mostly inulin to the HS diet (figure 5.9B). Furthermore, on the phylum level an increase 
in Actinobacteria is shown in the Fibersol group (p<0.001 for HS versus HS+Fibersol, 
figure 5.9C). Lastly, at genus levels microbial profiles are altered by the soluble fibres. 
For example, an unknown species from the S24-7 family is decreased in HS fed animals 
compared to chow fed animals (p<0.001) and increased by adding soluble fibres to the HS 
diet, mostly inulin (HS vs HS+inulin p<0.001, Chow vs HS+inulin NS).  
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Figure 5.9 Adding soluble fibres to the HS diet partly restored the ileum microbiota. After two weeks 
of feeding a decrease in microbial diversity as calculated by the Shannon score was observed in all HS fed 
mice which did not improve after adding the soluble fibres pectin, inulin or fibersol to this diet (A). The 
Bacteroidetes / Firmicutes ratio was decreased in HS fed animals and slightly increased after adding soluble 
fibres (B). Phylum (C) and genus (D) profiles show that microbial profiles in the ileum are altered by soluble. 
Significance was tested using a one-way ANOVA with Bonferroni post-hoc test (***= p<0.001, *= p<0.05) 
n≤4 for all groups 
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5.4 Discussion  
Here it is shown that a diet consisting of purified components compared to an equicaloric 
chow diet has fundamental effects on the gut-liver axis independent of the development 
of obesity. The semi-purified HS diet leads to substantial changes in 1. gene expression of 
metabolic activity in the different regions of the small intestine, 2. the small intestine 
microbiota with a large increase in Firmicutes at the expanse of Bacteriodetes, 3. luminal 
metabolite profiles showing an increase in amino acids and a decrease in SCFAs and 4. 
leads to pathological liver phenotypes as shown by apoptosis and TG content of the livers. 
Additionally, we show that these effects are in part due to a lack of soluble fibres 
highlighting the role of fibre not only in the colon, but also in the small intestine, and that 
fibres are beneficial for the gut-liver axis. For human diets this would indicate that a diet 
low on soluble fibres alter the small intestinal microbiota, to a profile that has been shown 
to be less favourable (Murphy, Velazquez, and Herbert 2015). Additionally, the chow diet 
can be compared with a more “whole food” diet, and the HS diet with a “processed” diet, 
emphasising in this chapter that a “whole food” diet is better for the health of both the 
small intestine and the liver.   
No changes in body weight of mice were found between these two diets in this study and 
by others (Dalby et al. 2017), which indicates that the observed effects here are 
independent of obesity development. Due to the known differences between the diets, 
some differences in gene expression in the small intestine were expected as part of a 
physiological adaptive response. For example, the increase in glucose and fructose uptake 
genes were increased about three-fold in the HS fed mice when compared to the chow fed 
mice, which correlated with the three-fold increase in sucrose content of the diet. On a 
long-term, glucose metabolism genes also changed in the ileum. In addition to these 
obvious differences, many unexpected differences were encountered. The major 
differences were mainly observed in the activity of transcription factors and the related 
regulation of their target genes in the small intestine indicating the vastly different effects 
the diets and their bioactive components have on the small intestinal immune and 
metabolic functions.  
Additionally, a dysregulation in the vitamin A pathway in the small intestine, indicating a 
potential decrease in absorption of vitamin A, in HS fed mice was found, which has 
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previously been described and found to be related to SCFA production in the small 
intestine (Goverse et al. 2017). We here confirm that adding soluble fibres to the HS diet 
at least partly restores vitamin A metabolism in the small intestine. Our results indicate a 
strong effect of soluble fibres on Bco1, an enzyme that catalysis the conversion of -
carotene to vitamin A and that is under control of the small intestine specific transcription 
factor Isx (Lobo et al. 2013). Dysregulation of the Isx-Bco1 pathway has been shown to 
affect lymphocyte differentiation in the gut as well as increase vitamin A levels in the liver 
(Widjaja-Adhi et al. 2017).  Fibersol showed to be less potent in decreasing Bco1 
expression, which might be related to the previous suggestion that fibersol is fermented in 
the more distal gut (Fastinger et al. 2008).  
 
Indoleamine 2,3-Dioxygenase 1 (Ido1) is the rate limiting enzyme in tryptophan 
catabolism via the kynurenine pathway which is responsible for 90% of the tryptophan 
metabolism (Kennedy et al. 2017). The gut microbiota is known to influence tryptophan 
metabolism, as germ free and antibiotic-treated mice show an increase in circulating 
tryptophan levels (Wikoff et al. 2009; Desbonnet et al. 2015). Since tryptophan 
metabolism is essential for the brain, dysregulation of the kynurenine pathway has been 
linked to a number of psychiatric disorders, including  anxiety and depression (Kennedy 
et al. 2017). In the current study, a decrease of Ido1 expression is observed on the HS diet, 
which could be caused by changes in microbiota. However, no improvement in Ido1 
expression was found after adding soluble fibres to the diet, indicating that the observed 
effect is likely not linked to the soluble fibre content. More research is needed to determine 
whether the observed differences in Ido1 expression correlates with microbial changes. 
An opportunity to investigate this will arise in the microbiota data of the study where 
soluble fibres are added to the HS diet.   
The switch from a predominant Bacteroidetes population to Firmicutes in the gut has 
previously been linked to linked to DIO  (Turnbaugh et al. 2008; Ley et al. 2006). 
However, recently it has been shown that the observed changes in the microbiota in mice 
on a high fat diet are largely due to the purification and lack of fibres in the diet (Dalby et 
al. 2017). In this study, they compared a chow diet with a HS diet and a HF diet, where 
starch and fat are exchanged and found, similar to our results presented in this chapter, 
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that the increase in Firmicutes is independent of the amount of fat but most likely related 
to the lack of soluble fibres in the diet. Here we additionally show that adding soluble fibre 
to a HS diet restores the amount of Bacteroidetes present in the ileum, with mostly inulin 
being very effective. Furthermore, genus profiles start moving towards profiles of starch 
fed animals when soluble fibres are added to the HS diet, indicating that the lack of soluble 
fibres is one of the main drivers for the differences in the microbiota between the chow 
and HS diet. However, the -diversity score did not recover after adding any of the soluble 
fibres, most likely a combination of fibres is required (Lozupone et al. 2012).  
A more in-depth look at differences in microbiota between these two diets showed four 
genera significantly higher in HS fed mice, of which Allobaculum and Lactococcus are 
capable of utilizing glucose for their metabolism (Herrmann et al. 2017) and 
Mogibacteriaceae have previously been shown to decrease with vegetable consumption 
(Kellingray et al. 2017). The only genera significantly lower on HS compared to Chow 
was an unidentified genus of the S24-7 family. The S24-7 family is known for its ability 
to ferment a wide range of carbohydrates, including fibres, of which the chow diet contains 
a large variety (Ormerod et al. 2016). In accordance with this, S24-7 increased after adding 
soluble fibres to the HS diet.   
Metabolite profiles in the ileum are vastly different between the diets, with differences in 
both amino acids and carbohydrates present in both conventionally raised and broad-
spectrum antibiotic-treated mice. Notably, the increase in amino acids in both the ileum 
and caecum of mice fed the HS diet, independent of the microbiota, could indicate 
malabsorption. This is emphasized by similar differences in the amino acid content found 
in the caecum of HS fed mice. While it has been shown in ileostomies that nitrogen loss 
from the ileum is common (Chacko and Cummings 1988), the difference between the diets 
are striking. Additionally, the differences in amino acids seem to be independent of the 
microbiota. Surprisingly, the HS diet provides less protein per kJoule (20 En% versus 27 
En% in the chow diet) and energy intake is similar between the groups, however the 
differences in digestion between the diets remain unknown. In humans it has previously 
been shown that cereal fibres inhibit the increase in urinary nitrogen to creatine ratio, a 
biomarker for protein intake and digestion, in subjects on a high protein diet (Weickert et 
al. 2011). This indicates that cereal fibres interfere with the digestion and/or absorption of 
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proteins in the small intestine (Weickert and Pfeiffer 2018), however we find an almost 
opposite effect here, with less protein absorption on a low-fibre diet. More research will 
be needed to reveal the complex interaction between dietary fibres and protein uptake.   
In line with the decreased health of the small intestine we observed a decrease in ileal 
villus length and an increase in intestinal permeability during long term (6 months) feeding 
of the HS diet. In chickens, adding dietary fibres to the diet has previously been shown to 
increase villus length in the ileum (De Maesschalck et al. 2015). This has been speculated 
to be due to butyrate formation from the present fibres; although our methods were not 
sensitive enough to determine butyrate in the ileum. However, in the caecum butyrate was 
decreased four-fold in HS fed animals. Sodium-butyrate supplementation is reported to 
increase ileal villus length in broiler chickens (Hu and Guo 2007) and butyrate has been 
shown to induce cell proliferation in the ileum (Canani et al. 2011). Most of the research 
so far in the effect of nutrition on small intestinal villus length is focussed on animal 
nutrition and feed-effectiveness. However, it would be interesting to test these effects in 
humans since the change in villus length correlated with changes in intestinal and liver 
health in our study.  The decrease in butyrate throughout the intestine, as shown in the 
caecum, could also explain the increase in intestinal permeability. Butyrate has been 
shown to facilitate the assembly of tight junctions via the activation of AMP- activated 
protein kinase (AMPK) in the intestinal cells (Peng et al. 2009). Unfortunately, we were 
unable to identify the causal role of soluble fibres for intestinal permeability, as the length 
of time of soluble fibre feeding was too short to observe differences.  
In the present study, no significant differences in weight gain were found between mice 
fed the chow or the HS diets. However, liver histology revealed damage to the hepatocyte 
architecture following HS feeding. These results were substantiated by our analysis of 
apoptosis via caspase 3 activity, triglyceride quantification and hepatic gene expression.   
Taken together, with the initial signs of parenchymal damage observed in this mouse study 
on a HS diet, we believe investigating the differences between chow and HS is an 
interesting approach to look at the effect of dietary patterns on liver health disconnected 
from changes in body weight.  
In conclusion, the HS diet is detrimental for gut and liver health, showing increased 
intestinal permeability and hepatic parenchymal damage and long-term even incidences 
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of hepatic carcinoma. Soluble fibres are in part able to counteract these effects, possibly 
via delaying starch digestion, lowering the glycaemic load, altering the microbiota and/or 
normalizing Fgf15 expression (see chapter 4). However, more research is needed to 
identify both the long-term effects of soluble fibres on the small intestine–liver axis.   
  





Chapter 6. Long term caloric restriction decreases bile acid levels in 
the ileum and a reduced expression of the enterokine Fgf15 
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6.1 Introduction  
The health benefits of a calorie restricted diet (CR) while avoiding malnutrition are widely 
acknowledged. First, the lack of calories reduces the incidence of obesity and related 
metabolic diseases (Heilbronn et al. 2006). Secondly, CR has been shown to increase the 
life-span of a wide range of species, from yeast to mice and primates (Fontana, Partridge, 
and Longo 2010; Fontana and Partridge 2015).  
Although it has become clear that bile acids act as metabolic hormone-like molecules 
(Kuipers, Bloks, and Groen 2014), we know very little about the role of bile acids and 
their metabolism in ageing during CR. Short term, it is known that plasma bile acid levels 
do not increase after CR in humans (Jahansouz et al. 2016; van Nierop et al. 2017). 
However, bile acids in the enterohepatic circulation increase after short term CR in mice 
in a dose-dependent manner (Z. D. Fu and Klaassen 2013). In this study, 30% and 40% 
CR for one month increased bile acids in enterohepatic circulation and their production 
via hepatic Cyp7a1, while a trend towards increased Fgf15 expression was observed in the 
ileum (Z. D. Fu and Klaassen 2013). The authors also show that the increase in bile acids 
is independent of sirtuin 1 (Sirt1) (Z. D. Fu, Cui, and Klaassen 2015), a transcription factor 
that is activated in response to CR and is considered to mediate some of the health benefits 
provoked by CR (Cohen et al. 2004; Bordone and Guarente 2005).    
An emerging area where CR is important in bile acid synthesis/physiology and metabolism 
is bariatric surgery (Albaugh et al. 2017). Bariatric surgery has been shown to increase 
circulating bile acids in mice (Ding et al. 2016), rats (Cummings et al. 2012) and humans 
(Steinert et al. 2013). Further, the important role of bile acid-sensing transcription factor 
FXR (Ryan et al. 2014) and of the G-protein coupled membrane receptor TGR5 (Ding et 
al. 2016) and their association with the beneficial effects of bariatric surgery have been 
elucidated.  
PhD thesis Britt Blokker 152
On the other hand and in the case of shorter term CR, obesity has also been associated 
with an increase in circulating bile acids and elevated bile acid synthesis (Haeusler et al. 
2016), and can be counteracted by three days of CR (Straniero et al. 2017). Additionally, 
circulating FGF19 levels are higher in lean than in obese people, but this could not be 
corrected by short term CR (Mráz et al. 2011). 
Lastly, it has been known for a long time that ageing can influence bile acid metabolism. 
Hepatic conversion of cholesterol to bile acids has been shown to decrease in elderly 
populations (Einarsson et al. 1985) along with lower activity of CYP7A1, the rate limiting 
step in this conversion (Bertolotti et al. 1993). Moreover, bile acid secretion decreased in 
ageing rats, and this could be partly prevented by a 40% CR diet (Ferland et al. 1989). 
 
Rusli et al (Rusli et al. 2017) performed a very interesting study in ageing mice where 
control fed mice were compared to 30% CR fed mice over 24 months. In collaboration 
with the group of Dr Wilma Steegenga (Wageningen University, NL), we were able to 
investigate bile acid metabolism and the microbiota from the small intestine in samples 
obtained from this study, providing a unique opportunity to investigate the effects of CR 
on bile acid metabolism during ageing. In this chapter, we show that bile acid metabolism 
is affected differentially during ageing in CR fed mice compared to control mice, showing 
an interesting decrease in both bile acids present in the ileum and the expression of 
signalling molecule Fgf15 during ageing.  
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6.2 Materials and Methods 
6.2.1 IDEAL study design 
The IDEAL study has been performed at Wageningen University in accordance with the 
Dutch national guidelines. Our research group at the University of East Anglia was 
provided with small intestinal samples from this study. For IDEAL, male C57B6/J mice 
were housed individually at the age of 9 weeks and were randomly distributed into a 
control group (HS, n=89) and a CR (n=117) group. The control group received the AIN-
93W diet ad libitum, a diet similar to the HS diet used in other chapters of this thesis 
(figure 6.1A). The CR mice received the AIN-93W-CR diet in portions containing 70 En% 
of the mean intake of the HS group supplemented with vitamins and minerals (figure 
6.1B), provided daily at 4.30pm. Mice were sacrificed at 6, 12 and 24 months of age, 
providing the opportunity to investigate effects of CR during ageing. Body weight was 
measured every week (figure 6.1C) showing a decrease in body weight gain in CR fed 
mice. A more elaborate description of the study can be found in previous publications 
(Rusli et al. 2015; Rusli et al. 2017).   
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Figure 6.1 Diets and body weight. Here, the high starch (HS) diet used in the previous chapters of this 
thesis is compared with the HS diet used in the IDEAL ageing study (A). The caloric restriction diet used in 
the IDEAL study is based on the HS diet but compensated for both minerals and vitamins (B). Results for 
body weight were collected in Wageningen University and show the expected lower body weight in CR fed 
mice during ageing (C).  
 
6.2.2 Samples analysed at UEA / Quadram Institute 
As part of a collaboration with Dr. Wilma Steegenga at Wageningen University we 
received the small intestine of the mice fed the HS and the CR diet that were sacrificed 
after 6, 12 or 24 months. We received both the tissue of the small intestine and the small 
intestinal content.  
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6.2.3 Gene expression 
RNA of liver and intestinal scraping samples was isolated. Samples were homogenised in 
1 ml Trizol (Qiazol, Qiagen, UK) for 30 seconds at 6000 rpm in a Precellys®24 (Bertin 
Technologies, France). After homogenization samples were transferred to a new 
Eppendorf tube and 200 µl Chloroform was added. Samples were centrifuged for 15 
minutes at 12.000 RCF 4˚C and the clear layer was transferred to a new collection tube. 
Iso-propanol was added and after mixing, resting for 5-10 minutes and centrifugation for 
10 minutes at 12.000 RCF 4˚C an RNA pellet was left. The pellet was washed in 85% 
ethanol and dissolved in 100 µl RNase Free water. RNA concentration was measured with 
a Nanodrop (Thermo Scientific, Wilmington, USA). cDNA was synthesized from 2 µg of 
RNA which was first treated with DNase (DNase kit, Invitrogen, 18068-015) and 
subsequently reverse transcription was performed. A quantitative polymerase chain 
reaction (Q-PCR) was performed using SYBR green master mix (Applied Biosystems, 
Thermo Fisher Scientific, UK) according to the producer’s instructions. Reactions were 
performed using 384 wells (Applied Biosystems, Thermo Fisher Scientific, UK) using 
5µL of SYBR green and primer mix (for a list of the primers used, see table 6.1) and 1.5µL 
of cDNA. The reaction was initialized at 50°C for 5 minutes and 95°C for 2 minutes, after 
which 40 cycles of denaturation (95°C 15 seconds) and annealing/extension (59°C 1 min) 
were performed. Afterwards, a melting curve was created and checked for a single product 
per gene. ΔCT values were calculated by subtracting the CT value of the housekeeping 
gene TBP from the gene CT value. ΔΔCT was calculated relative to control samples 
(Livak and Schmittgen 2001).  
 
Table 6.1 Primers used for q-PCR measurements in small intestine. 
Gene Forward  Reverse 
TBP (hk) GAAGCTGCGGTACAATTCCAG CCCCTTGTACCCTTCACCAAT 
GAPDH (hk) AGGTCGGTGTGAACGGATTTG TGTAGACCATGTAGTTGAGGTCA 
FXR  GGCCTCTGGGTACCACTACA AAGAAACATGGCCTCCACTG 
OSTA TTGTGATCAACCGCATTTGT CTCCTCAAGCCTCCAGTGTC 
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ASBT TGGAATGCAGAACACTCAGC GCAAAGACGAGCTGGAAAAC 
FABP6 CACCATTGGCAAAGAATGTG AACTTGTCACCCACGACCTC 
SHP TCTGCAGGTCGTCCGACTATT AGGCAGTGGCTGTGAGATGC 
FGF15 CAGTCTTCCTCCGAGTAGCG TGAAGACGATTGCCATCAAG 
 
Selected samples went for microarray analysis. After RNA isolation as described before, 
samples were send to WUR for microarray analysis. At WUR RNA quality was assessed 
with a Bioanalyzer (Aligent 2100 Bioanalyzer, Santa Clara, USA), and microarrays were 
performed using the Mouse gene Chip 1.1 array from Affymetrix (Thermo Fisher 
Scientific, Santa Clara, USA). After normalization process, ~22 k genes were included in 
the data set.  The limma R library was used to analyse the significant differential 
expression between the diets. Log2FC of 1.5 and a p-value of 0.05 were used as cut-off 
points and the rate discovery false for the p-value was calculated. Ingenuity Pathways 
Analysis (IPA) web-based software application was used to analyse, integrate and 
interpret the data 
 
6.2.4 Bile acid measurements 
As no bile acid measurements were performed in house at the time of arrival, we set up 
our own method in collaboration with the metabolomics unit of the Quadram Institute. A 
special thanks go to Mark Philo, who was a tremendous help in this process. Bile acids 
were measured in the scrapings and content of the three different parts of the small 
intestine, liver, colon faeces and serum. Here for, 50 mg (liver), 25 mg (intestine) or 50 
µL (serum) of tissue was homogenised in 1 ml of cold 70% methanol for 30 seconds at 
6000 rpm in a Precellys®24 (Bertin Technologies, France). After centrifugation (5 min, 
3000g, 4˚C) the supernatant was transferred to a new collection tube and MeOH content 
was removed by rotary evaporation (70 min, 50˚C). Volume was restored to 1ml by adding 
5% MeOH. To clean up the samples they were loaded onto Waters OASIS PRIME HLB 
1 30mg SPE cartridges, washed with 5% MeOH and eluted in 500 µl 100% MeOH. 
Internal standards were added at the following time points: before homogenisation, before 
rotary evaporation, before loading onto cartridges, after elusion.  
PhD thesis Britt Blokker 157
Cleaned-up extracts were analysed using HPLC – mass spectrometry operated in multiple 
reaction monitoring (MRM) mode.  
Each sample (5 µl) was analysed using an Agilent 1260 binary HPLC couples to an AB 
sciex 4000 QTrap triple quadrupole mass spectrometer. HPLC was achieved using a 
binary gradient of solvent A (Water + 5mM Ammonium Ac + 0.012% Formic Acid) and 
solvent B (Methanol + 5 mM Ammonium Ac + 0.012% Formic Acid) at a constant flow 
rate of 600 µl/min. Separation was made using a Supelco Ascentis Express C18 150 x 4.6, 
2.7µm column maintained at 40˚C. Injection was made at 50% B and held for 2 min, 
ramped to 95%B at 20 min and held until 24 minutes. The column equilibrated to initial 
conditions for 5 minutes.  
The mass spectrometer was operated in electrospray negative mode with capillary voltage 
of -4500V at 550˚C. Instrument specific gas flow rates were 25ml/min curtain gas, GS1: 
40ml/min and GS2: 50ml/min.  
See appendix 2 for LC-MS conditions and mass fragmentation monitoring values. 
Quantification was applied using Analyst 1.6.2 software to integrate detected peak areas 
relative to the deuterated internal standards.  
 
6.2.5 Microbiota analysis  
6.2.5.1 microbial DNA isolation from SI content 
The content of each part of the small intestine was gently pushed out of the intestine at the 
time of sacrifice and rinsed out using 200µ of PBS. 150µL of this was used to isolate 
microbial DNA from. In collaboration with the Hall lab (Quadram Institute, Norwich 
Research Park, UK), for DNA isolation we used the Qiagen DNA mini kit following an 
improved protocol with additional steps to ensure breakage of all bacterial samples kindly 
provided by Dr. M Lawson. Briefly, the samples were homogenised using glass beads for 
4x 30 seconds at 6000 rpm in a Precellys®24 (Bertin Technologies, France) and heated to 
95°C for 5 minutes in the middle. Additionally, samples were incubated with a lysis buffer 
containing 20mg/ml lysozyme after which the homogenising was repeated. Consequently, 
DNA was isolated using the Qiagen DNA mini kit following instruction from the 
producer. DNA quantity was assessed using both a nanodrop and a Qubit reader.  
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6.2.5.2 16S sequencing of the SI microbiota  
A minimum of 50 ng of DNA was sent to the Earlham Institute (Norwich Research Park, 
UK) for quality assessment and 16S sequencing using the Illumina platform. Results were 
further analysed in collaboration with Wiktor Jurkoswki, PhD and Sarah Bastkoswki, PhD 
from the Earlham Institute.   
The microbiome composition was established using QIIME version 1.9.0 (Caporaso et al. 
2010). Paired reads were merged during the Quantitative Insights into Microbial Ecology 
Qiime 1.9.0 illumina workflow employed on a high performance computing cluster. The 
mapping file includes the forward and reverse linker primer sequence and was used for 
demultiplexing. Demultiplexing, quality filter and mapping file validation was carried out 
as described in the Qiime illumina workflow manual.  Operational Taxonomic Units 
(OTUs) were picked within Qiime using the closed-reference OTU picking protocol with 
the RDP classifier by searching reads against the Greengenes database version gg_13_8 
to the 97% level, and reads were aligned with PyNAST.  A representative sequence tree 
was gained after clustering using Uclust version 1.2.22. 
We calculated richness as defined through Chao1 (Chao A, (2000)) and diversity as 
defined by Shannon (Shannon C, (1948)) using the R package Phyloseq (version 1.18.0) 
(McMurdie P et al., (2013)). The Shapiro-Wilk test was used to assess normality and 
showed that the alpha diversity values are not normally distributed. We tested if diets had 
a significant impact on the mouse microbiomes alpha diversity using the Kruskal-Wallis 
test. A modified one way ANOVA as implemented in lmPerm (version 2.1.0, Wheeler R 
E, (2010)) was employed, which uses permutation tests instead of normal theory test, and 
was used to test for effects diet as covariates.   
We used the fitZig function of the R package Metagenomeseq (Paulson et al. 2013) to 
establish significant differences in abundances of OTUs between groupings including 
covariates. We considered OTUs that were present in at least 25% of all samples.   
 
6.2.6 Additional analysis 
In addition to the measurement performed at UEA and Quadram, some measurements 
performed at Wageningen University were reanalysed. Here, microarray analysis was 
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performed from the livers of 4 mice per group (n total = 24), and our group extracted bile 
acid-related genes from this data set.  
 
6.2.7 Statistics 
Statistics have been performed using Graphpad Prism. The statistical tests used are 
indicated in each figure legend. Analysis of variance (ANOVA) provides a statistical test 
of whether the means of groups are equal. When groups were compared over time, a 2-
way ANOVA with Bonferroni post-hoc test was used. When three or more groups were 
compared at a single time point, a 1-way ANOVA was used with Bonferroni post-hoc. 
Lastly, when two groups were compared at one time point, an unpaired t-test was used to 
test for significance. p<0.05 was considered overall as statistically significant and 
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6.3 Results 
The IDEAL study has previously been shown to successfully prevent adverse health 
effects from ageing by CR (Rusli et al. 2017). Here, we aim to investigate the role of bile 
acids and bile acids metabolism during ageing and under CR.  
 
6.3.1 Bile acids in the ileum initially increase in CR mice but decrease during ageing 
Bile acids were measured in scrapings of the ileum and showed a different effect of ageing 
in the HS fed mice compared to CR mice. In the HS fed mice, no clear effect of ageing 
was found on the bile acids present in the ileum. However, during ageing in CR mice the 
total bile acids present in the ileal scrapings decreased, which led to a significantly 
different amount of total bile acids present in the HS versus CR mice in 24 months old 
mice (figure 6.2A). Additionally, the percentage of secondary bile acids present in the 
scrapings was lower in the CR fed mice, especially in old mice, indicating a difference in 
the microbiota (figure 6.2B). When the bile acids were analysed individually, the decrease 
in bile acids with ageing in the CR fed mice became very apparent (figure 6.2D). The bile 
acids that are primarily affected by ageing under CR conditions are CA, TCA, T-b-MCA 
and TDCA. No significant effects of ageing on individual bile acids in ileal scrapings were 
observed in HS fed animals (figure 6.2C).  
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Figure 6.2 Bile acids first increase but during ageing decrease in CR fed mice. Bile acids were measured 
in ileal scrapings, with total bile acids show an initial increase and later decrease in CR fed animals compared 
to HS fed animals (A). There is a smaller portion of secondary bile acids in CR fed animals, which is 
significant after 24 months of feeding (B). Ageing does not significantly affect HS fed animals (C) but does 
significantly decrease multiple bile acids in CR fed mice (D). Significance was tested using a 2-way ANOVA 
with Bonferroni post-hoc test in A and B and using a 1-way ANOVA with Bonferroni post-hoc test between 
all groups for C and D (*** = p<0.001, **= p<0.01, *= p<0.05) n=10 for all groups 
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6.3.2 The expression of the signalling molecule Fgf15 is altered by ageing and CR  
To investigate the consequences of the differences in bile acids in ageing in HS versus CR 
fed mice, genes involved in bile acid metabolism in the ileum were investigated. The 
signalling molecule Fgf15 increased during ageing in HS fed animals (HS 6 months versus 
12 months p<0.01), while in CR animals Fgf15 expression decreased with age (CR 6 
months versus 12 months p=0.04). This opposite response observed with ageing leads to 
a difference in Fgf15 expression between the different diets at all time points, with an 
increased Fgf15 expression in adult CR fed mice and a lower expression in middle-aged 
and old CR fed mice (figure 6.3A). No difference was found in the expression of the gene 
responsible for bile acid uptake (Asbt, figure 6.3B), although activity measurements will 
be needed to determine if bile acid uptake is regulated post-transcriptionally between diets. 
Additionally, no changes were found in other FXR target genes involved in bile acid 
metabolism as shown by the expression of Fxr itself, Fabp6 and Osta (figure 6.3C).  
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Figure 6.3 Gene expression of bile acid metabolism related genes in the ileum show Fgf15 being 
differentially regulated during ageing in HS compared to CR fed mice. Fgf15 expression is increased 
after 6 months of CR feeding but decreased after both 12 and 24 months of feeding a CR diet (A). Bile acid 
absorption is not altered at the transcriptional level during ageing on either diet (B) and FXR and FXR target 
genes also do not show differential regulation (C).  Significance was tested using a 2-way ANOVA with 
Bonferroni post-hoc test for both diet and time (**= p<0.01, *= p<0.05) n=10 for all groups 
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6.3.3 CR influences de novo bile acid synthesis and transport in the liver  
Since Fgf15 is known to inhibit hepatic Cyp7a1, the gene expression profiles in the liver 
were investigated for identifying genes involved in bile acid metabolism. Cyp7a1 was 
found to increase in expression in CR animals, while no change was observed during 
ageing in control fed animals. Gene expression of Cyp27a1, responsible for alternative 
bile acid synthesis pathway, was found to be unaltered by both age and diet type (figure 
6.4A).  
When Fgf15 arrives at the hepatocytes via the portal vein, it binds to its receptor Fgfr4. 
Additionally, it has been shown that Klotho- plays an important role in stabilizing 
FGFR4 after stimulation with Fgf15 (Triantis et al. 2010). Hence, expression of both Fgfr4 
and -Klotho (Klb) was studied, with Fgfr4 expression increasing during ageing 
independent of the diet, and Klb expression being increased in adult and middle-aged but 
not old CR fed mice compared to control mice (figure 6.4B).  
Lastly, gene expression of bile acid transporters in the liver were investigated. No changes 
were found for transporters at the basolateral or apical membrane, as shown here for Ntcp 
and Mrp2 (figure 6.4C). However, transporters involved in alternative bile acid transport, 
responsible for transporting bile acids from the hepatocytes into the circulation 
(Halilbasic, Claudel, and Trauner 2013), were found to be influenced by both age and diet 
(figure 6.4D). Mrp3, the most highly expressed basolateral transporter, shows a 
downregulation in CR fed mice which is significant after 24 months. Mrp4, which is 
expressed in far lower amounts, shows an initial increase in CR fed animals, however an 
age-dependent decrease can be observed in these animals.  
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Figure 6.4 Hepatic Cyp7a1 and alternative bile acid transport is differentially regulated during ageing 
between the diets. Bile acid synthesis was investigated by gene expression of both Cyp7a1, showing an 
increase with ageing in CR mice, and alternative bile acid synthesis via Cyp27a1 expression showing no 
regulation (A). The FGF15 receptor dimer shows an age-dependent increase for Fgfr4 and a diet-dependent 
regulation for Klotho (B). Classical bile acid transporters on both the basolateral and apical membrane 
showed no regulation (C), while alternative bile acid transport was regulated by the dietary intervention (D). 
Significance was tested using a 2-way ANOVA with Bonferroni post-hoc test for both diet and time (**= 
p<0.01, *= p<0.05) n=5 for all groups 
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6.3.4 Microbiota profiles in the ileum are different in mice on the CR diet 
To further investigate the role of CR in bile acid metabolism, we investigated the 
microbiota composition in the small intestine using 16S sequencing. Phylum profiles show 
a clear increase in Actinobacteria in adult and middle-aged CR fed mice and a slight 
decrease in Bacteroidetes (Figure 6.5A).  
From the PCoA plots it becomes clear that the microbiota is significantly different 
between the control and CR fed mice at all measured timepoints (p<0.01 for all), however 
microbiota differences appear to be more pronounced after 6 and 12 months compared to 
24 months (Figure 6.5B).  
Alpha diversity was calculated using the Shannon diversity score. This showed similar 
diversity between the two diet groups and during ageing for the small intestinal 
microbiota, with the only difference being observed in 12 months old mice that showed a 
slight decrease in diversity in the CR group (Figure 6.5C).  
Lastly, the microbiota was quantified by q-PCR against an E. Coli standard curve, showing 
no difference between diets, and a trend towards a decline in the number of bacteria 
present in the small intestine with age (Figure 6.5D).  
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Figure 6.5 Microbiota composition in the ileum is different between HS and CR fed mice. Microbial 
DNA was isolated form the ileum and 16S DNA was sequenced using the Illumina platform. Phylum levels 
show differentially distinct profiles with more Actinobacteria in the CR fed mice (A). PCoA plots show the 
separation of the two diet groups which is most prominent at 6 and 12 months of age (B). Alpha diversity 
was calculated using the Shannon diversity score (C) and microbial DNA was quantified using Q-PCR (D). 
Significance was tested using a 2-way ANOVA with Bonferroni post-hoc test for both diet and time ( *= 
p<0.05) n≤5 for all groups  
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6.3.5 More beneficial bacterial profiles in mice fed the CR diet for 6 and 12 months 
The different genera present in the ileum of each mouse were studied to provide a more 
detailed observation into the small intestinal microbiota. The profiles of genera present 
are shown for each individual mouse and show clear differences between HS and CR fed 
mice (Figure 6.6A). A significant increase in Lactobacillus was observed in CR mice at 
all measured time points. In addition, at 6 and 12 months an increase in Bifidobacterium 
and a decrease in Clostridiaceae was observed in these mice. The genera Allobaculum was 
first found to be increased at 6 months of CR feeding, but after 12 months showed a slight 
decrease (Figure 6.6B). The increase in Bifidobacterium explains the previously observed 
increase in Actinobacteria (Figure 6.5A), as this genus belongs to the phylum of the 
Actinobacteria and a similar increase is observed.  
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Figure 6.6 Multiple genera found to be differentially regulated in the ileum of CR mice. The genera 
present in the ileum are presented for each individual mouse, showing a clear difference between the diets 
(A). Significance was calculated using a Kruskal-Wallis test and after multiple measurement correction the 
significantly different genera between diets were plotted for each time point (B). (*** = p<0.001, **= p<0.01, 
*= p<0.05) n≤5 for all groups   
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6.4 Discussion 
We here show, for the first time, that very long-term CR (12 and 24 months) 1.5 to 2 fold 
decreases bile acids in the ileum and most likely via the transcription factor FXR decreases 
the expression of the important enterokine Fgf15.  
As discussed prior, short-term CR has been shown to increase BAs in enterohepatic 
circulation (Fu and Klaassen 2013). In line with this finding, we show a slight increase in 
total BAs in the ileum after 6 months of CR, however ileal BAs decrease with ageing in 
CR mice. This ultimately leads to less ileal BAs in CR mice compared to HS fed mice. 
Previous ageing studies have focused on the liver and hepatic cholesterol excretion, 
showing that this decreases with age. Here, in HS fed mice we do not observe changes in 
ileal BAs. It should be noted that these bile acids are measured in the scrapings of the 
ileum, and after the content has been washed out, portraying bile acids present in both the 
enterocytes and the mucus layer. The colon of these mice have previously been 
investigated by the group of Dr Steegenga at Wageningen University and show that during 
CR bile acids are decreased in the colon in both adult and aged mice (Kok et al. 2018). 
This indicates a more efficient enterohepatic circulation of bile acids, since bile acids that 
have reached the colon have escaped reabsorption in the ileum. Although we do not 
observe changes in gene expression of the apical bile acid transporter Asbt in the ileum, 
its activity may be increased post-transcriptionally. Additionally, Straniero et al 
hypothesized that part of the mechanism in which bile acids escape reabsorption in the 
ileum may be related to the food content in the ileum (Straniero et al. 2017). In CR fed 
animals there is less food components that reaches the ileum, which could lead to more 
freely available bile acids and an increased efficiency of the enterohepatic circulation. 
Furthermore, CR mice were fed once a day with a restricted amount of food. 
Consequently, a fasting period was created each day for CR mice, as is usual in rodent CR 
models. Short fasting periods, even under iso-caloric conditions, have been shown to 
influence glucose metabolism and autophagy and mimic some health effects of CR 
(Martinez-Lopez et al. 2017). Iso-caloric restricted time feeding studies would be required 
to entangle the different effects of CR and short-term fasting on bile acid metabolism.  
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When bile acid metabolism was investigated in the ileum, Fgf15 expression was found to 
be differentially regulated between the two diets. Correlating with the bile acid results for 
CR fed mice, Fgf15 expression was increased in adult mice whereas it was decreased in 
ageing mice. An opposite ageing effect was found in HS fed mice. Not much is known 
about FGF15/19 during ageing though FGF15/19 levels have been proposed to be 
beneficial during ageing (Hao et al. 2013). An engineered, non-cancerogenic form of 
FGF19 was shown to decrease liver damage in aged mice (Alvarez-Sola et al. 2017). 
However, Fgf15 itself has been shown to provoke the incidence of hepatic carcinoma 
(Uriarte et al. 2015; Uriarte et al. 2013). In the current study, HS fed mice show extensive 
liver damage which was mostly prevented by CR, as published previously (Rusli et al. 
2017).  
Because of the known regulatory effects of Fgf15 on hepatic Cyp7a1 expression (Kuipers, 
Bloks, and Groen 2014), liver bile acid metabolism was investigated. Cyp7a1 gene 
expression did not change during ageing in HS fed animals. Previously, it has been shown 
that Cyp7a1 activity decreases during ageing (Bertolotti et al. 1993), however this 
regulation might be post-transcriptional and therefore undetectable in our microarray 
results. In CR fed animals, Cyp7a1 expression is first decreased and later increased which 
correlated with the regulation of Fgf15 in the ileum.  
 
Additionally, -Klotho was found to be differentially regulated between the two diets, 
with higher expression in CR fed mice after 6 and 12 months of feeding. While the Klotho 
gene has been related to ageing and has been used to develop a short lifespan mouse model 
(Kuro-o et al. 1997), not much is known about the regulation of -Klotho. -Klotho-
knockout mice show altered regulation of bile acid metabolism, but no effects on ageing 
phenotypes (Ito et al. 2005).  
Furthermore, Mrp3 expression was found to be increased in CR fed animals and this 
difference became more apparent during ageing. Mrp3 is involved in alternative bile acid 
secretion from the liver into the bloodstream (Halilbasic, Claudel, and Trauner 2013). 
Unfortunately, we were not able to measure circulating bile acids due to a lack of samples. 
However, the increased expression of Mrp3 indicated a possible increase in circulating 
bile acids, which can influence the regulation of the ubiquitously expressed G protein-
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coupled bile acid receptor TGR5. TGR5 activation can regulate inflammation, obesity and 
diabetes (Duboc, Taché, and Hofmann 2014). More research will be needed to investigate 
the effects of very long-term CR on circulating bile acids and their role in regulating TGR5 
activity in different organs.  
 
Microbiota profiles of both diet groups show a large proportion of Firmicutes, which has 
traditionally been linked to the consumption of a HF diet. However, recently it has been 
shown that this is due to a lack of fibres in the diet. As discussed in chapter 5 of this thesis, 
the HS diet is a purified diet and does not contain any form of soluble fibre which explains 
the large proportion of Firmicutes (Dalby et al. 2017). The colonic microbiota composition 
of these mice has previously been analysed (Kok et al. 2018; van der Lugt et al. 2018). 
Although patterns are similar, there are some interesting differences between the small 
and large intestine. Firstly, Bifidobacterium is increased in presence in the colon of both 
adult and aged mice, while in the ileum only Bifidobacterium largely disappears at 24 
months of age. In the colon Bifidobacterium spp are recognized for their health promoting 
properties because of their anti-inflammatory effects (O’Callaghan and van Sinderen 
2016). In the ileum Allobaculum, a butyrate producer (Donohoe et al. 2011), is lower in 
abundance in adult CR mice, however it is higher in aged mice.  In the colon, where most 
of the butyrate is produced, Allobaculum is found to be increased in aged CR mice. 
Lactobacillus are upregulated and Clostridiaceae downregulated in both the small 
intestine and colon at all timepoints.   
 
The observed decrease in secondary bile acids indicates a decrease in BSH activity, a 
microbial enzyme present in the gut responsible for conversion of primary to secondary 
bile acids (Ridlon et al. 2014). BSH activity has been shown in bacteria belonging to the 
phyla Firmicutes, Bacteroidetes and Actinobacteria (Jones et al. 2008). Interestingly, both 
the Lactobacillus and the Bifido genera are known for their BSH activity. However, the 
microbiota is a complex mixture of bacteria, and the BSH enzyme is distributed across the 
major species (Ridlon et al. 2014). In germ-free mice inoculated with bacteria with and 
without BSH activity, BSH has been linked to a decrease in weight gain (Joyce et al. 
2014). However, the decrease in secondary bile acids in our case is mostly due to a 
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decrease in deoxycholic acid (DCA), a secondary bile acid that has been linked to obesity 
and cancer in mice (Yoshimoto et al. 2013). We show here for the first time, that long 
term CR might decrease BSH activity in the small intestine. However, more research will 
be needed to confirm this and elucidate the health consequences of this mechanism.  
 
BSH activity and nutritional regulation of BSH has previously been shown to increase 
FXR activity and thereby Fgf15 expression (Sayin et al. 2013b; F. Li et al. 2013). In the 
current study, it is difficult to link the differences in the microbiota directly to the changes 
in bile acid metabolism since the microbial alterations proceed the changes in bile acid 
metabolism. No direct correlations were found between the microbial changes and the 
expression of Fgf15 (data not shown), however this does not exclude a role for the 
microbiota. We hypothesize that CR influences bile acid metabolism via a complex 
interaction between hepatic, intestinal and microbial mechanism. More research will be 
needed to elucidate the molecular mechanism.  
 
In conclusion, very long-term CR decreases the amount of bile acids in the ileum which 
leads to a reduction in Fgf15 expression.   





Chapter 7. General Discussion 
Thesis Britt Blokker  
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7.1 Discussion  
In this thesis, a novel regulation of the important gut hormone Fgf15 is described. To the 
best of our knowledge, this is the first time it has been shown that dietary changes are 
capable of regulating Fgf15 expression independently of the microbiota. Starch digestion 
in the ileum, most likely via GlcNAcylation of the transcription factor FXR, induces the 
expression of Fgf15. Additionally, soluble fibres are capable of repressing its expression, 
hypothetically this might be caused by a reduction of starch hydrolysis and glucose uptake 
in the ileum.  FGF15/19 has been linked to a large variety of health effects, including a 
decrease in weight gain in response to a HF diet (Fu et al. 2004) and the prevention of 
and/or a possible cure of  NAFLD (Harrison et al. 2018). Purely for the sake of inducing 
Fgf15 expression, a high starch low fibre diet would be ideal. However, this thesis also 
outlines the negative health effects of such a diet, showing dysregulations in the gut-liver 
axis that in our mouse model eventually leads to the development of hepatic carcinoma in 
a subset of mice. Lastly, a decreased consumption of this diet in a CR model, counteracts 
most of these negative health effects and additionally in the long term downregulates the 
expression of Fgf15 in the ileum.  
 
Speculative relevance of Fgf15 regulation by glucose  
In this thesis, Fgf15 expression was shown to be induced after ileal exposure to glucose. 
This could be biologically relevant because of the postprandial effects of FGF15/19 on 
glucose metabolism. Glucose, under normal physiological conditions, only reaches the 
ileum when the small intestine is overloaded with either starch or glucose. However, the 
Western style diet, which is becoming increasingly and widely adopted across the world, 
contains an excess of refined carbohydrates. Similarly to our findings, digestible starch 
has shown to reach the colon in mice fed a similar HS diet (Lange et al. 2015) indicating 
that overloading the capacity of duodenum and jejunum to digest starch and to resorb 
glucose leads to ileal starch exposure. Potthoff et al showed that Fgf15 acts subsequently 
to insulin to decrease blood glucose levels by regulating the hepatic CREB-PGC1 
signalling cascade (Potthoff et al. 2011), a pathway that we also show to be affected by 
the glucose-induced Fgf15 expression (appendix 3). Additionally, in humans circulating 
FGF19 has been shown to increase after the consumption of glucose (Morton et al. 2014; 
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Matysik et al. 2011) Thus, the induction of FGF15/19 due to glucose reaching the ileum 
could potentially help the body deal with a high postprandial glucose load.   
 
Is starch or sucrose responsible for the increase in Fgf15? 
In chapter 3, ileal glucose absorption was shown to induce Fgf15 expression, presumably 
from the digestion of starch. However, the HS diet also contains 3-fold more sucrose 
compared to the chow diet. Nonetheless, the starch content of the diet is held responsible 
for the increase in Fgf15 expression for two reasons. Firstly, in chapter 5, the gene 
involved in the conversion of fructose to glucose, Fbp1, is shown to be upregulated in the 
duodenal part of the small intestine. This indicates that fructose, and hence the sucrose, is 
taken up in the proximal and middle part of the small intestine. Secondly, when the 
improved HS diets were designed, the HS low sucrose diet one diet was identical to the 
original HS diet except for its sucrose content. Thirdly, a high fat purified diet with the 
same sucrose concentration but lower starch content led a similar Fgf15 expression as 
chow diet. In chapter 4, this low sucrose HS diet induce the expression of FGF15 almost 
15-fold, indicating that the starch but not sucrose was responsible for the induction of 
FGF15.  
 
Possible alternative modes of regulation of FGF15/19 
Although in this thesis Fgf15 expression seems to be increased by activation of the 
transcription factor FXR, other factors could also influence its regulation. As mentioned 
in section 1.5.2 of the introduction, FGF15/19 expression is regulated through multiple 
pathways. One major pathway involved in the regulation of FGF15/19 is via vitamin A. 
This activation pathway is dependent of FXR as shown in FXR knockout mice (Schmidt 
et al. 2010). In chapter 5 of this thesis, we discussed that the HS diet leads to a disturbance 
of vitamin A uptake in the small intestine. This was also found by Goverse et al 
demonstrating that vitamin A absorption was dependent on SCFA production in the small 
intestine (Goverse et al. 2017). This is partly confirmed in chapter 5 of this thesis, as we 
demonstrated that adding soluble fibres to the diets restores Bco1 expression in the 
jejunum, a marker for vitamin A metabolism. Additionally, after treatment with 
antibiotics, Bco1 was upregulated in both the chow and HS fed animals (data not shown). 
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It is this dependency on the commensal microbiota and possibly their metabolites which 
uncouples vitamin A metabolism from Fgf15 expression in our models. After depletion of 
the microbiota by broad-spectrum antibiotics, Fgf15 expression was still differentially 
regulated between diets and could additionally continue to be downregulated by adding 
the highly fermentable soluble fibre FOS in combination with a broad-spectrum antibiotics 
treatment.  
Furthermore, Fgf15 expression can be regulated indirectly via the transcription factor 
PPAR (Zhou et al. 2014), or  Diet1 (Vergnes et al. 2013) and by circadian rhythms under 
the control of KLF15 (Han et al. 2015). While these factors may play a role in the 
regulation of Fgf15 in our models, the results suggest that FXR is the most prominent 
regulator. The potential effects of circadian rhythms were avoided as much as possible by 
sacrificing all mice in the morning, between 8am and 12pm. Furthermore, no difference 
was found in the gene expression of Diet1 in the ileum of chow and HS fed mice as tested 
by Q-PCR (data not shown). Lastly, while the expression of PPAR target genes was 
found to be downregulated by the HS diet in particular in the proximal and middle part of 
the SI (chapter 5), no obvious improvements of PPAR activity, as measured by target 
gene expression, could be found when fibres were added to the HS diet. In conclusion, 
although we cannot exclude other possible factors, here we demonstrate that in response 
to the HS diet the regulation of Fgf15 is most likely coordinated by FXR.   
 
Health effects of dietary fibres: new mechanism?  
As discussed in chapter 4 and 5 of this thesis, consumption of dietary fibres has been 
indisputably linked to improved health in humans (Kendall, Esfahani, and Jenkins 2010) 
for numerous reasons (see introduction). Here we show a potential new mechanism by 
which dietary fibres increase metabolic health, and additionally the less well understood 
role of dietary fibres for the small intestine is uncovered. In chapter 4, soluble fibres (FOS, 
inulin, pectin and fibersol) were shown to decrease the expression of Fgf15. This decrease 
could influence the conversion of cholesterol to bile acids via increased hepatic Cyp7a1 
expression, and may contribute to the known cholesterol-lowering properties of soluble 
fibres (Brown et al. 1999; Han et al. 2015b; Gunness et al. 2016). Cyp7a1 overexpression 
has previously been shown to reduce blood cholesterol levels (Li et al. 2011). This finding 
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could potentially also be of importance for the treatment of bile acid diarrhoea (BAD), 
since under these conditions increasing FGF15/19 is desirable (Walters 2014). Although 
more research will be needed to determine the relative significance in humans, a low fibre, 
high starch diet could potentially benefit BAD patients. Current dietary recommendations 
for BAD patients are to follow a low-fat diet, while no consistent recommendations on 
fibre intake are currently available (Jackson et al. 2017).  
Despite this being a very exciting new mechanism by which soluble fibres potentially 
lower cholesterol levels, it remains partly unclear how soluble fibres influence the 
expression of Fgf15. In chapter 4, we hypothesized that soluble fibres delay the uptake of 
glucose, possibly through the delay of the digestion of poly-, oligo- and disaccharides by 
blocking the activity of numerous -glucosidases. While more research is needed to 
confirm this (see future prospects), others have suggested similar mechanisms for inulin 
(Neyrinck et al. 2016). Although finding this mechanism was not our aim, more research 
on this subject may elucidate a new role for soluble fibres in controlling blood glucose 
levels. Additionally, the delay in digestible carbohydrate uptake could influence the 
microbiota in both the small and large intestine (Lange et al. 2015), leading to additional 
health effects.  
Although finding one of the potential mechanism of how soluble fibres decrease 
cholesterol levels is exciting, this might not influence current practice for the healthy 
population. In the UK, the current dietary guidelines advise 30 grams of fibres (SACN 
2015) however the majority of the population does not reach this recommended amount. 
The results in this thesis do not show reason to change these recommendations, however 
might emphasize the importance of the consumption of dietary fibres, in particular soluble 
fibres.       
 
The HS diet as a research model 
Overall in this thesis, different advantages and disadvantages of a semi-purified HS diet 
have been revealed. Interestingly, the HS diet does not change the body weight of the mice 
compared to mice fed a standard chow diet. This potentially makes the HS diet an 
extremely interesting research model to investigate the role of nutrition on gut-liver health 
without the interference of increased weight gain and development of obesity. Obesity has 
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been linked to elevated levels of C-reactive protein in a meta-analysis of 51 cross-sectional 
studies (Choi, Joseph, and Pilote 2013), indicating systemic low-grade inflammation. This 
has been linked to the changes in both gut microbiota composition and intestinal 
permeability (Cox, West, and Cripps 2015). However, low-grade systemic inflammation 
during obesity is also influenced by inflammation of expanding adipose tissue (Maachi et 
al. 2004). The HS diet provides an opportunity to investigate the health impact (e.g. effects 
on liver health) of an altered microbiota as well as long-term and prolonged intestinal 
permeability without the interference of the expanding adipose tissue.  
While on one hand this is mechanistically very interesting, it might also be relevant for 
human biology. The presence of NAFLD or NASH in the absence of an increased BMI 
has been named “lean NASH” and has been encountered in both Asia and the Western 
world, however its prevalence remains unclear (Das and Chowdhury 2013).  While some 
genetic mouse models for NAFLD, like Srebp-1c KO mice, also develop NAFLD without 
developing obesity (Takahashi, Soejima, and Fukusato 2012), these models might be less 
suited for nutritional research. As opposed to pharmacological research, nutrition 
provokes modest effects, and is often more suited for prevention. A mild model that over 
time leads to the development of NAFLD without the interference of obesity, like the HS 
diet, might be ideal for nutritional research. Adding bioactive food components or 
replacing ingredients from the diets to prevent or even improve the detrimental liver 
phenotypes could potentially have a large contribution to our knowledge on the biological 
effects of nutritional components and would also allow evidence-based strategies to 
reformulate ultra-processed convenience foods that are frequently consumed by the UK 
population.  
 
From this thesis, information about the HS diet phenotype can be drawn (see table 7.1). In 
summary, the HS diet has been found to increase the incidence of both NAFLD and liver 
cancer in mouse models. Adding soluble fibres to the diet can partly prevent the 
development of early stage NAFLD but longer experiments are needed to investigate its 
beneficial effects on hepatic cell proliferation and the development of liver cancer. Since 
the development of hepatic carcinoma has previously been linked to increased FGF15/19 
signalling (Uriarte et al. 2015; Alvarez-Sola, Uriarte, Latasa, Urtasun, et al. 2017), and 
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soluble fibres decrease the expression of Fgf15 (chapter 4), a decrease in hepatic 
carcinoma development is hypothesized on the long term. Furthermore, liver phenotypes 
have been shown to significantly improve when the HS diet is consumed in a caloric 
restricted way which is shown in CR mice (Rusli et al. 2017).  
When looking at the small intestinal microbiota the switch between phyla from 
predominantly Bacteroidetes in chow fed mice to mostly Firmicutes in HS fed mice is 
well-defined, and has recently been shown to also be true for the colonic faecal microbiota 
by others (Dalby et al. 2017). In this thesis it is shown that the small intestinal 
Bacteroidetes: Firmicutes ratio can be increased by adding soluble fibres to the HS diet, 
but not solely by limiting the intake of calories of this diet.  
 In line with this finding, vitamin A metabolism seems to improve in response to the 
addition of soluble fibres (chapter 5). This is in agreement with previous findings that 
vitamin A metabolism is dependent on the production of SCFA in the small intestine 
(Goverse et al. 2017).  The effects of CR on vitamin A metabolism remain unknown and 
require further investigation.  
Gene expression of many important metabolic and immune-related pathways in the small 
intestine are also differential regulated between chow and HS fed mice. For example, AhR 
signalling is downregulated in HS fed mice. Activity of the AhR, as measured by the 
expression of its target gene Cyp1a1, could not be increased by either adding soluble fibres 
to the diet or decreasing caloric intake.  Furthermore, Glut2 expression (among other 
glucose uptake genes) was increased over the long term in the ileum of HS fed mice. Short 
term Glut2 was even further increased by adding soluble fibres, while CR normalized its 
expression. Lastly, as discussed in detail throughout this thesis, the HS diet increased the 
expression of Fgf15 in the ileum. This could be decreased by adding soluble fibres to the 
diet and additionally in the long term via CR.   
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Table 7.1 Summary of the effects of the HS diet on obesity and the gut-liver axis. Additionally, the 
effects of adding soluble fibres or limiting the caloric intake on the HS diet are summarized.  
 
 
Using mice as a model for humans in bile acids research 
Current knowledge on bile acids in enterohepatic circulation is largely extrapolated from 
animal experiments, with rodent studies being the most prominent (Rudling 2016). 
However, there are several large differences between bile acid metabolism of humans and 
rodents which are important to recognize. One important difference is that in rodents bile 
acids are hydroxylated at the 6- position to form muricholic acids (MCAs), which is 
unique to rodents (Takahashi et al. 2016). It has been discussed previously, that in germ-
free conditions, the bile acid T--MCA reaches the ileum and antagonizes FXR to 
decrease Fgf15 expression (Sayin et al. 2013b).  However, since no MCAs are present in 
humans, it is not known how this mechanism may be relative in a human context. 
Importantly, antibiotic treatment has also shown to decrease circulating FGF19 in humans 
(Vrieze et al. 2014), possibly via a very similar mechanism involving UDCA (Mueller et 
al. 2015).  
  
Another important different lies in the fact that mice are one of several species that are 
known to eat their own faeces, a behaviour called coprophagy (Negro et al. 2002; 
Torrallardona, Harris, and Fuller 1996). Coprophagy can have major effects on the 
metabolism of different compounds, among which are bile acids. Bile acids that escape 
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reabsorption in the ileum are exposed to the large number of microbiota present in the 
caecum and colon. This leads to both deconjugation and the formation of secondary bile 
acids. In the case of coprophagy, these bile acids re-enter the circulation via the small 
intestine. Groen et al have showed that in the case of cholic acid feeding, the observed 
increase in circulating DCA is due to coprophagy. Importantly, they also show that in wild 
type mice on a chow diet, coprophagy has very little effect on circulating bile acids 
(Annemiek Groen, Cindy Kunne, and Elferink 2006). Coprophagy can be avoided by 
housing mice in metabolic cages, where due to a metal grate floor mouse are unable to eat 
faeces. Unfortunately, under UK regulations and due to limitations in the animal licenses 




We, in chapter 5 of this thesis, and others (Pellizzon and Ricci 2018) have discussed the 
multitude of differences between chow and semi-purified diets, however, in this thesis 
these diets are compared. To circumvent this, we attempted to isolate the effects of the 
separate ingredients. For example, by inhibiting starch digestion by adding acarbose in 
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7.2 Future prospects 
Human relevance  
In this thesis, dietary regulation of Fgf15 expression is shown in a mouse model and 
although there are indications that glucose is also capable of regulating FGF19 in humans 
(Morton et al. 2014), more research is required to determine its relevance in humans. 
Circulating FGF19 in humans can be measured via sandwich enzyme-linked 
immunosorbent assays (ELISA) from blood samples. A small human study where blood 
samples are taken postprandially after the consumption of a high starch, low fibre meal 
could confirm the rise of FGF19. As a control, a meal with a lower glycaemic index, 
replacing the simple carbohydrates by fat, could be used.  
Furthermore, a slightly longer study, where participants receive the diets for a week, would 
be advisable to pinpoint the effects of soluble fibres on circulating FGF19 in humans. A 
low fibre diet containing substantial amount of digestible starch (for example in the form 
of white rice) should be compared with a diet containing more sources of soluble fibres 
(for example supplemented with inulin).  
Because of the low amounts of sample needed to confirm the mechanism there might be 
an opportunity to use samples from existing human intervention studies, however it should 
be considered that blood samples need to be taken in the non-fasted state. Postprandial 
FGF19 levels, compared to fasted levels, have previously been shown to be more effective 
in the case of diagnosing BAD (Borup et al. 2015). Importantly, Matysik et al (Matysik et 
al. 2011) hypothesize that FGF19 found in the circulation is merely the “tip of the iceberg” 
of the FGF19 produced in the ileum, assuming a rapid and efficient transport from the 
ileum to the liver. It is important to emphasize that circulating FGF19 most have escaped 
the gut liver axis, as usually the FGF19 produced in the ileum is directly transported to the 
liver via the portal vein. So even though these studies are relatively simple and realistic 
they might not give all the needed answers.  
 
In order to really investigate how dietary patterns influence FGF19 expression in humans,  
ileal tissue samples are needed. Although more difficult to obtain, new techniques are 
being developed in the form of pills that measure in vivo in the human gastro-intestinal 
tract (Kalantar-Zadeh et al. 2018). Currently, the technique is optimised for measurements 
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as pH, however it is not unimaginable that in the future similar pills wills be able to take 
small samples of intestinal tissue.  Since only small amounts of tissue are needed for gene 
expression analysis this could in the future be used to study the expression of FGF19. 
First, a confirmation of the increase of FGF19 expression after a high starch and/or glucose 
diet as opposed to a high fat diet should be confirmed (Morton et al. 2014), after which 
the effect of the addition of soluble fibres to the high starch diets could be investigated.  
 
GlcNAcylation of FXR  
In chapter 4 it is hypothesized that Fgf15 expression is increased in the ileum of HS fed 
animals because of GlcNAcylation of FXR. To confirm this, both in vitro or in vivo 
experiments should be performed. The main challenge with in vitro experiments is the 
lack of relevant cell lines, however this could be circumvented by the use of primary cells. 
Primary cells isolation of the ileum could be performed as described (Graves et al. 2014), 
from mice on a chow background. Consequently, the primary cells should be incubated in 
high and low glucose medium in the presence or absence of the bile acid CDCA. CDCA 
is a very potent FXR agonist (Bramlett, Yao, and Burris 2000). If GlcNAcylation of FXR 
leads to an increase in Fgf15 expression, Fgf15 expression should be significantly 
increased in the CDCA stimulated high glucose group compared to the CDCA stimulated 
low glucose group. Because GlcNAcylation only stabilised the protein does not activate 
it, no difference in expression of Fgf15 is expected in the non-stimulated groups.  
Additionally, in vivo experiments can confirm an overall increase is GlcNAcylation. 
Based on a previous publication where hepatic FXR has been shown to be glycosylated 
(Berrabah et al. 2014), this can be investigated by using a combination of both western 
blotting and immunoprecipitation of using sWGA-agarose beads. In vivo more 
GlcNAcylation should be expected in the ileum of mice fed the HS diet.  
 
Effects of dietary fibres on the gut-liver axis 
Based on the result presented in chapter 4 and 5 of this thesis, the soluble fibres inulin, 
pectin and fibersol can counteract some of the adverse health effects provoked by the HS 
diet. In order to further explore the effects that the fibres have on the gut-liver axis, longer 
feeding experiments with these diets would be recommendable. As discussed, the HS diet 
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is a mild model, however it leads to development of relatively extreme liver phenotypes 
and increased intestinal permeability over time. To investigate if soluble fibres can prevent 
this, 6 months of feeding these diets would be advisable. After 6 months, outcome 
measurements should include liver phenotyping via histology, intestinal permeability 
measurements via FITC dextran, bile acids in the ileum and serum, microbiota 
determination via 16S sequencing and gene expression in both the intestine and liver.  
 
The impact of dietary soluble fibres on small intestinal glucose metabolism and uptake 
As discussed previously in this chapter, during this thesis we encountered a potentially 
very interesting new way of action for soluble fibres. We, in line with others (Neyrinck et 
al. 2016), show that soluble fibres potentially inhibit -glucosidases relevant e.g. for 
starch and sucrose hydrolysis in the small intestine. However, further research is required 
to elucidate this mechanism in detail. So far, we have presented gene expression data to 
support this theory, however activity measurements of the -glucosidases along the course 
of the small intestine (duodenum, jejunum and ileum) would provide more information. 
A ex-vivo method for activity measurements in the mucosa has been described by 
Dahlqvist (Dahlqvist 1968) and has been improved by Oku et al (Oku et al. 2014). As a 
positive control Acarbose should be included into the protocol of the experiment. 
Additionally, broad-spectrum metabolomics on all parts of the small intestine will give a 
better understanding of the digestion of carbohydrates from stomach to colon.  
Additionally, in vitro models could help untangling the mechanism. Due to the previously 
discussed lack of commercially available small intestinal cells line, primary cells culture 
would be advisable. Again using Acarbose as a positive control for the inhibition of -
glucosidases, the amount of glucose produced from oligo- and disaccharides in the 
presence or absence of soluble fibres could potentially be used as the outcome 
measurement, as described here (Neyrinck et al. 2016).  
 
Vitamin A metabolism in the small intestine  
In chapter 5 of this thesis vitamin A dysregulation in response to the HS diet is discussed. 
Others have shown that for optimal absorption of vitamin A, SCFA are needed in the small 
intestine (Goverse et al. 2017). While the results presented in this thesis support the need 
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of the small intestinal microbiota, further research might reveal this mechanism in more 
detail. So far, we have shown that in the HS diet vitamin A metabolism is dysregulated in 
the small intestine and that this can be at least party be prevented by adding soluble fibres 
to the HS diet, as shown by the expression of Bco1. Additionally, antibiotics treatment 
further dysregulated the uptake of vitamin A. However, the production of SCFA in the 
small intestine is relatively low so potentially other metabolites produced by the 
microbiota maybe also involved. Broad-spectrum metabolomics on the duodenal and 
jejunal content of mice fed a chow, HS and HS with added fibre diet could provide some 
candidates. Furthermore, a microbial transplant from HS to HS with added fibres mice 
and vice versa could provide mechanistical prove that the microbiota is responsible for the 
regulation of vitamin A metabolism in the small intestine.  
 
Bile acid metabolism under long-term CR  
While we were very grateful for the opportunity to study bile acid metabolism in the long-
term CR study IDEAL (chapter 6), some of the mechanisms by which CR influences bile 
acid metabolism and the bile acid pool size remain uncertain. If at all possible, measuring 
bile acid in the serum of these animals would add valuable information. Measuring 
circulating bile acids will provide information about how the change in bile acids is 
affecting other organs, outside of the liver and intestine.  
Furthermore, it would be extremely interesting to investigate the role of the microbiota in 
the changes in bile acid metabolism. However, due to the long-term studies to simulate 
ageing to observe the effects, eradicating the microbiota by broad-spectrum antibiotics 
might not be possible. An alternative could be to perform an inoculation experiment with 
the microbiota of mice that have been on the HS and CR diet for at least 12 months. 
Inoculation can take place in antibiotic treated mice, as described here (Ellekilde et al. 
2015). Although in chapter 6 it is discussed that the microbiota changes precede the 
changes in bile acids, this is only for the microbiota part that can be characterize by 16S 
sequencing. During inoculation the entire microbiota is transplanted, including 
metabolites produced by the microbiota, fungi and archaea. Investigating the effects of 
transplanting microbiota into a healthy host mouse after antibiotic depletion of the intrinsic 
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microbiota, could provide us with additional mechanistic information about the ways in 
which CR influences the gut-liver axis.   
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Appendix 1 Dietary composition 
The diets low and high fat diets used in our murine study came from Research Diets. 
Below you can find the composition of these diets. For a full description of the vitamin 
and mineral mixes used see http://www.researchdiets.com/open-source-diets/stock-
diets/dio-series-diets.  
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In our murine studies a control group was put on the standard chow diet used in the Disease 
Modelling Unit of the University of East Anglia (SDS diet RM3, Dietex international, 
UK).  
 
PhD thesis Britt Blokker 227
Appendix 2 Bile acid standards, LC-MS conditions and mass fragmentation 
monitoring values for bile acid measurements 
 
Bile acid standards: d4 Internal standards 
Each d4 internal standard is prepared at 1 mg/ml in MeOH 
Prepare 5 solutions of these all at 40 µg/ml by taking 400µl of each stock standard to 10 












Each bile acid is prepared at 1 mg/ml in MeOH and stored refrigerated. 
A 10 µg mix of the BAs is prepared in 70% MeOH by taking 100 µl of each individual 
bile acid (at 1 mg/ml) into a pooled vial and making to 10 ml total volume. Make all to 
total volume of 500µl with methanol. 
Std (ng/ml) Vol (µl) Of what std Make up vol 
(µl) (MeOH) 
Notes 
4000 200 10 µg/ml mix 300  
2000 100 10 µg/ml mix 400  
1000 50 10 µg/ml mix 450 Prep x 2 
500 25 10 µg/ml mix 475  
200 10 10 µg/ml mix 490  
100 50 1000 ng/ml mix 450 Prep x 2 
25 12.5 1000 ng/ml mix 487.5  
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15 75 100 ng/ml mix 425  
10 50 100 ng/ml mix 450  
5 25 100 ng/ml mix 475  
0 0 - 500  
 
Then to each of these, add 25µl of d4-Int Std mix #5 (40 µg/ml) to give 2000 ng/ml each. 
LC-MS 
Conditions 
Column: Supelco Ascentis Express C18 150 x 4.6, 2.7µm 
Flow: 600 µl/min 
Mobile phase A: Water + 5mM Amm. Ac + 0.012% Formic acid 
Mobile Phase B: Methanol + 5mM Amm. Ac + 0.012% Formic acid 
Inj: 5µl 
Column: 40°C 
Mobile phase preparation 
In one litre of MeOH or Water: 
5 mM Ammonium Acetate = 0.385g 










Source Conditions (negative mode) 
SOURCE  
CUR:  25 
TEM:  550 
GS1:  40 
GS2:  50 
ihe:  ON 
CAD:  -2 
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ID Q1 Q3 Dwell DP CE RT 
LCA 375.3 375.3 20 -90 -10 22.70 
CDCA 391.3 391.3 20 -120 -10 20.85 
DCA 391.3 391.31 20 -120 -10 21.17 
HDCA 391.3 391.32 20 -120 -10 18.29 
MCA 391.3 391.33 20 -120 -10 16.57 
UDCA 391.3 391.34 20 -120 -10 17.52 
a-MCA 407.3 407.3 20 -120 -10 15.93 
b-MCA 407.3 407.31 20 -120 -10 16.29 
CA 407.3 407.32 20 -120 -10 18.89 
GLCA 432.3 432.3 20 -80 -10 19.77 
GCDCA 448.3 448.31 20 -80 -10 17.72 
GDCA 448.3 448.32 20 -80 -10 18.28 
GCA 464.3 464.3 20 -80 -10 15.70 
TLCA 482.2 482.2 20 -130 -10 19.19 
TCDCA 498.3 498.3 20 -130 -10 17.10 
TDCA 498.3 498.31 20 -130 -10 17.64 
T-a-MCA 514.3 514.3 20 -130 -10 10.81 
T-b-MCA 514.3 514.31 20 -130 -10 11.06 
TCA 514.3 514.32 20 -130 -10 15.08 
       
d4-LCA 379.3 379.3 20 -90 -10 22.70 
d4-CDCA 395.3 395.31 20 -120 -10 20.83 
d4-DCA 395.3 395.3 20 -120 -10 21.13 
d4-CA 411.3 411.3 20 -120 -10 18.86 
d4-GCA 468.4 74 20 -80 -40 15.71 
       
P lipid query 153 153 20 -130 -10  
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Qualifiers 
ID Q1 Q3 Dwell DP CE RT 
GLCA 432.3 74 20 -80 -40 20.59 
GCDCA 448.3 74.11 20 -80 -40 18.31 
GDCA 448.3 74.12 20 -80 -40 18.93 
GCA 464.3 74 20 -80 -40 16.03 
TCDCA 498.3 80.1 20 -130 -60 17.33 
TDCA 498.3 80.11 20 -130 -60 17.87 
T-a-MCA 514.3 80.1 20 -130 -60 10.68 
T-b-MCA 514.3 80.11 20 -130 -60 11.02 
TCA 514.3 80.12 20 -130 -60 15.12 
TLCA 482.2 80 20 -130 -60 19.57 
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Appendix 3. Oral gavage of glucose leads to a time dependent increase of Fgf15 
expression in the ileum and corresponding hepatic glucose regulation. 
 
Appendix 3 Oral gavage of glucose leads to a time dependent increase of Fgf15 expression in the ileum 
and corresponding hepatic glucose regulation. Mice received a glucose load of 2g / kg BW via oral gavage 
(OG) and two mice per time-point were sacrificed at 0, 30, 60, 90 and 120 minutes after OG, blood glucose 
was measured at all time points and additionally at 15 minutes via a tail prick (A). Blood glucose shows an 
initial increase and consequent normalization after glucose OG (B). Ileal Fgf15 expression increases 90 
minutes after the glucose OG (C), while hepatic Cyp7a1 decreases (D). Hepatic glucose metabolism genes 
known to respond to FGF15/19 decrease in expression after 90 minutes, correlating with the increase in 
Fgf15 expression (E). Due to the low number of mice no statistical analysis could be performed. 
